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Polyamides containing N-methylpyrrole (Py), N-methylimidazole (1m) and 3-
hydroxy-l-methylpyrrole (Hp) are cell permeable small molecules that bind as 
antiparallel pairs in the minor groove of DNA according to a set of "pairing rules" with 
affinities and specificities for predetermined sequences comparable to DNA-binding 
proteins. Several of these ring pairings have only been demonstrated when placed internal 
in a hairpin and not for the terminal position in hairpin polyamides. Several series of 
eight ring hairpin polyamides with modification at the N-terminal position were 
synthesized and characterized. We observed that at the terminal position (i) the Py/Py 
pair functions similar to when placed internally preferring A-T and T-A base pairs over 
O-C and C-O, (ii) the Hp/Py pair could not distinguish between T-A over A-T possibly 
due to rotation of the terminal Hp to form an intramolecular hydrogen bond between the 
3-hydroxyl hydrogen and the carboxamide oxygen which would orient the key hydroxyl 
recognition element away from the minor groove. A new aromatic pair, 2-hydroxy-6-
methoxybenzamidell-methylpyrrole was designed and shown to distinguish T-A from 
A-T base pairs and both from O-C/C-O and (iii) the Py/lm pair in the classic eight ring 
hairpin motif showed no preference for C-O base pair possibly due to the mispositioning 
of the 1m residue located at the C-terminal end of the four ring polyamide subunit. 
Targeting of C-O was accomplished by replacing a pyrrole with a flexible ~-alanine and 
setting the imidazole back in register. 
Pyrrole-imidazole polyamides that target DNA sequences in the promoter have 
been shown to inhibit transcription of specific genes in cell culture. When bound to 
coding region of genes, polyamides do not appear to inhibit gene expression. A possible 
solution is to design molecule capable of modifying DNA when bound to the coding 
v 
regIOn. A series of polyamide-camptothecin conjugates were designed to trap the 
enzyme Topoisomerase I and induce cleavage at predetermined DNA sites. Cleavage 
yields were shown to be dependent on linker length between the DNA binding polyamide 
and the Topo I trapping camptothecin unit with the camptothecin unit with the longest 
linker showing greatest cleavage yield of over 90%. 
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Double helical DNA 
Deoxyribonucleic acid (DNA) is the medium found in Nature to carry the genetic 
blueprint of life. DNA is composed of two antiparallel oligodeoxyribonucleic strands 
associated by hydrogen bonds between the four bases adenine (A), thymine (T), cytosine 
(C), and guanine (G).l The common B-form DNA is characterized by a wide and shallow 
major groove and a narrow and deep minor groove (Figure 1.1).2 Sequences are 
distinguishable by the pattern of hydrogen bond donors and acceptors displayed on the 
edges of the base pairs and this hydrogen bond display dictates the pairing of the bases 
such that A pairs with T and G pairs with C (Figure 1.2). 
The successful completion of the human genome project has revealed that our 
genetic information, stored as DNA polymers, consists of three billion bases that code for 
25,000 to 30,000 genes. 3 Specific classes of proteins such as repressors and activators 
interact with DNA to control gene expression (Figure 1.3). Misregulation of gene 
expression is responsible for numerous cancerous and viral disease states. Small synthetic 
molecules that bind to specific DNA sequences could be useful as artificial transcription 
factors to regulate gene expression. 
DNA Recognition. 
Structural studies of naturally occurring protein DNA complexes have provided 
insights into designing novel DNA binding molecules. Protein:DNA interactions are 
characterized by hydrogen bonds, van der Waals interaction and electrostatic interactions. 
Nature has devised a combinatorial approach for DNA recognition utilizing a twenty 
amino acid code to form complex tertiary folded structures. Examples of DNA binding 
protein motifs include, zinc fingers, leucine zippers, and the helix turn helix motifs 
2 
3' 5' 
Figure 1.1. B-form double helix DNA. Antiparallel strand are in dark and light grey. (left) space filling 




Minor Groove Minor Groove 
5' 3' 
Figure 1.2. A schematic model of recogmtIOn of the minor groove, with hydrogen bond alone 
representative on (H) and hydrogen bond acceptors as two dots. 
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(Figure 1.4).4 Within these complexes, specificity for target sites IS achieved by 
noncovalent interactions between the protein side chains, and the nucleobases and 
phosphates of the DNA. Due to the complexity of protein-DNA interactions, the design 
of proteins for the recognition of predetermined target has been challenging. A promising 
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Figure 1.3. Model of protein regulation of gene expression. Initiation of gene expression requires a 
combinatorial assembly of transcription factors. 
Besides proteins, small molecules isolated from Nature form another class of 
DNA binding ligands. Some examples include chromomycin, distamycin, actinomycin 
D, and calicheamicin oligosaccharide (Figure 1.5).6 These molecules bind either in the 
minor groove or intercalate through the bases. The structural simplicity of distamycin 
made it an attractive starting point for the design of sequence specific DNA binding small 
molecule. Distamycin consists of three N-methyl carboxamide units and netropsin 
consists of two N-methyl carboxamide units. The crescent shaped molecules bind in the 
minor groove of DNA at A-T rich regions. 
An early goal in the Dervan group was to expand the sequence targeted by 
distamycin in order to bind G·e base pairs.7 Various heterocycles were attached to the N-
terminal position of distamycin to recognize the sequence 5'-WGWWW-
4 
Figure 1.4. X-ray crystal structures from several families of DNA binding proteins. Proteins can contact 
DNA via interaction with the bases in the major and minor grooves as wells as the sugar phosphate 
backbone. 
Chromomycin ' 5' -GGCT-3 ' 
Actinomycin D ' 5' -GC-3 ' 
Nft 
H}- ~ ,/Nft 
° h~ H~O 
~N~ 'O-{~~, 
\ 
Distamycin · 5'-(A,Tk3' 
Calicheamicin oligosaccharide ' 5'-TCCT-3' 
Figure 1.5. Chemical structures of natural products that bind DNA. 
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3' where W = A or T. Footprinting experiments unexpectedly showed 2-imidazole 
netropsin bound to the sequence 5'-WGWeW-3'. The twofold symmetry of the binding 
site was puzzling until NMR structural studies in collaboration with the Wemmer Group 
showed that at high concentration, distamycin could bind as a 2: 1 complex rather than a 
1: 1 complex (Figure 1.6).8 The binding of 2-imidazole netropsin to the site 5'-WGWeW-
3' as an antiparallel dimer allowed the development of a set of pairing rules for the 
recognition by N-methylpyrrole (Py), N-methylimidazole (1m) and N-methyl-3-
hydroxypyrrole (Hp) amino acids. 9 A Py/lm pair targets a e-G base pair while an ImlPy 
pair targets a G-e base pair. The basis for discrimination of a G-e base pair is from the 
formation of a hydrogen bond between imidazole N3 and the exocyclic amine of guanine. 
A Py/Py pair is partially degenerate and recognizes both A-T and T-A base pairs.lO High 
resolution NMR and crystal structures have confirmed that specific hydrogen bonds are 
made from the carboxamide nitro gens to the base pairs and the imidazole nitrogen to 
guanine. The use of Hp/Py and Py/Hp pairs for discrimination of T-A and A-T base pairs, 
respectively, completes the code. I I Specificity for A, T base pairs is accomplished by a 
5' 3' 
1:1 DistamycinoDNA Complex 2:1 DistamycinoDNA Complex 
Figure 1.6. A schematic representation of binding in the minor groove by distamycin in a 1: 1 and 2: 1 
complex. 
6 
hydrogen bond between 3-hydroxy of Hp and the second lone pair on the 02 of thymine, 
as well as a steric destabilization if Hp were placed over an adenine (Figure 1.7). 
The affinity of 2-imidazole netropsin is modest (micromolar range). To increase 
its affinity, two molecules of 2-imidazole netropsin were connected in a head to tail 
fashion with an alkyl linker. The resulting hairpin structure bound DNA with a 100-fold 
increase in affinity.12 Connecting the two distamycin like components allowed for the 
design of heterodimeric polyamides to target asymmetric sequences; for example, 
ImPyPy-y-PyPyPyDp bound the sequence 5'-WGWWW-3'. The development of a solid 
phase methodology to synthesize Py-Im polyamides has greatly facilitated the 
examination of other motifs.13 Extension of the binding site size has been achieved by 
addition of more rings to the hairpin or by covalently two hairpins to create a tandem 
structure (Figure 1.8). 
Application of Py-Im Polyamides in transcription regulation 
Py-1m polyamides have been shown to regulate gene expression. 14 In one case Py-
1m polyamides were designed to inhibit the binding of T AT A-binding protein (TBP) and 
LEF-I, two essential transcription factors that bind in the promoter region of HIV -1. 
Individually, each was shown to inhibit in vitro HIV -1 transcription between 60% and 
80%. However, together the two polyamides showed synergistic effects and reduced 
HIV -1 transcription to undetectable levels in cell culture. This experiment showed that 
Py-Im polyamides are capable of inhibiting transcription when rationally designed to 
target specific sequences. 
In a second case Py-Im polyamides are designed to activate instead of inhibit gene 
transcription. IS The polyamide ImPyPyPy-y-PyPyPyPy-P-Dp was coupled to a known 
transcriptional activator peptide. A promoter with six match sites for the polyamide-
peptide conjugate was placed 40 base pairs upstream from the TAT A box. Up to 40-fold 
activation of transcription was observed over basal levels with these conjugates. These 
7 
>)-<l::=::]\~o y A •• " .. H-Nr c=> Py/Im targets e-G 
'2!"C" """~~ 
~:'A" "':~_ c=> PylHp targets A·T 
'N"':_H .......... ~ ...• .. . ......... H60 c=> Py/Py targets A-T and T-A °:t;mr··;f ... :. . .............. H ;:,> 
-~i;~", "..,jJ, c=> HplPy targets T·A 
.; ••...•. H, A 0 c=> Im/Py targets G-e 
)00 \ 
5' 3' H-N}:" 
< H-r..:!: 
Figure 1.7. A schematic representation of the polyamide pair rules. 
5' - T G T A C A - 3' 5'-T G T TAT T G T T A-3' 
~
3'-A CAT G T- 5' 3'-A C A A T A A C A A 
6 bp 11 bp 
5'- T G T G A A C A - 3' 5'-A G G G A T T C C C T-3' 
~
3'-A CAe T T G T-5' 3'-T C C C T A A G G G A-5' 
8 bp 11 bp 
5'-A G C AGe T G C T-3' 5'-A T A AGe A G C T G C T T T T 
~~
3' - T C GTe G A eGA - 5' 3'-T A T T C G T C G A C G A A A A A-5' 
10 bp 16 bp 
Figure 1.8. Representative motifs for polyamide:DNA recognition. Open circles and filled circles represent pyrrole 
and imidazole rings respectively. ~-alanine and y-turm are depicted as diamonds and curved lines respectively. The 
plus sign represcnts the dimethylaminopropylamide tail of the a-amino-y-turn. 
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experiments show that polyamides can be used to manipulate a variety of transcriptional 
processes, and point the way to other experiments using small molecules that sequence 
specifically bind to DNA. 
Scope of this Work 
This first part of this thesis describes the development of new pairings at the terminus of 
polyamides to target a wider sequence variation with high affinity and specificities. A set 
of pairing rules has been developed to target all four base pairs. However, DNA 
recognition by several of these ring pairs can only be achieved when they are placed at an 
internal position in a hairpin rather than the terminal position in hairpin where "end 
effects" potentially alter molecular interactions necessary for specificity. Efforts to target 
T-A base pairs at the N-terminal position are described in chapters 2 and 3. Chapter 2 
describes the synthesis and binding studies of hydroxypyrrole (Hp) ring for the targeting 
of T-A base pairs. Chapter 3 describes the development of a new ring hydroxy benzoic 
acid (Hb) in place of hydroxypyrrole for the recognition of T-A base pair at the N-
terminus of polyamides. Efforts to target C-G base pairs using a pyrrole/imidazole are 
described in chapters 4 and 5. Efforts to target A-T base pairs are described in chapter 6. 
The second part of this thesis describes the design of polyamide conjugates to trap the 
endogenous enzyme Topoisomerase 1. Chapter 7 describes the design and synthesis of a 
camptothecin polyamide conjugate capable of sequence specifically trapping 
Topoisomerase 1. Chapter 8 describes the application of the camptothecin polyamide 
conjugate for the studies on gene repair in vivo. 
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Recognition of T-A Sequences at the N-Terminal 
Position by Hairpin Polyamides with 
Hydroxypyrrole / Pyrrole Pairs 
The text of this chapter was taken in part from a publication coauthored with Dr. Vlf 
Ellervik and Prof Peter B. Dervan. 
(Ellervik, u.; Wang, C. C. c.; Dervan, P. B. 1. Am. Chem. Soc. 2000, 122,9354-9360.) 
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Abstract 
In order to evaluate hairpin polyamides capable of distinguishing T-A/A-T base pairs at 
the terminal position, a series of hairpins with 3-hydroxy-l-methylpyrrole substituted at 
the 4-position by H, formamide and acetamide (Hp-l, Hp-2, Hp-3) were synthesized. The 
equilibrium association constants (Ka) were determined by quantitative DNase I footprint 
titration experiments for three pairs Hp-lIPy, Hp-2/Py, Hp-3/Py at four six base pair 
DNA sites, which differ at a common position 5'-TNTACA-3' (N=T, A, G, C). 
Remarkably only one pair Hp-3/Py afforded discrimination of T-A from A-T and with 
only modest sequence specificity. This study suggests that Hp/Py pairs may be limited 
within the hairpin motif to internal positions for T-A discrimination and there is a need 




Polyamides containing three aromatic amino acids, N-methylpyrrole (Py), N-
methylimidazole (1m) and 3-hydroxy-l-methylpyrrole (Hp), bind as antiparallel pairs in 
the minor groove of DNA with affinities and specificities for predetermined sequences 
comparable to DNA-binding proteins.} Im/Py pair binds G-C, while a Py/lm pair 
recognizes C-G. A Py IPy pair binds both A -T and T-A base pairs in preference to G-C 
and C-G. An Hp/Py pair prefers T-A over A-T, C-G or G-e. The T-A discrimination by 
Hp/Py pairs arises from a combination of specific hydrogen bonds with the thymine-02 
and shape selective recognition of an asymmetric cleft between the thymine-02 and 
adenine-C2.2 
Polyamide dimers linked by a y turn unit creates a hairpin structure which sets the 
ring pairs unambiguously in registeL 3 We have observed that hairpin polyamides with 1m 
at the N-terminal position usually have higher affinities than the corresponding Py 
analogs.} The placement of an 1m and Py in the first and eighth position of an eight-ring 
polyamide create an IrnlPy pair at the N- and C-terminal positions of the hairpin, biasing 
our choice of target DNA sequences beginning in a G-C base paiL} 
We would like to explore ring pairings that would allow the DNA sequence 
repertoire to be broadened wherein the target sequence begins with T or A. We have 
shown that Hp/Py pairs when placed internal in a hairpin distinguish T-A from A-T.4 
However, this has not been demonstrated for the terminal position in hairpin polyamides 
where "end effects" would potentially alter molecular interactions necessary for 
specificity. For example, the substituent at the 4-position of the N-terminal five-
membered ring is flanked in the minor groove by ~-alanine at the C-terminus. It is an 
important step forward in our gene regulation studies5 to be able to target DNA sequences 
in promoters beginning with A-T or T-A base pairs. 
We describe here a series of eight-ring polyamide hairpins with the general 
sequence XPyPyPy_(R)H2Ny-lmPyPyPy-~-Dp with the N-terminal position X= 3-
14 
hydroxy-l-methylpyrrole substituted at the 4-position with groups of increasing size H, 
formamide, acetamide (Hp-l, Hp-2, Hp-3) (Figure 2.1). 
<±l 
I O~H3 
° V~"1 I yo 
't;)NH ' N N _ A······" "--\ ------- ' ,-\ ~ --- - ---!' ---NXN--
~:tNH -- C •. 
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Figure 2.1. Hydrogen bonding model of the polyamide:DNA complex between eight-ring hairpin 
polyamides XPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (X = substituted Py or Hp) with 5 'TTTACA-3' sites. A 
circle with two dots represents the lone pairs of N3 of purines and 02 of cytosine. Two touching circles 
with dots represent the two lone pairs of the 02 of thymine. Circles containing an H represent the exocyclic 
amino hydrogen of guanine. Putative hydrogen bonds are illustrated by dotted lines. 
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Since Py is in the eighth position, the terminal pairs in the hairpin conformation are Hp-
lIPy, Hp-2/Py and Hp-3/Py. For controls the parent pyrrole series without the 3-hydroxy 
was also synthesized, 1-methylpyrrole substituted at the 4-position with H, formamide 
and acetamide (Py-l, Py-2, Py-3) afford end cap pairs Py-lIPy, Py-2/Py and Py-3/Py 
(Figure 2.1). In addition, X= 1m at the N -terminal was included to establish a baseline 
with previously published work. Seven eight-ring hairpin polyamides, differing in the 
terminal position, were synthesized for this study by solid-phase methods (Figure 2.2).6 
Figure 2.2. Structures of po\yamides. (Py-l)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (1), (Py-2)pyPyPy-
(R)H2Ny-ImPyPyPy-~-Dp (2), (Py-3 )PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (3), (Hp-l)PyPyPy-(R)H2Ny-
ImPyPyPy-~-Dp (4), (Hp-2)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (5), (Hp-3)PyPyPy-(R)H2Ny-ImPyPyPy-~­
Dp (6), ImPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (7). 
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The plasmid pCWl5 was designed to contain the four six-base pair recognition sites 5'-
TTTACA-3', 5'-TATACA-3', 5'-TGTACA-3' and 5'-TCTACA-3' which differ at a 
single common position allowing for comparison of the affinities between different 
terminal pairs and the four Watson Crick base pairs in the minor groove of DNA (Figure 
2.3). 




32p 3' -A'I!ACATT'IiACCTACCGCCGA'I\ACATA'IjACCTACCGCCGA_,,-,,-,,-,,=.== 
Figure 2.3. 284 base pair EeoRIIPvuII restriction fragment derived from plasmid pCWIS. The targeted six-
base pair binding sites are shown in boxes. 
Results 
Synthesis. Initial attempts to synthesize 3-methoxy-l-methylpyrrole carboxylic 
acid (13) for incorporation in the polyamides were unsuccessful, probably due to the 
strong electrondonating properties of the methoxy group. The 3-benzoyloxy-l-
methylpyrrole carboxylic acid 10 was synthesized, but all coupling attempts resulted in 
N-benzoylation of the polyamide-resin. Instead the 3-methoxy-l-methylpyrrole unit was 
introduced at the N -terminal position as a dimeric building block 11 which was 
synthesized in six steps from t-buty 1 3-hydroxy -l-methy lpyrrole-2-carboxy late (8) 
(Figure 2.4).7 The hydroxy ester 8 was benzoylated using benzoyl chloride/pyridine to 
give compound 9. The t-butyl ester was hydrolyzed using TMSOTf/DIEA8 and pyrrole 
acid 10 was then coupled with an excess of methyl 4-amino-l-methylpyrrole-2-
carboxylate.6 Subsequent debenzoylation, methylation and hydrolysis of the methyl-ester 
afforded the dimeric building block 11. 
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Figure 2.4. Synthesis of dimcric building block 11. 
The polyamide resins Boc-PyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin and Boc-
PyPyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin were synthesized in a stepwise manner from 
Boc-p-alanine-PAM resin (0.55 mmol/g) using Boc-chemistry solid-phase methodology 
(Figure 2.5).6 The terminal monomers and dimer were then coupled to the deprotected 
resins. Hydroxypyrrole amino acid residues were introduced as orthogonally protected 3-
methoxy-l-methylpyrrole (Op)4C derivatives. A sample of the resin was then cleaved by a 
single-step aminolysis reaction with ((dimethyl)amino)propylamine (55°C, 16 hours) and 
subsequently purified by reversed-phase HPLC to provide (Py-l)PyPyPy-(R)H2Ny-
ImPyPyPy-p -Dp (1), (Py-2)PyPyPy-(R)H2Ny-ImPyPyPy-p-Dp (2), (Py-3)PyPyPy-( 
R)H2Ny-ImPyPyPy-P-Dp (3), and ImPyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (7). Polyamides 
containing 3-methoxypyrrole at the N-terminus were de protected by treatment with 
sodium ethanethiolate in DMF (lOO°C, 1 h) and purified by reversed-phase HPLC to 
provide (Hp-l)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (4), (Hp-2)PyPyPy-(R)H2Ny-
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Figure 2.S. Solid-phase synthetic scheme for (Hp-l)PyPyPy-(R)H2Ny-lmPyPyPy-~-Dp (4) starting from 
commercially available Boc-~-PAM-resin: (i) 80% TFAlDCM, 0.4 M PhSH. (ii) Boc-Py-OBt, DIEA, 
DMF. (iii) 80% TFAlDCM, 0.4 M PhSH. (iv) Boc-Py-OBt, DIEA, DMF. (v) 80% TFAlDCM, 0.4 M 
PhSH. (vi) Boc-Py-OBt, DIEA, DMF. (vii) 80% TFA/DCM, 0.4 M PhSH. (viii) Boc-lm-acid, DCC, HOBt, 
DIEA, DMF. (ix) 80% TFAlDCM, 0.4 M PhSH. (x) Fmoc-a-Boc-y-diaminobutyric acid, HBTU, DIEA, 
DMF. (xi) 80% TFAlDCM, 0.4 M PhSH. (xii) Boc-Py-OBt, DIEA, DMF. (xiii) 80% TFA/DCM, 0.4 M 
PhSH. (xiv) Boc-Py-OBt, DIEA, DMF. (xv) 80% TFAlDCM, 0.4 M PhSH. (xvi) 11, DCC, HOBt, DIEA, 
DMF, r.1. 2h and then 37°C 2h. (xvii) Piperidine:DMF 3:1. (xviii) (Dimethylamino)propylamine, 55°C, 
16h. (xix) NaH, EtSH, DMF, 100°C, I hour. 
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Quantitative DNase I footprinting titrations. Quantitative DNase I footprint 
titrations were performed on the 3' -32P-end-labeled 284 base pair EcoRIIPvuII restriction 
fragment of the pCW 15 plasmid to determine the equilibrium association constant (Ka) of 
each eight-ring hairpin polyamide to the four different binding sites 5'-TNTACA-3' 
(where N=T, A, G, C)(Table 1, Figure 2.6). Polyamide 1-3, with Py/Py pairs in the 
terminal position, bound to A-T and T-A with higher affinities than for G-C or C-G but 
did not distinguish T-A from A-T as expected. Remarkably, within the HplPy series, only 
polyamide 6 with the Hp-3lPy terminal pairs showed a preference for T-A over A-T. 
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Figure 2.6. (a) Quantitative DNase I footprint titration experiment with (Py-3)pyPyPy-(R)H2Ny-ImPyPyPy-
P-Dp (3) on the 284 bp EcoRIIPvuII restriction fragment from plasmid pCWI5: lane 1, intact DNA; lane 2, 
A specific reaction; lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 
I nM, 2 nM, 5 nM, 10 nM (Py-3)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (3); (b) Quantitative DNase I footprint 
titration experiment with (Hp-3)PyPYPy-(R)H2Ny-ImPyPyPy-P-Dp (6) on the 284 bp EcoRIIPvuII 
restriction fragment from plasmid pCWI5: lane I, intact DNA; lane 2, A specific reaction; lane 3, DNase I 
standard; lanes 4-13,500 pM, I nM, 2 nM, 5 nM, 10 nM, 20 nM, 50 nM, 100 nM, 200 nM, 500 nM (Hp-
3)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (6); The four sites 5'-TTTACA-3', 5'-TATACA-3', 5'-TGTACA-3' 
and 5'-TCTACA-3' sitcs that were analyzed are shown on the right side of the gel. 
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Table 1. Equilibration Association Constants (MI)" 
Polyamide 5'-TTTACA-3' 5'-TATACA-3' 5'-TGTACA-3' 5'-TCTACA-3' 
1 3.6 (±0.7) x 1010 3.0 (±0.3) x 1010 8.4 (±0.9) x 109 3.7 (±0.9) x 109 
2 5.6 (±0.8) x 1010 1.2 (±0.2) x 1011 1.5 (±0.2) x 1010 9.3 (±1.2) x lOy 
3 1.1 (±0.2) x 1010 9.4 (±2.0) x 109 1.9 (±0.1) x 109 1.3 (±0.2) x 109 
4 1.3 (±0.2) x 1010 1.1 (±0.3) x 1010 2.7 (±0.9) x 109 3.0 (±3.0) x lOx 
5 1.3 (±0.8) x 1010 1.1 (±0.9) x 1O 11l 1.2 (±0.9) x 1010 1.8 (± 1.0) x 109 
6 2.1 (±0.2) x 109 6.2 (± 1.6) x 108 1.1 (±0.3) x 109 1.5 (±OA) x lOx 
7 2.0 (±O.5) x 1010 1.1 (±0.2) x 1010 2.9 (±0.5) x 1011 2.9 (±0.5) x 1010 
"Values reported are mean values from at least three DNase I footprint titration experiments, with the 
standard deviation for each data set indicated in parentheses. The assays were performed at 22°C at pH 7.0 
in the presence of 10 mM TrisoHCI, 10 mM KCl, 10 mM MgCI2, and 5 mM CaCI2. 
Discussion 
Polyamide 1, with a Py/Py pair in the terminal position, binds the sequences 5'-
TTTACA-3' and 5'-TATACA-3' with comparable affinity (3.6 x 101OM-l vs 3.0 X 1010 
M-l). Polyamide 1 binds 5'-TGTACA-3' and 5'-TCTACA-3' sequences with 4.3 and 9.7 
times lower affinity. The discrimination of T-A I A -T over G-C I C-G at the N -terminal 
position is comparable to results shown when the Py/Py pair is placed in internal 
positions of the hairpin polyamide. 3b The introduction of an acetamide group on the 1-
methylpyrrole does not change the specificity for T-A I A-T over G-C I C-G but lowers 
the affinity for all four binding sites by a factor of 3, probably due to steric interactions of 
the methyl group with the floor of the minor groove or the adjacent ~-alanine. Changing 
the acetamide group to formamide which reduces the steric bulk of the substituent 
restores the affinity. 
For the 3-hydroxy series, polyamide 4 (Hp-l)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp 
was expected to bind the sequence 5'-TTTACA-3' more tightly than 5'-TATACA-3' due 
to the (Hp-l)/Py pair at the N-terminal position. However, no sequence preference was 
observed. One possible explanation could be rotation of the terminal hydroxypyrrole to 
form a hydrogen bond between the 3-hydroxyl hydrogen and the carbonyl oxygen. This 
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conformation would place the key hydroxyl group away from the minor groove (Figure 
7). On the other hand polyamide 6 binds the sequence 5'-TTTACA-3' with higher 
affinity than 5'-TATACA-3', a 3.4-fold specificity. Perhaps the amide at the 4-position 
forms an hydrogen bond with the thymine-02 and thereby locks the orientation of the 
terminal hydroxypyrrole in the proper configuration (Figure 7). As in the Py/Py series the 
introduction of the acetamide group in polyamide 6 decreases the overall binding affinity. 
Replacing the acetamide with formamide in polyamide 5 restored the binding affinity but 
the specificity was lost. Both Hp-2/Py and Hp-3/Py pairs at the terminal position afforded 
poor sequence discrimination as demonstrated by the similar affinities at the sequences 
5'-TTTACA-3' and 5'-TGTACA-3'. In conclusion Hp/Py pairs may be limited to 
internal positions for T-A discrimination and there is a need for the design of new pairs 
for the terminal position for distinguishing T-A from A-T (and both from G-C and C-G) 
in the minor groove of DNA. 
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Figure 2.7. a) Binding model for the complex formed he tween (Hp-l)PyPyPy-(R)H 2Ny-ImPyPyPy-P-Dp 
(4), and a 5'-TITACA-3' sequence. h) Binding model for the complex formed hetween (Hp-3)PyPyPy-
(R)H2Ny-ImPyPyPy-P-Dp (6), and a 5'-TITACA-3' sequence. 
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Experimental Section 
B oc-~-alanine-( -4-carboxamidomethy I )-benzy I-ester -copol y( styrene-
divinylbenzene) resin (Boc-~-PAM-Resin), N,N' -Dicyclohexylcarbodiimide (DCC), N-
Hydroxybenzotriazole (HOBt), 2-( IH-Benzotriazole-l-yl)-l, 1 ,3,3-tetramethyluronium 
hexa-fluorophosphate (HBTU) were purchased from Peptides International. N,N-
diisopropylethylamine (DIEA) and N,N-dimethylformamide (DMF) were purchased from 
Applied Biosystems. The DMF was distilled under reduced pressure prior to synthesis. 
(R)-2-Fmoc-4-Boc-diaminobutyric acid was from Bachem, dichloromethane (DCM) was 
reagent grade from EM, thiophenol (PhS H) and dimethylaminopropylamine from 
Aldrich, and trifluoroacetic acid (TFA) from Halocarbon. IH NMR were recorded on a 
Varian Mercury 300 instrument. Chemical shifts are reported in ppm downfield from the 
signal for Me4Si, with reference to the solvent residual signal. UV spectra were measured 
on a Hewlett-Packard Model 8452A diode array spectrophotometer. High-resolution fast 
atom bombardment mass spectra were recorded at the Mass Spectroscopy Laboratory at 
the University of California - Los Angeles. Matrix-assisted, laser desorptionlionization 
time of flight mass spectrometry was carried out at the Protein and Peptide 
Microanalytical Facility at the California Institute of Technology. HPLC analysis was 
performed on a Beckman Gold system using a RAINEN CIS, Microsorb MV, 5!Jm, 300 x 
4.6 mm reversed-phase column in 0.1 % (w/v) TFA with acetonitrile as eluent and a flow 
rate of 1.0 mUmin, gradient elution 1.25% acetonitrile/min. Preparatory HPLC was 
carried out on a Beckman HPLC using a Waters DeltaPak 25 x 100 mm, 100 !Jm CI8 
column, 0.1 % (w/v) TFA, 0.25% acetonitrile/min. 18MQwater was obtained from a 
Millipore MilliQ water purification system, and all buffers were 0.2 !Jm filtered. Thin-
layer chromatography was performed on silica gel 60 F254 precoated plates. Reagent-
grade chemicals were used unless otherwise stated. 
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t-Butyl 3-benzoyloxy-l-methylpyrrole-2-carboxylate (9). t-Butyl 3-hydroxy-l-
methylpyrrole-2-carboxylate7 (8) (627 mg, 3.2 mmol) was dissolved in DCM (3 mL) and 
pyridine (0.515 mL, 6.4 mmol) was added. The mixture was cooled to ODC and benzoyl 
chloride (0.553 mL, 4.8 mmol) was added during 5 minutes. The temperature was raised 
to room temperature during 1 hour. The mixture was partitioned between water and Et20 
and the water layer extracted with Et20 two times. The combined organic phases were 
dried (MgS04) and concentrated. The crude product was purified by chromatography 
(Si02, 2: 1 hexanes-EtOAc) to afford 9 (928 mg, 97%). IH NMR (CDCI3) 8 8.10-8.25 
(m, 2 H), 7.40-7.70 (m, 3 H), 6.68 (d, 1 H, ] = 3.0 Hz), 6.02 (d, 1 H, ] = 3.0 Hz), 3.88 (s, 
3 H), 1.31 (s, 9 H); 13C NMR (CDCI3) 8 164.93, 160.07, 141.45, 134.72, 133.56, 130.75, 
130.43, 129.89, 129.06, 128.60, 126.22, 102.16,81.04,38.35,28.69. HRMS calcd. for 
C17H19N04: 301.1314; found: 301.1322. 
3-Benzoyloxy-l-methylpyrrole-2-carboxylic acid (10). t-Butylester 9 (886 mg, 
2.9 mmol) was dissolved in dioxane (19 mL) and DIEA (1.07 mL, 6.2 mmol) was added 
followed by TMSOTf (1.193 mL, 6.0 mmol) during 20 minutes under argon. The mixture 
was allowed to stir for 4 hours at room temperature and then partitioned between water 
and Et20 and the water layer extracted with Et20 two times. The combined organic 
phases were dried (MgS04) and concentrated. The crude product was purified by 
chromatography (Si02, 1:1 hexanes-EtOAc) to give 10 (438 mg, 61%) together with 
unreacted starting material (201 mg, 23%). IH NMR (CDCl3) 88.10-8.30 (m, 2 H), 7.40-
7.60 (m, 3 H), 6.77 (d, 1 H, ] = 2.8 Hz), 6.20 (d, 1 H, ] = 3.0 Hz), 3.88 (s, 3 H); 13C 
NMR (CDCl3) 8 164.99, 163.22, 143.27, 133.48, 133.21, 130.44, 130.06, 129.81, 128.61, 
128.48, 127.23, 112.58, 102.42, 38.38 HRMS calcd. for C13HIIN04: 245.0688; found: 
245.0697. 
4-[[[3-methoxy-l-methylpyrrole-2-yl]carbonyl]amino ]-I-methylpyrrole-2-
carboxylic acid (11). To a solution of 10 (438 mg, 1.8 mmol) in DMF (3 mL) was added 
DCC (361 mg, 1.8 mmol) and HOBt (229 mg, 1.7 mmol). The mixture was allowed to stir at 
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room temperature for 1.5 hours and the DCU was removed by filtration. Separately, to a 
solution of methyl 4-nitro-1-methy1pyrrole-2-carboxylate6 (1.00 g, 5.8 mmol) in DMF (4 
mL) was added Pd/C (10%, 100 mg) and the mixture was hydrogenated in a Parr bomb 
apparatus (500 psi of H2) for 1 hour. The catalyst was removed by filtration through Celite 
and the two solutions mixed and allowed to stir at 3rC for 6.5 hours and then at 55°C for 3 
hours. The reaction mixture was poured on ice and extracted with Et20 three times. The 
organic phase was dried (MgS04) and concentrated. The residue was dissolved in NaOMe-
MeOH (0.05 M, 20mL) and allowed to stir at room temperature for 1.5 hours and then 
neutralized by Amberlite lR-120 H+. The mixture was concentrated and the residue 
dissolved in DMF (10 mL) and K2C03 (1.24 g, 9.0 mmol) was added followed by a solution 
of Mel (0.277 mL, 3.0 mmol in 1 mL of DMF) during 10 minutes. The mixture was 
allowed to stir at room temperature for 14 hours and then filtered and partitioned between 
water and DCM. The water phase was extracted with CH2Cl2 twice. The combined organic 
phases were dried (MgS04), concentrated and the ester was isolated by chromatography 
(Si02, 2:1 hexanes-EtOAc). The ester was dissolved in MeOH (10 mL), NaOH (aq, 1 M, 10 
mL) was added, and the mixture was heated to 50°C for 20 h. All volatiles were removed in 
vacuo and the resulting solution was acidified by addition of HCl (aq, 3M). The solid was 
removed by filtration and dissolved in DCM/MeOH and subsequently purified by 
chromatography (Si02, 15:1 DCM/MeOH) to afford 11 (130 mg, 26%). IH NMR (CDCl3) 8 
8.74 (s, 1 H), 7.54 (d, 1 H, ] = 1.8 Hz), 6.82 (d, 1 H, ] = 2.1 Hz), 6.54 (d, 1 H, ] = 2.7 Hz), 
5.82 (d, 1 H, ] = 3.0 Hz), 3.94, 3.92, 3.90 (s, 3 H each) 13C NMR (CDCl3); 8 165.60, 
159.11, 150.63, 125.48, 122.65, 122.36, 119.04, 110.12, 109.78,92.97,58.54,38.28,37.28. 
HRMS calcd. for CJ3HlSN304: 277.1063; found: 277.1052. 
Boc-PyPy-(R)Fmocy-ImPy PyPy- ~-PAM-resin and Boc-PyPyPy-(R)Fmocy-
ImPyPyPy-~-PAM-resin. Boc-PyPy-(R)Fmocy-lmPyPyPy-~-PAM-resin (0.350 mmol/g) 
and Boc-PyPyPy-(R)Fmocy-lmPyPyPy-~-PAM-resin (0.335 mmol/g) were synthesized in a 
stepwise fashion from 0.55 mmol/g Boc-~-PAM-resin by manual solid-phase methods.6 (R)-
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2-Fmoc-4-Boc-diaminobutyric acid was incorporated as previously described for Boc-y-
aminobutyric acid. 3c,6 
Procedure for cleavage from the resin. After the coupling was completed the resin 
was filtered off the reaction and washed with DMF (2 x 30 s). DMF (1 mL) and piperidine 
(3 mL) were added and the mixture shaken for 30 minutes at 22De. The resin was filtered off 
and washed with DMF (2 x 30 s), DCM (3 x 30 s), MeOH (1 x 30 s), Et20 (1 x 30 s) and 
dried in vacuo. The resin was treated with (dimethylamino)propylamine (l mL) with 
periodic agitation at 55 DC for 16 hours. The reaction mixture was then filtered to remove the 
resin, TFA (0.1 % (w/v), 7 mL) added and the resulting solution purified by reversed-phase 
HPLe. The pure compounds were recovered as white powders upon lyophilization of the 
appropriate fractions. 
Deprotection of 3-methoxy-l-methylpyrrole polyamides. To a slurry of NaH (80 
mg, 60% in mineral oil) in DMF (0.50 rnL) was added a solution of ethanethiol (0.32 mL) in 
DMF (0.50 mL) and the mixture was heated to 100DC for 5 minutes in a sealed tube. The 
polyamide, dissolved in DMF (1.00 mL) was added to the ethanethiolate solution and the 
mixture was heated to 100DC for 1 hour in a sealed tube and then cooled to ODe. The mixture 
was added to HOAc (3 mL) and all volatiles were removed (high vacuum, 40DC). The 
residue was dissolved in CH3CN (l mL) and TFA (7 mL, 0.1 % (w/v)) and purified by 
preparative HPLe. 
(Py-l)PyPyPy-(R)H2Ny-ImPyPyPy-f3-Dp (1). I-methylpyrrole-2-carboxylic acid 
(50 mg, 0.40 mmol) was dissolved in DMF (l mL) and HBTU (75 mg, 0.20 mmol) and 
DIEA (0.5 mL) were added and the mixture stirred for 10 minutes and added to deprotected 
Boc-PyPyPy-(R)Fmocy-ImPyPyPy-f3-PAM-resin (100 mg) and the mixture shaken for 4 
hours at 22De. The compound was then cleaved from the resin according to the general 
procedure. Preparative HPLC gave 1 (20 mg, 49% recovery). UV Amax (H20) 240, 308 
(69500); IH NMR (DMSO-d6) 8 10.97, 10.06,9.90,9.89,9.84,9.78 (s, 1 H each), 8.28 (bs, 
3 H), 8.13 (t, 1 H, J = 5.5 Hz), 7.99 (q, 1 H, J = 6.0 Hz), 7.48 (s, 1 H), 7.20 (d, 1 H, J = l.5 
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Hz), 7.17 (t, 1 H, J = 1.8 Hz), 7.14 (d, 1 H, J = 1.5 Hz), 7.12 (t, 1 H, J = 1.8 Hz), 7.09 (d, 1 
H, J = 1.8 Hz), 7.02 (s, 2 H), 6.99 (d, 1 H, J = 1.8 Hz), 6.91 (d, 1 H, J = 1.8 Hz), 6.89 (t, 1 
H, J = 2.1 Hz), 6.85 (dd, 1 H, J = 3.9, 1.8 Hz), 6.82 (d, 1 H, J = 1.8 Hz), 5.99 (dd, 1 H, J = 
3.9,2.7 Hz), 3.92, 3.81,3.80,3.79,3.78,3.77,3.75,3.74 (s, 3 H each), 3.20-3.40 (m, 4 H), 
3.05 (q, 2 H, J = 6.3 Hz), 2.90-3.00 (m, 2 H), 2.67 (d, 6 H, J = 4.5 Hz), 2.29 (t, 2 H, J = 7.2 
Hz), 1.90-2.00 (m, 2 H), 1.68 (p, 2 H, J = 7.8 Hz); MALDI-TOF-MS calcd. for 
CS9H73N21 010 (M + H): 1236.6; found: 1236.7. 
(Py-2)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (2). Boc-Pyrrole-OBt ester6 (50 mg, 0.14 
mmol) was dissolved in DMF (0.5 mL) and DIEA (0.25 mL) and added to the deprotected 
Boc-PyPyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin (50 mg) and the mixture shaken for 4 hours 
at 22°C. The resin was washed with DMF (2 x 30 s) and DCM (2 x 30 s) and the Boc group 
cleaved with 80% TFA/DCM/O.5 M PhSH (1 x 30 s, 1 x 20 min). The resin was washed 
with DCM (2 x 30 s) followed by DMF (2 x 30 s). Formic acid (l mL) and AC20 (0.2 mL) 
were added and the mixture shaken for 1 h. The compound was then cleaved from the resin 
according to the general procedure. Preparative HPLC gave 2 (4.5 mg, 21 % recovery). UV 
Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 11.01, 10.10, 10.05 (s, 1 H each), 
9.90-10.00 (m, 4 H), 9.88 (s, 1 H), 8.32 (bs, 3 H), 8.18 (t, 1 H, J = 5.7 Hz), 8.10 (d, 1 H, J = 
1.8 Hz), 8.03 (q, 2 H, J = 5.7 Hz), 7.52 (s, 1 H), 7.24 (d, 1 H, J = 1.5 Hz), 7.20 (d, 2 H, J = 
1.5 Hz), 7.19 (d, 1 H, J = 1.5 Hz), 7.15-7.18 (m, 3 H), 7.13 (d, 1 H, J = 1.5 Hz), 7.04-7.08 
(m,3 H), 6.96 (d, 1 H, J = 1.5 Hz), 6.90 (d, 1 H, J = 2.1 Hz), 6.87 (d, 1 H, J = 1.5 Hz), 3.96, 
3.84 (s, 3 H each), 3.83, 3.82 (s, 6 H each), 3.79, 3.78 (s, 3 H each), 3.09 (q, 2 H, J = 5.4 
Hz), 2.94-3.04 (m, 2 H), 2.75, 2.74 (s, 1 H each), 2.71 (d, 6 H, J = 4.8 Hz), 2.33 (t, 2 H, J = 
7.5 Hz), 1.20-2.00 (m, 8 H). MALDI-TOF-MS calcd. for C60H74N22011 (M + H): 1279.6; 
found: 1279.6. 
(Py-3)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (3). Boc-Pyrrole-OBt ester6 (l00 mg, 0.28 
mmol) was dissolved in DMF (1 mL) and DIEA (0.5 mL) and added to the deprotected Boc-
PyPyPy_(R)Fmocy-ImPyPyPy-p-PAM-resin (100 mg) and the mixture shaken for 4 hours at 
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22°C. The resin was washed with DMF (2 x 30 s) and DCM (2 x 30 s) and the Boc group 
cleaved with 80% TFA/DCM/O.5 M PhSH (1 x 30 s, 1 x 20 minutes ). The resin was 
washed with DCM (2 x 30 s) followed by DMF (2 x 30 s). DMF (1 mL) and AC20 (0.5 mL) 
were added and the mixture shaken for 5 minutes . The compound was then cleaved from 
the resin according to the general procedure. Preparative HPLC gave 3 (15 mg, 35% 
recovery). UV Amax (H20) 240, 308 (69500); IH NMR (DMSO-d6) 8 10.97, 10.07, 9.90 (s, 
1 H each), 9.88 (s, 2 H), 9.85, 9.84, 9.78 (s, 1 H each), 8.27 (bs, 3 H), 8.13 (t, 1 H, ] = 4.8 
Hz), 8.00 (g, 2 H, ] = 6.0 Hz), 7.48 (s, 1 H), 7.21 (d, 1 H, ] = 1.5 Hz), 7.16 (t, 1 H, ] = 1.2 
Hz), 7.14 (d, 1 H, ] = 1.5 Hz), 7.12 (bs, 1 H), 7.08 (dd, 1 H, ] = 3.0, 1.2 Hz), 7.02 (d, 1 H, ] 
= 1.8 Hz), 7.01 (d, 1 H, ] = l.8 Hz), 6.91 (d, 1 H, ] = 1.8 Hz), 6.82 (d, 1 H, ] = 1.5 Hz), 
6.80 (d, 1 H, ] = 2.1 Hz), 3.92, 3.79 (s, 3 H each), 3.78 (s, 6 H), 3.77, 3.76, 3.75, 3.74 (s, 3 
H each), 3.20-3.35 (m, 4 H), 3.04 (g, 2 H, ] = 6.6 Hz), 2.94 (p, 2 H, ] = 6.6 Hz), 2.28 (t, 2 
H, ] = 7.5 Hz), 1.91 (s, 3 H), l.67 (p, 2 H, ] = 7.5 Hz). MALDI-TOF-MS calcd. for 
C61H76N22011 (M + H): 1293.6; found: 1293.7. 
(Hp-l)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (4). Compound 11 (22 mg, 0.08 mmol) 
was dissolved in DMF (0.3 mL) and HOBt (9 mg, 0.07 mmol) and DCC (15 mg, 0.07 
mmol) were added and the mixture was allowed to stir for 20 minutes and then added to the 
deprotected Boc-PyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin (50 mg) followed by DIEA (0.1 
mL) and the mixture shaken for 2.0 hours at 22°C and then 2.0 hours at 37°C. The 
compound was then cleaved from the resin according to the general procedure. Preparative 
HPLC gave methyl protected (Hp-l)PyPyPy-(R)H 2Ny-ImPyPyPy-P-Dp (9 mg, 39% 
recovery).UV Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 10.97, 10.06,9.90, 
9.89, 9.84, 9.82, 8.73 (s, 1 H each), 8.27 (bs, 3 H), 8.13 (t, 1 H, ] = 5.7 Hz), 8.00 (g, 2 H, ] 
= 5.7 Hz), 7.48 (s, 1 H), 7.23 (d, 1 H, ] = l.8 Hz), 7.20 (d, 1 H, ] = 1. 8 Hz), 7.15 (bs, 1 H), 
7.12 (bs, 1 H), 7.09 (d, 1 H, ] = 1. 8 Hz), 7.02 (bs, 2 H), 6.93 (d, 1 H, ] = 1.8 Hz), 6.91 (d, 1 
H, ] = l.8 Hz), 6.82 (d, 1 H, ] = l.8 Hz), 6.80 (d, 1 H, ] = 2.7 Hz), 5.90 (d, 1 H, ] = 2.7 
Hz), 3.92, 3.80, 3.79 (s, 3 H each), 3.78 (bs, 9 H), 3.76, 3.75, 3.74 (s, 3 H each), 3.04 (g, 2 
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H, J = 6.0 Hz), 2.94 (p, 2 H, J = 5.0 Hz). 2.67 (d, 6 H, J = 4.5 Hz), 2.28 (t, 2 H, J = 7.2 
Hz), 1.92 (bs, 2 H), 1.67 (p, 2 H, J = 7.2 Hz). MALDI-TOF-MS calcd. for C60H75N21011 
(M + H): 1266.6; found: 1266.7. The methyl protected (Hp-l)PyPyPy-(R)H2Ny-ImPyPyPy-
P-Dp (2.1 mg, 1.7 /-lmol) was deprotected to give 4 (1.3 mg, 63% recovery). UV Amax (H20) 
240,310 (69500); IH NMR (DMSO-d6) 8 11.12, 10.44, 10.19, 10.03, 10.02,9.96,9.89,9.09 
(s, 1 H each), 8.39 (bs, 3 H), 8.26 (t, 1 H, J = 2.2 Hz), 8.12 (q, 2 H, J = 2.1 Hz), 7.61 (s, 1 
H), 7.36 (d, 1 H, J = 1.5 Hz), 7.33 (d, 1 H, J = 1.5 Hz), 7.28 (d, 2 H, J = 1.5 Hz), 7.25 (bd, 2 
H, J = 1.8 Hz), 7.20 (d, 1 H, J = 1.5 Hz), 7.12-7.18 (m, 2 H), 7.05 (t, 2 H, J = 2.1 Hz), 6.96 
(d, 1 H, J = 1.5 Hz), 6.80 (d, 1 H, J = 2.1 Hz), 5.73 (d, 1 H, J = 2.7 Hz), 4.05, 3.93, 3.92, 
3.91, 3.90, 3.88 (s, 3 H each), 3.87 (s , 6 H), 3.17 (q, 2 H, J = 6.0 Hz), 3.06 (bt, 2 H, J = 8.1 
Hz), 2.80 (s, 3 H), 2.42 (t, 2 H, J = 7.2 Hz), 2.06 (bs, 2 H), 1.80 (bt, 2 H, J = 7.8 Hz), 1.30 
(s, 1 H); MALDI-TOF-MS calcd. for C59H73N21 011 (M + H): 1252.6; found: 1252.6. 
(Hp-2)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (5). Boc-Op acid4c (50 mg, 0.18 mmol) 
was dissolved in DMF (1.0 mL) and HBTU (60 mg, 0.16 mmol) and DIEA (0.5 mL) were 
added and the mixture stirred for 10 minutes and added to the deprotected Boc-PyPyPy-
(R)Fmocy-ImPyPyPy-p-PAM-resin (50 mg) and the mixture shaken for 4.0 hours at 22°C. 
The resin was washed with DMF (2 x 30 s) and DCM (2 x 30 s) and the Boc group cleaved 
with 80% TFA/DCM/O.5 M PhSH (l x 30 s, 1 x 20 minutes ). The resin was washed with 
DCM (2 x 30 s) followed by DMF (2 x 30 s). Formic acid (l mL) and AC20 (0.2 mL) were 
added and the mixture shaken for 1 h. The compound was then cleaved from the resin 
according to the general procedure. Preparative HPLC gave methyl protected (Hp-
2)PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (6 mg, 27% recovery). UV Amax (H20) 240, 312 
(69500); IH NMR (DMSO-d6) 8 11.10, 10.19, 10.03, 10.02, 9.99, 9.96, 9.88, 9.21 (s, 1 H 
each), 8.41 (bs, 3 H), 8.27 (t, 1 H, J = 6.0 Hz), 8.23 (d, 1 H, J = 1.5 Hz), 8.12 (q, 2 H, J = 
6.0 Hz), 7.61 (s, 1 H), 7.36 (d, 1 H, J = 1.8 Hz), 7.33 (d, 1 H, J = 1.5 Hz), 7.29 (s, 1 H), 7.28 
(s, 2 H), 7.25 (s, 2 H), 7.22 (d, 1 H, J = 1.5 Hz), 7.15 (d, 2 H, J = 1.8 Hz), 7.14 (d, 1 H, J = 
1.5 Hz), 7.04 (d, 1 H, J = 1.5 Hz), 6.96 (d, 1 H, J = 1.5 Hz), 4.05 (s, 3 H), 3.93 (s, 6 H), 
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3.91,3.90,3.88,3.87,3.86,3.85 (s, 3 H each), 3.17 (q, 2 H, J = 6.3 Hz), 3.07 (p, 2 H, J = 
5.4 Hz), 2.80 (d, 6 H, J = 4.5 Hz), 2.42 (t, 2 H, J = 7.5 Hz), 2.02-2.12 (m, 2 H), 1.81 p, 2 H, 
J = 7.8 Hz); MALDI-TOF-MS calcd. for C61H76N22012 (M + H): 1309.6; found: 1309.7. 
The methyl protected (Hp-2)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (1.8 mg, 1.4 /lmol) was 
deprotected according to the general procedure to give 5 (0.7 mg, 37% recovery). UV Amax 
(H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 10.96, 10.60, 10.21, 10.06 (s, 1 H each), 
9.89 (bs, 2 H), 9.83, 9.79 (s, 1 H each), 8.99 (s, 1 H), 8.25 (bs, 3 H), 8.13 (bs, 1 H), 7.99 (bs, 
3 H), 7.48, 7.24, 7.20 (s, 1 H each), 7.14, 7.11 (s, 2 H each), 7.08, 7.02, 7.00, 6.94, 6.91 (s, 1 
H each), 6.83 (s, 2 H), 3.91 (s, 3 H), 3.78, 3.77, 3.75, (s, 3 H each), 3.73 (s, 6 H), 3.04 (q, 2 
H, J = 6.6 Hz), 2.95 (p, 2 H, J = 6.6 Hz), 2.67 (d, 6 H, J = 3.9 Hz), 2.28 (t, 2 H, J = 7.2 Hz), 
1.90-2.00 (m, 2 H), 1.67 (p, 2 H, 6.8 Hz), 1.17 (s, 1 H); MALDI-TOF-MS calcd. for 
C60H74N22012 (M + H): 1295.6; found: 1295.8. 
(Hp-3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (6). Boc-Op acid4c (50 mg, 0.18 mmol) 
was dissolved in DMF (l.0 mL) and HBTU (60 mg, 0.16 mmol) and DIEA (0.5 mL) were 
added and the mixture stirred for 10 minutes and added to the deprotected Boc-PyPyPy-
(R)Fmocy-ImPyPyPy-~-PAM-resin (100 mg) and the mixture shaken for 4.0 hours at 22°C. 
The compound was then cleaved from the resin according to the general procedure. 
Preparative HPLC gave methyl protected (Hp-3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (15 mg, 
46% recovery). UV Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 10.99, 10.20, 
9.92, 9.90 (s, 1 H each), 9.85 (s, 2 H), 9.34, 9.02 (s, 1 H each), 8.38 (bs, 3 H), 8.17 (t, 1 H, J 
= 5.9 Hz), 7.96-8.10 (m, 2 H), 7.47 (s, 1 H), 7.23 (d, 1 H, J = l.2 Hz), 7.21 (bs, 1 H), 7.17 
(d, 1 H, J = 1.2 Hz), 7.16 (bs, 2 H), 7.13 (d, 1 H, J = 1.2 Hz), 7.09-7.12 (m, 4 H), 7.05 (s, 1 
H), 7.02 (bs, 2 H), 6.99 (d, 1 H, J = l.8 Hz), 6.90 (d, 1 H, J = l.2 Hz), 6.81 (bs, 2 H), 3.92 
(s, 3 H), 3.89 (s, 1 H), 3.79, 3.78 (s, 6 H each), 3.75 (s, 3 H each), 3.73 (s, 6 H), 3.71 (s, 3 
H), 3.20-3.35 (m,4 H), 3.04 (q, 2 H, J = 6.3 Hz), 2.93 (p, 2 H, J = 4.5 Hz), 2.65 (d, 6 H, J = 
4.5 Hz), 2.28 (t, 2 H, J = 6.6 Hz), 1.96 (s, 1 H), l.95 (s, 3 H), 1.69 (p, 2 H, J = 7.2 Hz). 
MALDI-TOF-MS calcd. for C62H78N22012 (M + H): 1323.6; found: 1323.8. The methyl 
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protected (Hp-3)PyPyPy-(R)H2Ny-ImPyPyPy-/3-Dp (3.1 mg, 2.4 !-lmol) was deprotected 
according to the general procedure to give 6 (0.7 mg, 23% recovery). UV Amax (H20) 240, 
308 (69500); IH NMR (DMSO-d6) b 11.12, 10.97, 10.17, 10.06,9.92,9.89,9.84,9.78 (s, 1 
H each), 9.24 (bs, 1 H), 8.26 (bs, 3 H), 8.13 (t, 1 H, ] = 5.6 Hz), 8.00 (q, 2 H, ] = 5.67 Hz), 
7.48,7.24,7.20 (s, 1 H each), 7.15, 7.11 (s, 2 H each), 7.09, 7.02, 7.00, 6.93, 6.91, 6.83, 
6.76 (s, 1 H each), 3.91, 3.79 (s, 3 H each), 3.78 (s, 6 H), 3.77, 3.74, 3.73, 3.72 (s, 3 H each), 
3.04 (q, 2 H, ] = 6.0 Hz), 2.94 (p, 2 H, ] = 3.9 Hz), 2.68 (d, 6 H, ] = 3.3 Hz), 2.28 (t, 2 H, ] 
= 6.6 Hz), 1.99 (s, 3 H), 1.94 (bs, 2 H), 1.67 (p, 2 H, ] = 5.8 Hz), 1.17 (s, 1 H); MALDI-
TOF-MS calcd. for C61H76N22012 (M + H): 1309.6; found: 1309.7. 
ImPyPyPy-(R)HzNy-ImPyPyPy-/3-Dp (7). Imidazole acid (50 mg, 0.40 mmol) was 
dissolved in DMF (1.0 mL) and HBTU (140 mg, 0.37 mmol) and DIEA (0.5 mL) were 
added and the mixture stirred for 10 minutes and added to the deprotected Boc-PyPyPy-
(R)Fmocy-ImPyPyPy-/3-PAM-resin (100 mg) and the mixture shaken for 2.5 hours at 22°C. 
Preparative HPLC gave 7 (20 mg, 50% recovery). UV Amax (H20) 240,312 (69500); IH 
NMR (DMSO-d6) b 10.97, 10.42, 10.06 (s, 1 H each), 9.91 (bs, 2 H), 9.88, 9.84 (s, 1 H 
each), 8.28 (bs, 2 H), 8.13 (t, 1 H, ] = 5.7 Hz), 7.99 (q, 2 H, ] = 5.7 Hz), 7.48, 7.34 (s, 1 H 
each), 7.23 (d, 1 H, ] = 1.6 Hz), 7.20 (d, 1 H, ] = 1.4 Hz), 7.17 (d, 1 H, ] = 1.4 Hz) 7.15 (bs, 
1 H), 7.10-7.20 (m, 2 H), 7.09 (bs, 1 H), 7.02 (bs, 2 H), 6.99 (t, 1 H, ] = 1.2 Hz), 6.91 (bs, 1 
H), 6.83 (bs, 1 H), 3.93 (s, 6 H), 3.92, 3.79, 3.78, 3.77, 3.75, 3.73 (s, 3 H each), 3.31 (q, 2 H, 
] = 5.7 Hz), 3.23 (q, 2 H, ] = 5.7 Hz), 3.04 (q, 2 H, ] = 6.0 Hz), 2.90-2.97 (m, 2 H), 2.68 (d, 
6 H, ] = 4.8 Hz), 2.28 (t, 2 H, ] = 7.2 Hz), 1.88-2.00 (m, 2 H), 1.67 (p, 2 H, ] = 8.1 Hz). 
MALDI-TOF-MS calcd. for CssHnN22010 (M + H): 1237.6; found: 1237.7. 
Construction of plasmid DNA. The plasmid pCW15 was constructed by 
hybridization of the inserts, 5' -CT AGCGGCT ATGT AAA TGGA TGGCGGCT ATGT A 
T ATGGATGGCGGCT ATGTACATGGATGGCGGCT ATGT AGATGGATTGCA-3' 
and 5'-ATCCATCTACATAGCCGCCATCCATGTACATAGCCGCCATCCATATA 
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CATAGCCGCCATCCA TTT ACAT AGCC-3'. The hybridized insert was ligated into 
linearized pUC 19 XbaI IPstI plasmid using T4 DNA ligase. The resultant constructs were 
used to transform Top lOF' OneS hot competent cells from Invitrogen. Ampicillin-
resistant white colonies were selected from 25 mL Luria-Bertani medium agar plates 
containing 50 ~g/mL ampicillin and treated with XGAL and IPTG solutions. Large-scale 
plasmid purification was performed with Qiagen Maxi purification kits. Dideoxy 
sequencing was used to verify the presence of the desired insert. 
Preparation of 3'· and 5'·End·Labeled Restriction Fragments. The plasmid 
pCW 15 was linearized with EcoRI and Pvull and then treated with Sequenase (version 
2.0 from United States Biochemical), deoxyadenosine 5'-[a-32P]triphosphate and 
thymidine 5'-[a-32P]triphosphate for 3' labeling. The 3' labeled fragment was loaded 
onto a 7% non-denaturing polyacrylamide gel, and the desired 284 base pair band was 
visualized by autoradiography and isolated. Chemical sequencing reactions were 
performed according to published methods. 9 
Quantitative DNase I Footprinting. DNase I Footprinting reactions were carried 
out as previously described. 1h Photostimulable storage phosphorimaging plates (Kodak 
Storage Phosphor Screen S0230 obtained from Molecular Dynamics) were pressed flat 
against gel samples and exposed in the dark at 22°C for 12-16 hours. A Molecular 
Dynamics 400S Phosphorlmager was used to obtain all data from the storage screens. 
The data were analyzed by performing volume integration of all bands using ImageQuant 
v. 3.2 software. All DNA manipulations were performed according to standard 
protocols. 10 
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Chapter 3 
Hydroxybenzamide/Pyrrole Pairs Distinguishes T-A 
from A -T Base Pairs in the Minor Groove of DNA 
The text of this chapter was taken in part from a publication coauthored with Dr. Ulf 
Ellervik and Prof Peter B. Dervan. 
(Ellervik, U.; Wang, C. C. c.; Dervan, P. B. 1. Am. Chern. Soc. 2000, 122,9354-9360.) 
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Abstract 
A new aromatic pair, 2-hydroxy-6-methylbenzamidell-methylpyrrole at the terminal 
position of hairpin polyamides has been designed for distinguishing T-A from A-T base 
pairs and both from G-C/C-G in the minor groove of DNA. Four eight-ring hairpin 
polyamides with benzamide (Bz), 2-hydroxybenzamide (Hb-l), 2-hydroxy-6-
methylbenzamide (Hb-2), and 2-hydroxy-6-methylbenzamide (Hb-3) at the N-terminal 
position were synthesized. The equilibrium association constants (Ka) were determined at 
four DNA sites which differ at a single common position, 5'-TNTACA-3' (N = T, A, G, 
C). Quantitative DNase I footprint titration experiments reveal that (Hb-3)PyPyPy-
(R)H2N'Y-ImPyPyPy-~-Dp (4) bound the sequences 5'-TTTACA-3' and 5'-TATACA-3' 
with high affinity Ka = 2.6 X 1010 M-l and Ka = 8.4 X 109 M-l, respectively, a three-fold 
specificity for T vs A. Importantly, the sequences 5'-TGTACA-3' and 5'-TCTACA-3' 
are bound with 50 and 200 times lower affinity, revealing an overall specificity of Hb-




The ability to distinguish T-A from A-T base pairs by synthetic ligands which 
bind in the minor groove of DNA is an essential milestone for targeting specific AfT rich 
sequences, within promoters for gene regulation studies.! We recently reported that the 2-
hydroxypyrrole/pyrrole pair (Hp/py)2 for distinguishing T-A from A-T is most suitable 
for internal positions in polyamides. 3 The Hp ring at the N-terminal position affords 
lower affinity and sequence specificity for A-T/T-A vs G-C/C-G than anticipated.3 
During the early development of minor groove binders, it was shown that six-membered 
aromatic rings such as 2-pyridine, as well as the five membered ring imidazole 1m, when 
paired with Py could target G-C base pairs. 4 The question arises whether 2-
hydroxybenzene (Hb) at the N-terminal position of hairpin polyamides could act as a 
mimic of the 2-hydroxypyrrole (Hp) with improved affinity and specificity for T. 
We describe here a series of eight-ring polyamide hairpins with the general 
sequence XPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp and the N-terminal position X= benzamide 
(Bz), 2-hydroxybenzamide (Hb-l), 2-hydroxy-6-methylbenzamide (Hb-2), and 2-
hydroxy-6-methoxybenzamide (Hb-3). Since Py is in the eighth position, the terminal 
pairs in the hairpin conformation are Hb-l/Py, Hb-2/Py and Hb-3/Py (Figure 3.1). 
For controls the parent benzamide without the hydroxy is included. A total of 11 eight-
ring hairpin polyamides differing in the terminal position were synthesized by solid phase 
methods (Figure 3.2a and b). The plasmid pCW15 was designed to contain four six-base 
pair recognition sites 5-TNTACA-3' (where N=T,A,G,C) which differ at a single 
common position allowing for comparison of the affinities between different terminal 
pairs and the four Watson Crick base pairs in the minor groove of DNA (Figure 3.3). 
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R R' 
Bz H H 
Hb-1 OH H 
Hb-2 OH Me 
Hb-3 OH OMe 
5'-A T T T A C A A-3' 
3'-T A A A T G T T-5' 
Figure 3.1. Hydrogen bonding model of the polyamide:DNA complex between eight-ring hairpin 
polyamides containing substituted benzamides with the 5'TTTACA-site. A circle with two dots represents 
the lone pairs of N3 of purines and 02 of cytosine. Two touching circles with dots represent the two lone 
pairs of the 02 of thymine. Circles containing an H represent the exocyclic amino hydrogen of guanine. 
Putative hydrogen bonds are illustrated by dotted lines. 
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Figure 3.2a. Structures of poly ami des 1-4. BzPyPyPy-(R)H2NY-ImPyPyPy-~-Dp (1), (Hb-l)PyPyPy-
(R)H2Ny-ImPyPyPy-~-Dp (2), (Hb-2)PyPyPy-(R)H2NY-ImPyPyPy-~-Dp (3), (Hb-3)PyPyPy-(R)H2Ny-
ImPyPyPy-~-Dp (4). 
8 
Figure 3.2h. Structures of polyamides 5-11. 
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32p 3 ' -A*,CATT'IiACCTACCGCCGATIACATA*CCTACCGCCGA~t..!.::==-= CCTACCGCCGA-c.===-== 
Figure 3.3284 base pair EcoRVPvuII restriction fragment derived from plasmid peWIS. The targeted six-
base pair recognition sites are shown in boxes. 
Results 
Polyamide synthesis. Boc-PyPyPy-(R)Fmocy-ImPyPyPy-~-PAM-resin was 
synthesized in a stepwise manner from Boc-~-alanine-PAM resin (0.55 mmol/g) using 
solid-phase methodologi in 16 steps (Figure 3.5). Sterically hindered acids such as Hb-2 
and Hb-3 were coupled as acid chlorides. A sample of the resin was then cleaved by 
aminolysis with ((dimethyl)amino)propylamine (55 DC, 16 h) and purified by reversed-
phase HPLC to provide BzPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (1). Methyl-protected 
polyamides 2-4 were subsequently deprotected by treatment with sodium ethanethiolate 
in DMF (lOODC, 1 h)l and purified by reversed-phase HPLC to afford (Hb-l)PyPyPy-
(R)H2Ny-ImPyPyPy-~-Dp (2), (Hb-2)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (3) and (Hb-
3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (4) (Figure 3.5). A deprotection study of the 
dimethoxybenzene compound (7) showed a maximum yield of the monomethoxy 
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Figure 3.4. Deprotection study of 
compound 7. The dimethoxy compound 
7 was deprotected at 100°C with EtS' and 
samples were taken out at different times 
and analyzed by HPLC. The different 
amounts of the dimethoxy-, 
monomethoxy- and the diol were 
measured. 
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Figure 3.5. Solid-phase synthetic scheme for (Hb-3)PyPyPy-(R)H2Ny-lmPyPyPy-~-Dp (4) starting from 
commercially available Boc-~-PAM-resin: (i) 80% TFAIDCM, 0.4 M PhSH. (ii) Boc-Py-OBt, DIEA, 
DMF. (iii) 80% TFAIDCM, 0.4 M PhSH. (iv) Boc-Py-OBt, DIEA, DMF. (v) 80% TFA/DCM, 0.4 M 
PhSH. (vi) Boc-Py-OBt, DIEA, DMF. (vii) 80% TFAIDCM, 0.4 M PhSH. (viii) Boc-lm-acid, DCC, HOBt, 
DIEA, DMF. (ix) 80% TFA/DCM, 0.4 M PhSH. (x) Fmoc-a-Boc-y-diaminobutyric acid, HBTU, DIEA, 
DMF.(xi) 80% TFAIDCM, 0.4 M PhSH. (xii) Boc-Py-OBt, DIEA, DMF. (xiii) 80% TFA/DCM, 0.4 M 
PhSH. (xiv) Boc-Py-OBt, DIEA, DMF. (xv) 80% TFA/DCM, 0.4 M PhSH. (xvi) Boc-Py-OBt, DIEA, 
DMF. (xvii) 80% TFAIDCM, 0.4 M PhSH. (xviii) 2,6-Dimethoxybenzoic acid, DMF, DCM, 
oxalylchloride, DIEA, r.t. 3h. (xix) Piperidine:DMF 3: 1. (xx) (Dimethylamino)propylamine, 55°C, 
16h.(xxi) NaH, EtSH, DMF, 100°C, I h. 
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Quantitative DNase I footprinting titrations. Quantitative DNase I footprint 
titrations on the 3,-32P-end-labeled 284 bp pCWl5 EcoRIIPvuII restriction fragment (10 
mM Tris-HCl, 10 mM KCl, 10 mM MgCl2 and 5 mM CaCI2, pH 7.0, 22°C) (Figure 3.6) 
reveals that BzPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (1) binds the 5' -TTTACA-3'and 5'-
TATACA-3'sites with comparable equilibration association constants, Ka = 1.9x 1011 M-
1 and Ka = l.2 X 1011 M-l respectively. Polyamide 1 binds the two sites 5'-TGTACA-3' 
and 5'-TCTACA-3' with five and ten-fold lower affinity, respectively, revealing that the 
Bz/Py pair is specific for both T-A and A-T over G-C and C-G. 
Three polyamides containing 2-hydroxybenzamides at the N-terminal position 
(Hb-1)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (2), (Hb-2)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp 
(3), (Hb-3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (4) were tested for their ability to 
discriminate 5'-TTTACA-3' vs 5'-TATACA-3' (Table 3.1). (Hb-1)PyPyPy-(R)H2Ny-
ImPyPyPy-~-Dp (2), containing a single hydroxyl bound both 5'-TTTACA-3' and 5'-
TATACA-3' with the same affinity (Ka = 1.9 x 10IoM-l). (Hb-2)PyPyPy-(R)H2Ny-
ImPyPyPy-~-Dp (3), with a 2-hydroxyl and a 6-methyl substitution also bound the two 
sites with equal affinity. Discrimination of 5'-TTTACA-3' from 5'-TATACA-3' was 
achieved by replacing the 6-methyl group in polyamide 5 with 6-methoxy. (Hb-
3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (4) bound 5' -TTTACA-3' with an affinity of Ka = 
1.9 X 1010 M-l and 5'-TATACA-3' with three-fold lower affinity. Importantly, 
polyamide 4 bound to 5'-TGTACA-3' and to 5'-TCTACA-3' with 55 and 200 times 
lower affinity, respectively. 
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Figure 3.6. (a) Quantitative DNase I footprint titration experiment with BzPyPyPy-(R)H2Ny-ImPyPyPy-~­
Dp (1) on the 284 bp EcoRVPvuII restriction fragment from plasmid pCWI5: lane 1, intact DNA; lane 2, A 
specific reaction; lane 3, G specific reaction lane 4, DNase I standard; lanes 5-21, 0.1 pM, 0.2 pM, 0.5 pM, 
1 pM, 2 pM, 5 pM, 10 pM, 15 pM, 25 pM, 40 pM, 65 pM, 100 pM, 150 pM, 250 pM, 450 pM, 650 pM, 1 
nM BzPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (1); The four sites 5'-TTTACA-3', 5'-TATACA-3', 5'-
TGTACA-3' and 5'-TCTACA-3' sites that were analyzed are shown on the right side of the gel. (b) 
Quantitative DNase I footprint titration experiment with (Hb-3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (4) on 
the 284 bp EcoRVPvuII restriction fragment from plasmid pCWI5: lane 1, intact DNA; lane 2, A specific 
reaction lane 3, G specific reaction lane 4, DNase I standard; lanes 5-21, 10 pM, 20 pM, 50 pM, 100 pM, 
150 pM, 250 pM, 400 pM, 650 pM, 1 nM, 1.5 nM, 2.5 nM, 4 nM, 6.5 nM, 10 nM, 20 nM, 50 nM, 100 nM 
(Hb-3)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (7); The four sites 5'-TTTACA-3', 5'-TATACA-3', 5'-
TGTACA-3' and 5'-TCTACA-3' sites that were analyzed are shown on the right side of the gel. 
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Table 3.1. Equilibration Association Constants (M- I )" 
Polyamide 5'-TTTACA-3' 5'-TATACA-3' 
1 1.9 (±0.3) x lOll 1.2 (±O.I) x 1011 
2 1.9 (±O.I) x 10111 1.9 (±0.3) x 10 10 
3 
4 
1.0 (±0.2) x 10111 
2.6 (±0.9) x 10111 
1.0 (±0.1) x 10111 
8.4 (± 1.0) x 109 
5'-TGTACA-3' 
3.5 (± 1.0) x 1010 
6.3 (±1.7) x 109 
1.5 (±0.6) x 109 
4.7 (±0.5) x lOR 
5' -TCTACA-3' 
1.7 (±0.7) x 10111 
3.7 (±0.6) x 109 
::;1.0 x lOR 
::;1.0 x lOR 
aValues reported are mean values from at least three DNase I footprint titration experiments, with the 
standard deviation for each data set indicated in parentheses. The assays were perfomed at 22°C at pH 7.0 
in the presence of 10 mM Tris·HCI, 10 mM KCI, 10 mM MgCI2, and 5 mM CaCI2 • 
Table 3.2. Equilibration Association Constants (M- I )" 
Polyamide 5'-TTTACA-3' 5'-TATACA-3' 
5 1.5 x 109 5.7 X lOR 
6 2.1 X 10111 3.9 X 1010 
7 4.2 X 109 1.5 x 109 
8 4.6 X 1010 4.0x 10 111 
9 6.1 X 109 7.0x109 
10 2.6 X 1011 1.1 X lOll 
5'-TGTACA-3' 
5.5x1OR 
5.4 x 109 
4.9x1OR 
1.1 X 10111 
1.1 x 109 
4.0x 10111 
5'-TCTACA-3' 
1.3 x lOR 
1.6 X 109 
2.1 X lOR 
8.3 X 109 
1.0 X 109 
3.5 X 1010 
11 4.8x101O 5.7xlOlO 2.8x10 IO 6.lxl09 
aThe assays were performed at 22°C at pH 7.0 in the presence of 10 mM Tris· HCI, 10 mM KCI, 10 
mM MgCI2, and 5 mM CaCI2. 
Discussion 
BZPyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (1) demonstrates that a simple benzene ring is able 
to pair with a I-methylpyrrole ring (Bz/Py) to distinguish A-T/T-A base pairs from 
G-C/C-G base pairs in the minor groove of DNA. The Bz/Py pair is a higher affinity 
binder than the Py/Py pair at the terminal position. Interestingly, the Hb-lIPy pair with a 
single hydroxyl group did not discriminate T from A. The hydroxyl group is likely in the 
wrong conformation, oriented away from the floor of the minor groove and forming a 
hydrogen bond with the proximal carbonyl group. In order to force the hydroxyl group 
toward the minor groove of the DNA by an unfavorable steric interaction, two 2-
hydroxybenzamides substituted at the 6 position with methyl- and methoxy- were 
examined. Quantitative footprint titration reveal that T versus A discrimination can be 
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achieved with the 6-methoxy but not 6-methyl derivative. These results suggest that the 
6-methyl substituent projecting to the floor of the helix is not large enough to prevent the 
hydroxyl group from hydrogen bonding to the carbonyl group. Presumably the steric bulk 
of the 6-methoxy group favors the rotamer with the hydroxyl group oriented toward the 
minor groove (Figure 3.7). Polyamide 4 with the Hb-3/Py pair binds 5'-TTTACA-3' and 
5'-TATACA-3' with binding affinities of Ka = 2.6 X lOloM-I and Ka = 8.4 X 109 M-I, 
respectively. Although the three-fold T versus A selectivity is similar to the Hp-3/Py pair, 
the overall affinity is significantly higher, and most importantly, the selectivity of AfT vs 
G/C is dramatically improved. The new hydroxybenzamide/pyrrole pair (Hb/Py) is a step 
towards hairpin polyamides capable of differentiating pure A-T tract sequences important 
in gene regulation studies. 
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Boc-p-alanine-( -4-carboxamidomethy I )-benzy I-ester -copoly( styrene-di viny lbenzene) 
reSlll (Boc-P -PAM-Resin), N ,N' -Dicyclohexylcarbodiimide (DCC), N-
Hydroxybenzotriazole (HOBt), 2-( IH-Benzotriazole-l-yl)-I, 1,3,3-tetramethyluronium 
hexa-fluorophosphate (HBTU) and Boc-p-alanine were purchased from Peptides 
International. N,N-diisopropylethylamine (DIEA) and N,N-dimethylformamide (DMF), 
were purchased from Applied Biosystems. The DMF was distilled under reduced 
pressure prior to synthesis. (R)-2-Fmoc-4-Boc-diaminobutyric acid was from Bachem, 
dichloromethane (DCM) was reagent grade from EM, thiophenol (PhS H) and 
dimethylaminopropylamine from Aldrich, and trifluoroacetic acid (TFA) from 
Halocarbon. I H NMR were recorded on a Varian Mercury 300 instrument. Chemical 
shifts are reported in ppm downfield from the signal for Me4Si, with reference to the 
solvent residual signal. UV spectra were measured on a Hewlett-Packard Model 8452A 
diode array spectrophotometer. Matrix-assisted, laser desorptionlionization time of flight 
mass spectrometry was carried out at the Protein and Peptide Microanalytical Facility at 
the California Institute of Technology. HPLC analysis was performed on a Beckman 
Gold system using a RAIN EN CIS, Microsorb MV, 5flm, 300 x 4.6 mm reversed-phase 
column in 0.1 % (w/v) TFA with acetonitrile as eluent and a flow rate of l.0 mLimin, 
gradient elution l.25% acetonitrile/min. Preparatory HPLC was carried out on a 
Beckman HPLC using a Waters DeltaPak 25 x 100 mm, lOOflm CIS column, 0.1 % (w/v) 
TFA, 0.25% acetonitrile/min. 18MQ water was obtained from a Millipore MilliQ water 
purification system, and all buffers were 0.2flm filtered. Reagent-grade chemicals were 
used unless otherwise stated. 
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Boc-PyPyPy-(R)Fmocy- ImP y P y P y - ~ -PAM-resin. Boc-PyPyPy-(R)Fmocy-
ImPyPyPy-~-PAM-resin (0.335 mmollg) was synthesized, as previously reported\ III a 
stepwise fashion from 0.55 mmol/g Boc-~-PAM-resin by manual solid-phase methods. 
Procedure for cleavage from the resin. After the coupling was completed, the resin 
was filtered off the reaction and washed with DMF (2 x 30 seconds). DMF (l mL) and 
piperidine (3 rnL) were added and the mixture shaken for 30 minutes at 22°C. The resin was 
filtered off and washed with DMF (2 x 30 seconds), DCM (3 x 30 seconds), MeOH (l x 30 
seconds), Et20 (1 x 30 seconds) and dried in vacuo. The resin was treated with 
(dimethylamino)propylamine (1 mL) with periodic agitation at 55°C for 16 hours. The 
reaction mixture was then filtered to remove the resin, TFA (0.1 % (w/v), 7 mL) added and 
the resulting solution purified by reversed-phase HPLC. The pure compounds were 
recovered as white powders upon lyophilization of the appropriate fractions. 
Deprotection of methyl-protected polyamides. To a slurry of NaH (80 mg, 60% in 
mineral oil) in DMF (0.50 mL) was added a solution of ethanethiol (0.32 mL) in DMF (0.50 
mL) and the mixture was heated to 100°C for 5 minutes in a sealed tube. The polyamide, 
dissolved in DMF (1.00 rnL), was added to the ethanethiolate solution and the mixture was 
heated to 100°C for I hour in a sealed tube, and then cooled to DoC. The mixture was added 
to HOAc (3 mL) and all volatiles were removed (high vacuum, 40°C). The residue was 
dissolved in CH3CN (1 mL) and TFA (7 mL, 0.1 % (w/v» and purified by preparative 
HPLC. 
BzPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (1). Benzoic acid (70 mg, 0.57 mmol) was 
dissolved in DMF (1.0 mL) and HBTU (75 mg, 0.20 mmol) and DIEA (0.5 mL) were 
added. The mixture was allowed to stir for 10 minutes and added to the deprotected Boc-
PyPyPy-(R)Fm()cy-ImPyPyPy-~-PAM-resin (100 mg). The mixture was shaken for 5.0 hours 
at 22°C, and the polyamide was cleaved from the resin according to the general procedure. 
Preparative HPLC gave 1 (16 mg, 39% recovery). UV Amax (H20) 240, 312 (69500); 1 H 
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NMR (DMSO-d6) 8 11.10, 10.42, 10.20, 10.07, 10.04, 10.02,9.97 (s, IH each), 9.41 (bs, 1 
H), 8.42 (bs, 2 H), 8.26 (t, 1 H, ] = 5.7 Hz), 8.12 (q, 2 H, ] = 5.6 Hz), 8.00 (dd, 2 H, ] = 6.3, 
1.5 Hz), 7.56-7.70 (m, 3 H), 7.40 (d, 1 H, ] = 1.5 Hz), 7.33 (d, 1 H, ] = 1.5 Hz), 7.30 (d, 1 H, 
] = 1.8 Hz), 7.28 (d, 1 H, ] = 1.5 Hz), 7.26 (d, 1 H, ] = 2.1 Hz), 7.25 (d, 1 H, ] = 2.1 Hz), 
7.21 (d, 1 H, ] = 2.1 Hz), 7.18 (d, 1 H, ] = 1.8 Hz), 7.15 (d, 2 H, ] = 1.5 Hz), 7.05 (d, 1 H, ] 
= 2.1 Hz), 6.95 (d, 1 H, ] = 1.5 Hz), 4.05, 3.94, 3.93, 3.92, 3.91,3.88,3.87 (s, 3 H each), 
3.30-3.50 (m, 4 H), 3.17 (q, 2 H, ] = 6.3 Hz), 3.06 (p, 2 H, ] = 4.8 Hz), 2.81 (d, 6 H, ] = 4.8 
Hz), 2.42 (t, 2 H, ] = 7.2 Hz), 2.00-2.10 (m, 2H), 1.81 (p,2 H, ] = 7.5 Hz); MALDI-TOF-
MS calcd. for C6(#nN2001O (M+H): 1233.6; found: 1233.7. 
(Hb-l)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (2). 2-Methoxybenzoic acid (70 mg, 0.46 
mmol) was dissolved in DMF (1.0 mL) and HBTU (75 mg, 0.20 mmol) and DIEA (0.5 mL) 
were added. The mixture allowed to stir for 10 minutes and then added to the deprotected 
Boc-PyPyPy-(R)Fmocy-ImPyPyPy-~-PAM-resin (100 mg). The mixture was shaken for 4.5 
hours at 22°C and the polyamide was cleaved from the resin according to the general 
procedure. Preparative HPLC gave methylprotected (Hb-l)PyPyPy-(R)H2Ny-ImPyPyPy-~­
Dp (15 mg, 35% recovery). UV Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 
11.10, 10.19, 10.07 (s, 1 H each), 10.03 (s, 2 H), 10.01, 9.97 (s, 1 H each), 8.38-8.50 (bs, 2 
H), 8.26 (t, 1 H, ] = 6.0 Hz), 8.12 (q, 2 H, ] = 6.0 Hz), 7.72 (d, 1 H, ] = 1.8 Hz), 7.69 (d, 1 
H, ] = l.8 Hz), 7.61 (s, 1 H), 7.58 (d, 1 H, ] = 2.1 Hz), 7.55 (bs, 1 H), 7.52 (d, 1 H, ] = 1.8 
Hz), 7.38 (d, 1 H, ] = 1.8 Hz), 7.33 (d, 1 H, ] = 1.5 Hz), 7.29 (d, 1 H, ] = 1.5 Hz), 7.28 (d, 1 
H, ] = l.5 Hz), 7.25 (s, 2 H), 7.22 (s, 1 H), 7.10-7.20 (m, 4 H), 7.05 (d, 1 H, ] = 1.5 Hz), 
6.95 (d, 1 H, ] = 1.5 Hz), 4.05, 3.96, 3.93, 3.92, 3.91,3.90, 3.88, 3.87 (s, 3 H each), 3.30-
3.50 (m, 4 H), 3.17 (q, 2 H, ] = 6.0 Hz), 3.07 (p, 2 H, ] = 5.7 Hz), 2.80 (d, 6 H, ] = 4.8 Hz), 
2.42 (t, 2 H, ] = 7.2 Hz), 2.06 (bs, 2 H), 1.80 (p, 2H, ] = 8.7 Hz); MALDI-TOF-MS calcd. 
for C61H74N20011 (M+H): 1263.6; found: 1263.7. The methylprotected (Hb-l)PyPyPy-
(R)H2Ny-ImPyPyPy-~-Dp (3.1 mg, 2.5 /lmol) was deprotected according to the general 
procedure to give 2 (0.5 mg, 16% recovery). UV Amax (H20) 240, 312 (69500); IH NMR 
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(DMSO-d6) 8 12.25, 10.96, 10.43, 10.06,9.92,9.90,9.88,9.83 (s, 1 H each), 8.25 (bs, 3 H), 
8.13 (t, 1 H, ] = 5.9 Hz), 7.98 (q, 2 H, ] = 6.0 Hz), 7.92 (dd, 1 H, ] = 8.4, 1.8 Hz), 7.48 (s, 1 
H), 7.37 (ddd, 1 H, ] = 8.7, 7.2, 1.5 Hz), 7.28 (d, 1 H, ] = 1.5 Hz), 7.20 (d, 1 H, ] = 1.8 Hz), 
7.17 (d, 1 H, ] = 1.5 Hz), 7.14 (d, 1 H, ] = 1.5 Hz), 7.11 (bs, 2 H), 7.08 (d, 1 H, ] = 1.5 Hz), 
7.07 (d, 1 H, ] = 2.1 Hz), 7.02 (d, 2 H, ] = 1.5 Hz), 6.85-6.95 (m, 3 H), 6.82 (d, 1 H, ] = 1.5 
Hz), 3.92, 3.82, 3.79, 3.78, 3.77, 3.75, 3.73 (s, 3 H each), 3.04 (q, 2 H, ] = 6.6 Hz), 2.93 (bt, 
2 H, ] = 7.2 Hz), 2.68 (bs, 6 H), 2.28 (t, 2 H, ] = 7.2 Hz), 1.92 (bq, 2 H, ] = 7.7 Hz), 1.67 (p, 
2 H, ] = 7.8 Hz); MALDI-TOF-MS calcd. for C6oHnN20011 (M+H): 1249.6; found: 
1249.7. 
(Hb-2)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (3). 2-Methoxy-6-methylbenzoic acid (26 
mg, 0.16 mmol) was dissolved in DMF/DCM (1: 1,0.2 mL) and added to a mixture of DMF 
(0.1 mL) and oxalylchloride (2M in DCM, 0.072 mL). The mixture was allowed to stir for 
20 minutes and DMF (0.3 mL) and DIEA (0.2 mL) were added. The mixture was then added 
to the deprotected Boc-PyPyPy-(R)Fmocy-ImPyPyPy-~-PAM-resin (50 mg) and shaken for 
4.0 hours at 22°C. The polyamide was cleaved from the resin according to the general 
procedure. Preparative HPLC afforded methylprotected (Hb-2)PyPyPy-(R)H2Ny-ImPyPyPy-
~-Dp (9 mg, 41 % recovery). UV Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 
10.27, 10.19 (s, 1 H each), 10.03 (s, 2 H), 10.00,9.97 (s, 1 H each), 8.26 (t, 1 H, ] = 6.0 Hz), 
8.12 (q, 2 H, ] = 5.1 Hz), 7.61 (s, 1 H), 7.30-7.40 (m, 3 H), 7.29 (d, 1 H, ] = 1.5 Hz), 7.28 
(d, 1 H, ] = 2.4 Hz), 7.25 (bs, 2 H), 7.22 (d, 1 H, ] = 1.8 Hz), 7.15 (bs, 2 H), 7.04, 7.03, 7.00, 
6.96 (s, 1 H each), 6.95 (d, 1 H, ] = 1.5 Hz), 6.93, 6.91 (s, 1 H each), 4.05 (2, 3 H), 3.92, 
3.91 (s, 6 H each), 3.88, 3.87, 3.81 (s, 3 H each), 3.30-3.50 (m, 4 H), 3.17 (q, 2 H, ] = 6.0 
Hz), 3.05 (bt, 2 H, ] = 7.6 Hz), 2.79 (s, 6H), 2.42 (t, 2 H, ] = 7.2 Hz), 2.27 (s, 3 H), 2.06 (bs, 
2H), l.80 (p, 2 H, ] = 8.1 Hz); MALDI-TOF-MS calcd. for C62H76N20011 (M+H): 1277.6; 
found: 1277.7. The methylprotected (Hb-l)PyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (3.1 mg, 2.4 
/-lmo!) was deprotected according to the general procedure to give 3 (1.4 mg, 48% recovery). 
UV Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 10.19, 10.18, 10.03, 10.02, 
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10.00,9.96,9.63 (s, 1 H each), 8.25 (bt, 1 H, J = 5.8 Hz), 8.12 (q, 2 H, J = 3.4 Hz), 7.61 (s, 
1 H), 7.32 (d, 1 H, J= 1.7 Hz), 7.31 (d, 1 H, J= 1.8 Hz), 7.29 (d, 1 H, J= 2.1 Hz), 7.28 (d, 1 
H, J = 2.1 Hz), 7.24 (d, 2 H, J = 1.8 Hz), 7.22 (d, 1 H, J = 1.5 Hz), 7.10-7.20 (m, 3 H), 7.06 
(d, 1 H, J = 2.1 Hz), 7.04 (d, 1 H, J = 1.8 Hz), 6.95 (d, 1 H, J = 1.5 Hz), 6.78 (d, 1 H, J = 8.1 
Hz), 6.73 (d, 1 H, J = 7.2 Hz), 4.05 (s, 3 H), 3.92, 3.91 (s, 6 H each), 3.88, 3.87 (s, 3 H 
each), 3.17 (q, 2 H, J = 6.0 Hz), 3.04 (bs, 2 H), 2.78 (s, 6 H), 2.41 (t, 2 H, J = 6.9 Hz), 2.25 
(s, 3 H), 2.05 (bs, 2 H), 1.79 (p, 2 H, J = 6.6 Hz); MALDI-TOF-MS calcd. for 
C61H74N20011 (M+H): 1263.6; found: 1263.7. 
(Hb-3)PyPyPy-(R)H2N'Y-ImPyPyPy-~-Dp (4). 2,6-Dimethoxybenzoic acid (28 mg, 
0.16 mmol) was dissolved in DMF/DCM (1: 1, 0.2 mL) and added to a mixture of DMF (0.1 
mL) and oxalylchloride (2M in DCM, 0.072 mL). The mixture was allowed to stir for 20 
minutes and DMF (0.3 mL) and DIEA (0.2 mL) were added. The mixture was added to the 
deprotected Boc-PyPyPy-(R)Fmoc'Y-ImPyPyPy-~-PAM-resin (50 mg) and shaken for 3.0 
hours at 22°C. The polyamide was then cleaved from the resin according to the general 
procedure. Preparative HPLC gave methylprotected (Hb-3)PyPyPy-(R)H2N'Y-ImPyPyPy-~­
Dp (10 mg, 48% recovery). UV "-max (H20) 240, 308 (69500); IH NMR (DMSO-d6) () 
10.96, 10.06, 10.03,9.90,9.88,9.87,9.83 (s, 1 H each), 8.26 (bs, 3 H), 8.12 (t, 1 H, J = 6.2 
Hz), 7.99 (q, 2 H, J = 5.7 Hz), 7.48 (s, 1 H), 7.27 (t, 2 H, J = 8.4 Hz), 7.20 (d, 1 H, J = 1.6 
Hz), 7.16 (d, 1 H, J = 1.8 Hz), 7.14 (d, 1 H, J = 2.1 Hz), 7.13 (d, 1 H; J = 1.8 Hz), 7.11 (d, 1 
H, J = 1.5 Hz), 7.08 (d, 1 H, J = 1.5 Hz), 7.02 (d, 1 H, J = 1.9 Hz), 7.01 (d, 1 H, J = 1.6 Hz), 
6.90 (d, 1 H, J = 1.5 Hz), 6.89 (d, 1 H, J = 2.1 Hz), 6.82 (d, 1 H, J = 1.8 Hz), 6.66, 6.63 (s, 1 
H each), 3.92, 3.79, 3.78 (s, 3 H each), 3.78 (s, 6 H), 3.75, 3.74 (s, 3 H each), 3.67 (s, 6 H), 
3.04 (q, 2 H, J = 6.0 Hz), 2.94 (p, 2 H, J = 4.8 Hz), 2.68 (d, 6 H, J = 4.5 Hz), 2.28 (t, 2 H, J 
= 6.9 Hz), 1.94 (bs, 2 H), 1.67 (p, 2 H, J = 7.6 Hz); MALDI-TOF-MS calcd. for 
C62H 76N 20012 (M+H): 1293.6; found: 1293.7. The methylprotected (Hb-3)PyPyPy-
(R)H2N'Y-ImPyPyPy-~-Dp (2.7 mg, 2.1 /-Imol) was deprotected according to the general 
procedure to give 4 (1.9 mg, 42% recovery) together with (2,6-dihydroxybenzoyl)HN-
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PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (1.3 mg, 28% recovery). UV Amax (H20) 240, 310 
(69500); IH NMR (DMSO-d6) () 11.84, 10.08, 10.06, 9.89, 9.88, 9.83 (s, 1 H each), 8.25 
(bs, 3 H), 8.12 (t, 1 H, J = 5.7 Hz), 7.98 (q, 2 H, J = 4.8 Hz), 7.48 (s, 1 H), 7.18-7.28 (m, 3 
H), 7.16 (d, 1 H, J = 1.5 Hz), 7.14 (d, 1 H, J = 1.5 Hz), 7.11 (bs, 2 H), 7.08 (d, 1 H, J = 1.5 
Hz), 7.02 (d, 2 H, J = 1.5 Hz), 7.01 (d, IH, J = 1.8 Hz), 6.91 (d, 1 H, J = 1.5 Hz), 6.83 (d, 1 
H, J = 1.8 Hz), 6.52 (d, IH, J = 7.8 Hz), 6.47 (d, 1 H, J = 8.4 Hz), 3.92 (s, 3 H), 3.80 (s, 6 
H), 3.79, 3.78, 3.77, 3.75, 3.73 (s, 3H each), 3.04 (q, 2 H, J = 6.0 Hz), 2.94 (p, 2 H, J = 4.8 
Hz), 2.68 (d, 6 H, J = 4.2 Hz), 2.28 (t, 2 H, J = 7.5 Hz), 1.94 (bq, 2H, J = 8.4 Hz), 1.67 (p, 2 
H, J = 8.7 Hz); MALDI-TOF-MS calcd. for C61H74N20012 (M+H): 1279.6; found: 1279.7. 
2,6-DimethylbensoylHN-PyPyPy-(R)H2Ny-ImPypypy-P-Dp (5). 
2,6-Dimethylbenzoic acid (24 mg, 0.16 mm01) was dissolved in DMF/DCM (1: 1, 0.2 mL) 
and added to a mixture of DMF (0.1 mL) and oxalylchloride (2M in DCM, 0.072 mL). The 
mixture was stirred for 20 minutes and DMF (0.3 mL) and DIEA (0.2 mL) were added. The 
mixture was then added to the deprotected Boc-PyPyPy-(R)Fmocy-ImpyPyPy-p-PAM-resin 
(50 mg) and shaken for 4.0 hours at 22°C. Preparative HPLC gave 5 (6 mg, 27% recovery). 
UV Amax (H20) 240, 312 (69500); MALDI-TOF-MS calcd. for C62H76N20010 (M+H): 
1261.6; found: 1261.8. 
2,6-Dihydroxy-bensoylHN-PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (6). 
Methyl-protected 4 (2.1 mg, 1.6 flmo1) was deprotected according to the general procedure 
but heated for 7.5 hours. Preparative HPLC gave 6 (0.6 mg, 29% recovery). UV Amax (H20) 
240, 310 (69500); MALDI-TOF-MS calcd. for C6oHnN20012 (M+H): 1265.6; found: 
1265.5. 
(2-Hydroxy-l-naphtoyl)HN-PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (9). 
2-Methoxy-1-naphtoic acid6 (32 mg, 0.16 mmo1) was dissolved in DMF/DCM (1:1, 0.2 mL) 
and added to a mixture of DMF (0.1 mL) and oxa1ylch10ride (2M in DCM, 0.072 mL). The 
mixture was stirred for 20 minutes and DMF (0.3 mL) and DIEA (0.2 mL) were added. The 
mixture was then added to the deprotected Boc-PyPyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin 
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(50 mg) and shaken for 3.0 hours at 22°C. Preparative HPLC gave methylprotected 9 (7 mg, 
33% recovery). UV Amax (H20) 230, 314 (69500); IH NMR (DMSO-d6) () ; MALDI-TOF-
MS calcd. for C6SH76N200)) (M+H): 1313.6; found: 1313.7. The methylprotected 
compound (3.4 mg, 2.6 ~mol) was treated according to the general procedure. Preparative 
HPLC gave 9 (1.8 mg, 54% recovery). UV Amax (H20) 230, 314 (69500) ; MALDI-TOF-
MS calcd. for C64H74N20011 (M+H): 1299.6; found: 1299.7. 
2,6-Ditluoro-bensoyIHN-PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (10). 
2,6-Difluoro-benzoic acid (70 mg, 0.44 mmol) was dissolved in DMF (1.0 mL) and HBTU 
(75 mg, 0.20 mmol) and DIEA (0.5 mL) were added and the mixture stirred for 10 minutes 
and added to the deprotected Boc-PyPyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin (100 mg) and 
the mixture shaken for 5.0 hours at 22°C. Preparative HPLC gave 10 (8 mg, 20% recovery). 
UV Amax (H20) 240, 307 (69500); MALDI-TOF-MS calcd. for C60H70F2N20010 (M+H): 
1269.6; found: 1269.7. 
Indolyl-PyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (11). 
I-Methyl indole-2-carboxylic acid (57 mg, 0.32 mmol) was dissolved in DMF (1.0 mL) and 
HOBt (30 mg, 0.22 mmol) and DCC (46 mg, 0.23) were added and the mixture stirred for 10 
minutes and added to the deprotected Boc-PyPyPy-(R)Fmocy-ImPyPyPy-p-PAM-resin (l00 
mg) followed by DIEA (0.5 mL) and the mixture shaken for 3.0 hours at 22°C. Preparative 
HPLC gave 11 (10 mg, 24% recovery). UV Amax (H20) 240, 312 (69500); MALDI-TOF-
MS calcd. for C63H7SN21 010 (M+H): 1286.6; found: 1286.6. 
Quantitative DNase I Footprinting. DNase I Footprinting reactions were carried 
out on the 284 bp EcoRI / Pvull restriction fragment of pCW15 as previously described.3 
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Chapter 4 
Expanding the Recognition of the Minor Groove 
of DNA by Hairpin Polyamides to Include 
5'-CWWC-3' Sequences 
The text of this chapter was taken in partfrom a publication coauthored with Dr. U(l 
Ellervik and Pr(~f Peter B. Dervan. 
(Wang, c. c. c.; Ellervik, U.; Dervan, P. B. Bioorg. Med. Chern. 2001, 3, 653-657.) 
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Abstract 
In order to evaluate hairpin polyamides capable of distinguishing C-G base pairs at the 
terminal position three polyamides, PyPyPyPy-(R)H2Ny-ImPyPyIm-p-Dp (1), PyPyPyPy-
(R)H2Ny-ImPy-p-Im-p-Dp (2) and BZPyPyPy-(R)H 2Ny-ImPy-p-Im-p-Dp (4) were 
synthesized. The equilibrium association constants (Ka) were determined at four DNA 
sites which differ at a single common position, 5'-TNTACA-3' (N = T, A, G, C). 
Quantitative DNase I footprint titration experiments reveal that PyPyPyPy-(R)H2Ny-
ImPyPyIm-p-Dp (1) binds the four binding sites with similar affinities, Ka = 1.3-1.9 x 
1010 M -I indicating that there is no preference for any specific base pair. In contrary 
PyPyPyPy-(R)H2Ny-ImPy-p-Im-p-Dp (2) with a flexible aliphatic p-alanine next to the 
key imidazole group bound to the match site 5'-TCTACA-3' with Ka = 4.9 X 1OIoM-I 
and the single base pair mismatch sites with 5-25-fold lower affinity. Compound 4 
showed similar results to compound 2. These results expand the repertoire of sequences 
targetable by hairpin to include sequences in promoters beginning with C-G base pairs 
and will be an important step forward in our gene regulation studies. 
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Introduction 
Polyamides containing three aromatic amino acids, N-methylpyrrole (Py), N-
methyl imidazole (1m) and 3-hydroxy-l-methylpyrrole (Hp), bind as antiparallel pairs in 
the minor groove of DNA with affinities and specificities for predetermined sequences 
comparable to DNA-binding proteins.! Im/Py pair binds G-C, while a Pyllm pair 
recognizes C-G. A Py/Py pair binds both A-T and T-A base pairs in preference to G-C 
and C-G. An Hp/Py pair prefers T-A over A-T, C-G or G-e. 
Polyamide dimers linked by a y turn unit creates a hairpin structure which sets the 
ring pairs unambiguously in register.2 We have observed that hairpin polyamides with 1m 
at the N-terminal position usually have higher affinities than the corresponding Py 
analogs.! The placement of an 1m and Py in the first and eighth position of an eight-ring 
polyamide create an ImlPy pair at the N- and C-terminal positions of the hairpin, biasing 
our choice of target DNA sequences beginning with a G-C base pair.! 
We would like to explore ring pairings that would allow the DNA sequence 
repertoire to be broadened wherein the target sequence begins in a C-G base pair. We 
have shown that Py/lm pairs when placed internal in a hairpin distinguish C-G from 
G-e.' However, this has not been demonstrated for the terminal position in hairpin 
polyamides where the 1m residue would necessarily be placed at the C-terminus. 
Replacement of a Py ring with a flexible ~-alanine amino acid has been demonstrated to 
be necessary to target GWG sequences.4 It remains to be determined whether a flexible ~­
alanine linker would also be necessary to allow targeting of C-G in the terminal position. 
The ability to target DNA sequences in promoters beginning with C-G base pairs will be 
an important step forward in our gene regulation studies.! 
We describe here three eight-ring hairpin polyamides with Py/Im at the N-
terminal and C-terminal positions (Figure 4.1). PyPyPyPy-(R)H2Ny-ImPyPyIm-~-Dp (1) 
contains eight ring residues and PyPyPyPy-(R)H2Ny-lmPy-~-Im-~-Dp (2) and BzPyPyPy-
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(R)H2Ny-ImPy-p-Im-p-Dp (4) contain a flexible p-alanine amino acid and seven other 
rings residues. In addition, ImPyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (3)5 was included to 
establish a baseline with previously published work (Figure 4.2). All four eight-ring 
hairpin polyamides were synthesized by solid-phase methods.6 The plasmid pCW155 was 
designed to contain the four six-base pair recognition sites 5' -TTT ACA-3' , 5' -TAT ACA-
3', 5'-TGTACA-3' and 5'-TCTACA-3' which differ at a single common position 
allowing for comparison of the affinities between different terminal pairs and the four 
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Figure 4.1. (a) Hydrogen bonding model of the polyamide:DNA complex between eight-ring hairpin 
polyamide PyPyPyPy-(R)H2Ny-ImPyPyIm-~-Dp and a 5'-TCTACA-3' site. A circle with two dots 
represents the lone pairs of N3 of purines and 02 of cytosine. Two touching circles with dots represent the 
two lone pairs of the 02 of thymine. Circles containing an H represent the exocyclic amino hydrogen of 
guanine. Putative hydrogen bonds are illustrated by dotted lines. (b) Hydrogen bonding model of the 
polyamide:DNA complex between seven-ring hairpin polyamide PyPyPyPy-(R)H2Ny-ImPy-~-Im-~-Dp 
and a 5'-TCTACA-3' site. 
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Figure 4.2. Structures of polyamides. PyPyPyPy-(R)H2Ny-ImPyPyIm-~-Dp (1), PyPyPyPy-(R)H2Ny-
ImPy-~-Im-~-Dp (2), ImPyPyPy-(R)H2NY-ImPypypy -~-Dp (3), BzPyPyPy-(R)H2Ny-ImPy-~-Im-~-Dp 
(4). 
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Figure 4.3. 284 base pair EcoRU Pvull restriction fragment derived from plasmid pew 15. The targeted six-
base pair recognition sites are shown in boxes. 
Results 
Polyamide synthesis. PyPyPyPy-(R)Fmocy-ImPyPylm-~-PAM-resin and 
PyPyPyPy-(R)Fmocy-ImPy-~-Im-~-PAM-resin were synthesized in a stepwise manner 
from Boc-~-alanine-PAM resin (0.55 mmol/g) using solid-phase methodologl in 14 
steps (Figure 4.4). A sample of the resin was then cleaved by aminolysis with 
«dimethyl)amino)propylamine (55°C, 16 hours) and purified by reversed-phase HPLC to 
provide PyPyPyPy-(R)H2Ny-ImPyPylm-~-Dp (1) PyPyPyPy-(R)H2Ny-ImPy-~-Im-~-Dp 
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Figure 4.4. Solid-phase synthetic scheme for PyPyPyPy-(R)H2Ny-1mPy-~-1m-~-Dp (2) starting from 
commercially available Boc-~-PAM-resin: (i) 80% TFA/DCM, 0.4 M PhSH. (ii) Boc-~-Ala-Im-acid, 
HBTU, DIEA, DMF. (iii) 80% TFA/DCM, 0.4 M PhSH. (iv) Boc-Py-OBt, DIEA, DMF. (iii) 80% 
TFA/DCM, 0.4 M PhSH. (iv) Boc-1m-acid, DCC, HOBt, DIEA, DMF. (v) 80% TFAlDCM, 0.4 M PhSH. 
(vi) Fmoc-a-Boc-y-diaminobutyric acid, HBTU, DIEA, DMF.(vii) 80% TFA/DCM, 0.4 M PhSH. (viii) 
Boc-Py-OBt, DIEA, DMF. (ix) 80% TFAIDCM, 0.4 M PhSH. (x) Boc-Py-OBt, DIEA, DMF. (xi) 80% 
TFA/DCM, 0.4 M PhSH. (xii) Boc-Py-OBt, DIEA, DMF. (xiii) 80% TFA/DCM, 0.4 M PhSH. (xiv) Py-
acid, HBTU, DIEA, DMF. (xv) Piperidine:DMF 3: I. (xvi) (Dimethylamino)propylamine, 55°C, l6h. 
Quantitative DNase I footprinting titrations. Quantitative DNase I footprint 
titrations on the 3'-32P-end-Iabeled 284 bp pCW15 EcoRIIPvuII restriction fragment (10 
mM Tris-HCI, 10 mM KCI, 10 mM MgCb and 5 mM CaCI2, pH 7.0, 22°C) (Figure 4.5) 
reveal that PyPyPyPy_(R)H2Ny-ImPyPyIm-~-Dp (1) binds the four binding sites with 
similar affinities, Ka = 1.3-1.9 x 1010 M -I, indicating that there is no preference for any 
specific base pair (Table 1). In contrary compound 2 with a flexible aliphatic ~-alanine 
next to the key imidazole group bound the 5'-TCTACA-3' site with Ka = 4.9 X 1OIOM-I 
and the single base pair mismatched sites 5'-TGTACA-3', 5'-TTTACA-3'and 5'-
TATACA-3' with lower affinities (Ka = 1.0 x 10IoM-I, Ka = 8.0 X 109 M-l and Ka = 2.0 
X 109 M-l respectively). Compound 4 showed results similar to compound 2. The control 
compound ImPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (3) bound the 5' -TGTACA-3' site with 
Ka = 2.9 X 1011 M -I and the three single base pair mismatches at lower affinities (Ka = 
59 































• C, -,":'CTACA 3' 
S -';'GTA'-':-A-3' 
1.2 
• ') -'T'CTACA-j' 
-'['G'rACP,-3 ' 
-0.2 -0.2 
10. 13 10.12 10"11 10. 10 10- 9 10.8 10-7 10-1310.1210-11 10. 10 10- 9 10- 8 10. 7 
~l ~l 
Table 4.1. Equilibration Association Constants (M' I )" 
Polyamide 5'-TTTACA-3' 5'-TATACA-3' 
1 1.7 (±0.3) x 1010 1.3 (±0.4) x 10 10 
2 8.0 (±2.0) x lOy 2.0 (±1.0) x lOY 
3 2.0 (±O.S) x 1010 1.1 (±0.2) x 1010 
4 1.2 (±O.I) x 1010 6.7 (±4.2) x lOY 
Figure 4.5. (a) Quantitative DNase I 
footprint titration experiment PyPyPyPy_ 
(R)H2Ny-ImPyPyIm-~-Dp (1) on the 284 bp 
EcoRIIPvulI restnctlOn fragment from 
plasmid pCWI5: lane I, intact DNA; lane 2, 
A specific reaction; lane 3, DNase I 
standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 
100 pM, 200 pM, 500 pM, I nM, 2 nM, 5 
nM, 10 nM PyPyPyPy-(R)H2Ny-
ImPyPylm-~-Dp (1); The four sites 5'-
TTTACA-3', 5'-TATACA-3', 5'-TGTACA-
3' and 5'-TCTACA-3' sites that were 
analyzed are shown on the right side of the 
gel. (b) Quantitative DNase I footprint 
titration PyPyPyPy-(R)H2Ny-ImPy-~-Im-~­
Dp (2) on the 284 bp EcoRIIPvuII restriction 
fragment from plasmid pCWI5: lane I, 
intact DNA; lane 2, A specific reaction lane 
3, DNase I standard; lanes 4-13, 10 pM, 20 
pM, 50 pM, 100 pM, 200 pM, 500 pM, I 
nM, 2 nM, 5 nM, 10 nM PyPyPyPy-
(R)H2Ny-ImPy-~-Im-~-Dp (2); The four 
sites 5'-TTTACA-3', 5'-TATACA-3', 5'-
TGTACA-3' and 5'-TCTACA-3' sites that 
were analyzed are shown on the right side of 
the gel. c) Binding isotherms derived from 
the DNase I footprinting gels of polyamide 1 
and the four different sites 5'-TTTACA-3', 
5'-TATACA-3', 5'-TGTACA-3' and 5'-
TCTACA-3'. d) Binding isotherms derived 
from the DNase I footprinting gels of 
polyamide 2 and the four different sites 5'-
TTTACA-3', 5'-TATACA-3', 5'-
TGTACA-3' and 5'-TCTACA-3'. 
5'-TGTACA-3' 5'-TCTACA-3' 
1.9 (±O.S) x 1011) 1.9 (±O.S) x 1010 
1.0 (±0.4) x 1010 4.9 (±0.9) x 1010 
2.9 (±O.S) x lOll 2.9 (±O.S) x 10 10 
1.4(±O.I)x lOll) 4.9 (± 1.8) x 1010 
"Values reported arc mean values from at least three DNase I footprint titration experiments, with the 
standard deviation for each data sct indicated in parentheses. The assays were perfomed at 22°C at pH 7.0 
in the presence of 10 mM Tris·HCI, 10 mM KCI, 10 mM MgCI 2, and 5 mM CaCI2• 
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Discussion 
PyPyPyPy-(R)H2Ny-ImPyPyIm-f3-Dp (1) showed no preference for its designed matched 
binding site 5' -TCTACA-3' over the three single base pair mismatches. The lack of 
discrimination could be due to the mispositioning of the 1m residue located at the C-
terminal end of the four ring polyamide subunit. PyPyPyPy-(R)H2Ny-ImPy-f3-Im-f3-Dp 
(2) instead showed a 5-25-fold selectivity for the 5'-TCTACA-3' site over the three 
single base pair mismatched sites. The replacement of a pyrrole ring with a flexible f3-
alanine resets the imidazole ring to provide the optimal hydrogen bond formation 
between the imidazole N3 and the exocyclic amine of guanine. This study opens the 
opportunity to target sequences starting at a C-G base pair and also validates the use of 
flexible f3-alanine residue to reset the register of the C-terminal imidazole amino acid. 
These results gives us an opportunity to target new biologically important DNA 
sequences. 
Experimental Section 
B oc-f3-alanine-(-4-carboxamidomethy 1)-benzy I-ester -copol y( styrene-di viny lbenzene) 
reSIn (B oc-f3 -PAM-Resin), N ,N' -Dicyclohexylcarbodiimide (DCC), N-
Hydroxybenzotriazole (HOBt), 2-( IH-Benzotriazole-l-yl)-I, 1,3,3-tetramethyluronium 
hexa-fluorophosphate (HBTU) and Boc-f3-alanine were purchased from Peptides 
International. N,N-diisopropylethylamine (DIEA) and N,N-dimethylformamide (DMF), 
were purchased from Applied Biosystems. DMF was distilled under reduced pressure 
prior to synthesis. (R)-2-Fmoc-4-Boc-diaminobutyric acid was from Bachem, 
dichloromethane (DCM) was reagent grade from EM, thiophenol (PhS H) and 
dimethylaminopropylamine from Aldrich, and trifluoroacetic acid (TFA) from 
Halocarbon. 1 H NMR were recorded on a Varian Mercury 300 instrument. Chemical 
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shifts are reported in ppm downfield from the signal for Me4Si, with reference to the 
solvent residual signal. UV spectra were measured on a Hewlett-Packard Model 8452A 
diode array spectrophotometer. Matrix-assisted, laser desorptionlionization time of flight 
mass spectrometry was carried out at the Protein and Peptide Microanalytical Facility at 
the California Institute of Technology. HPLC analysis was performed on a Beckman 
Gold system using a RAIN EN CIS, Microsorb MV, 5flm, 300 x 4.6 mm reversed-phase 
column in 0.1 % (w/v) TFA with acetonitrile as eluent and a flow rate of 1.0 mL/min, 
gradient elution 1.25% acetonitrile/min. Preparatory HPLC was carried out on a 
Beckman HPLC using a Waters DeltaPak 25 x 100 mm, lOOflm CIS column, 0.1 % (w/v) 
TFA, 0.25% acetonitrile/min. 18MQ water was obtained from a Millipore MilliQ water 
purification system, and all buffers were 0.2flm filtered. Reagent-grade chemicals were 
used unless otherwise stated. 
PyPyPyPy_(R)Fmocy-ImPyPyIm-~-PAM-resin and PyPyPyPy_(R)Fmocy-ImPy-
~-Im-~-PAM-resin PyPyPyPy-(R)Fmocy-ImPyPyIm-~-PAM-resin (0.333 mmol/g) and 
PyPyPyPy-(R)Fmocy-ImPy-~-Im-~-PAM-resin (0.338 mmol/g) were synthesized in a 
stepwise fashion from 0.55 mmol/g Boc-~-PAM-resin by manual solid-phase methods. 6 (R)-
2-Fmoc-4-Boc-diaminobutyric acid was incorporated as previously described for Boc-y-
aminobutyric acid. 3(,6 
Procedure for cleavage from the resin. After the coupling was completed the resin 
was filtered off the reaction mixture and washed with DMF (2 x 30 seconds). DMF (1 mL) 
and piperidine (3 mL) were added and the mixture shaken for 30 minutes at 22°C. The resin 
was filtered off and washed with DMF (2 x 30 seconds), DCM (3 x 30 seconds), MeOH (l 
x 30 seconds), Et20 (l x 30 seconds) and dried in vacuo. The resin was treated with 
(dimethylamino)propylamine (l mL) with periodic agitation at 55°C for 16 hours. The 
reaction mixture was then filtered to remove the resin, TFA (0.1 % (w/v), 7 mL) added and 
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the resulting solution purified by reversed-phase HPLC. The pure compounds were 
recovered as white powders upon lyophilization of the appropriate fractions. 
PyPyPyPy_(R)H2Ny-ImPyPyIm-~-Dp (1). PyPyPyPy-(R)Fmocy-ImPyPyPy-~-PAM­
resin (100 mg) was cleaved and purified by preparative HPLC to give 1 (13 mg, 31 % 
isolated yield). UV Amax (H20) 240, 312 (69500); IH NMR (DMSO-d6) 8 10.97, 10.26, 
10.07 (s, 1 H each), 9.84-9.92 (m, 3 H), 9.78 (s, 1 H), 8.20-8.30 (m, 3 H), 8.12 ( t, 1 H, ] = 
5.8 Hz), 8.03 (t, 2 H, ] = 6.3 Hz), 7.91 (t, 1 H, ] = 5.8 Hz), 7.48 (s, 1 H), 7.44 (s, 1 H), 7.20 
(d, 1 H, ] = 1.2 Hz), 7.19 (d, 1 H, ] = 1.8 Hz), 7.16 (t, 2 H, ] = 1.5 Hz), 7.12 (d, 2 H, ] = 1.8 
Hz), 7.06 (d, 1 H, ] = 1.8 Hz), 7.02 (d, 1 H, ] = 1.8 Hz), 6.99 (d, 1 H, ] = 1.8 Hz), 6.90 (d, 1 
H, ] = 1.8 Hz), 6.89 (t, 1 H, ] = 2.1 Hz), 6.86 (dd, 1 H, ] = 2.1, 4.2 Hz), 5.99 (dd, 1 H, ] = 
2.7,4.2 Hz), 3.92, 3.87, 3.81, 3.80, 3.79, 3.78, 3.77, 3. 75 (s, 3 H each), 3.04 (q, 2 H, ] = 6.3 
Hz), 2.90-3.00 (m, 2 H), 2.67 (d, 6 H, ] = 4.8 Hz), 2.30 (t, 2 H, ] = 6.0 Hz), 1.90-2.00 (m, 2 
H), 1.66 (bp, 2 H, ] = 7.8 Hz); MALDI-TOF-MS calcd. for CSSH73N22010 (M+H): 1237.6; 
found: 1237.7. 
PyPyPyPy_(R)H2Ny-ImPy-~-Py- ~ -Dp (2). Py Py PyPy -(R)Fmocy-ImPy-~-Im-~­
PAM-resin (100 mg) was cleaved and purified by preparative HPLC to give 2 (8 mg, 18% 
isolated yield). UV Amax (H20) 240, 312 (60830); IH NMR (DMSO-d6) 8 1l.10, 10.44, 
10.13, 10.03, 10.01,9.92 (s, 1 H each), 8.40, (bs, 2 H), 8.26 (t, 1 H, ] = 6.0 Hz), 8.16 (t, 2 H, 
] = 6.0 Hz), 8.04 (t, 1 H, ] = 5.7 Hz), 7.60 (s, 1 H), 7.48 (s, 1 H), 7.30 (t, 2 H, ] = 1.5 Hz), 
7.29 (d, 1 H, ] = 1.8 Hz), 7.25 (d, 1 H, ] = 1.5 Hz), 7.15 (d, 1 H, ] = 1.5 Hz), 7.13 (d, 1 H, ] 
= l.5 Hz), 7.04 (d, 1 H, l.5 Hz), 7.00-7.15 (m, 2 H), 6.99 (dd, 1 H, ] = 2.1, 4.2 Hz), 6.13 
(dd, 1 H, ] = 2.4, 3.9 Hz), 4.04, 3.98, 3.95, 3.93, 3.92, 3.88, 3.87 (s, 3 H each), 3.30-3.40 (m, 
2 H), 3.17 (q, 2 H, ] = 6.0 Hz), 3.07 (p, 2 H, ] = 4.8 Hz), 2.81 (d, 6 H, ] = 5.1 Hz), 2.63 (d, 2 
H, ] = 6.9 Hz), 2.43 (t, 2 H, ] = 6.9 Hz), 2.00-2.10 (m, 2 H), 1.80 (p, 2 H, ] = 7.2 Hz); 
MALDI-TOF-MS calcd. for CssHnN21 010 (M+H): 1186.6; found: 1186.7. 
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BzPyPyPy-(R)H2Ny-ImPy~Py-~-Dp (4). A mixture ofDMF (l mL), DIEA (0.5 mL) 
and benzoyl chloride (0.05 mL, 0.4 mmol) was added to deprotected Boc-PyPyPy-(R)Fmocy-
ImPy~Im-~-PAM-resin (100 mg) and shaken for 10 minutes at 22°C. The compound was 
then cleaved and purified by preparative HPLC to give BzPyPyPy-(R)H2Ny-ImPy~Py-~-Dp 
(4) (8 mg, 17% isolated yield). UV Amax (H20) 240,312 (60830); IH NMR (DMSO-d6) () 
10.97,10.31, 10.30, 10.00,9.94,9.89 (s, 1 H each), 9.29 (bs, 1 H), 8.27 (bs, 2 H), 8.13 (t, 1 
H, ] = 5.7 Hz), 8.04 (t, 2 H, ] = 6.0 Hz), 7.85-7.95 (m, 3 H), 7.40-7.60 (m, 5 H), 7.34 (s, 1 
H), 7.27 (d, 1 H, ] = 1.8 Hz), 7.18 (d, 1 H, ] = 2.1 Hz), 7.16 (d, 1 H, ] = 1.8 Hz), 7.12 (d, 1 
H, ] = 1.8 Hz), 7.06 (d, 1 H, ] = 1.8 Hz), 7.02 (d, 1 H, ] = 1.8 Hz), 6.91 (d, 1 H, ] = 1.8 Hz), 
6.88 (d, 1 H, ] = 1.8 Hz), 3.90, 3.84, 3.82, 3.80, 3.79, 3.75, 3.74 (s, 3 H each), 3.36 (bp, 2 H, 
] = 6.0 Hz), 3.22 (q, 2 H, ] = 6.3 Hz), 3.03 (q, 2 H,J = 6.3 Hz), 2.93 (p, 2 H, ] = 5.7 Hz), 
2.67 (d, 6 H, ] = 4.8 Hz), 2.49 (t, 2 H, ] = 7.2 Hz), 2.29 (t, 2 H, ] = 6.6 Hz), 1.90-2.00 (m, 2 
H), 1.66 (p, 2 H, ] = 7.8 Hz); MALDI-TOF-MS calcd. for CS6H71N20010 (M+H): 1183.6; 
found: 1183.8. 
Preparation of 3'- and 5'-End-Labeled Restriction Fragments. The plasmid 
pCW15 5 was linearized with EcoRI and Pvull and then treated with Sequenase (version 2.0 
from United States Biochemical), deoxyadenosine 5'-[a-32P]triphosphate and thymidine 5'-
[a-32P]triphosphate for 3' labeling. The 3' labeled fragment was loaded onto a 7% non-
denaturing polyacrylamide gel, and the desired 284 base pair band was visualized by 
autoradiography and isolated. Chemical sequencing reactions were performed according to 
published methods. 7 
Quantitative DNase I Footprinting. DNase I Footprinting reactions were carried 
out as previously described. 3b Photostimulable storage phosphorimaging plates (Kodak 
Storage Phosphor Screen S0230 obtained from Molecular Dynamics) were pressed flat 
against gel samples and exposed in the dark at 22°C for 12-16 hours. A Molecular 
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Dynamics Typhoon PhosphorImager was used to obtain all data from the storage screens. 
The data were analyzed by performing volume integration of all bands using ImageQuant 
v. 3.2 software. All DNA manipulations were performed according to standard 
protocols.8 
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Chapter 5 
Incorporation of p-alanine to Restore Sequence Specificity in 
the Minor Groove of DNA by Hairpin Polyamides; 
Discrimination of 5'-CWWG-3' Sequences 
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Abstract: Eight-ring hairpin polyamides containing three aromatic amino acids, N-
methylpyrrole (Py), N-methylimidazole (1m) and 3-hydroxy-l-methylpyrrole (Hp) 
recognize predetermined six-base pair sites in the minor groove of DNA. ImPyPylm-
(R)H2Ny-PyPyPyPy-~-Dp (1) showed twofold preference for its designed matched 
binding site 5'-tAGTAGt-3' over the single base pair mismatch 5'-tAGTACt-3' while 
polyamide ImPy-~-Im-(R)H2Ny-PyPyPyPy-~-Dp (2) instead showed a six-fold selectivity 
for the 5' -tAGTAGt-3 site over the mismatched site. These results follow earlier findings 
where replacement of a pyrrole ring with a flexible ~-alanine resets the imidazole ring to 
provide the optimal hydrogen bond formation between the imidazole N3 and the 
exocyclic amine of guanine. This information was used to design polyamides to target a 
general 5' -CWWG-3' site. Polyamide PyPy-~-Im-(R)H2Ny-PyPy-~-Im-~-Dp (6), where 
two Py residues were replaced by ~-alanine, differentiated the 5'-tACTAGTg-3' site from 
the two mismatch sites 5'-tACTACTg-3' and 5'-tAGTAGTg-3'. 
This study opens the opportunity to target general 5' -CWWG-3' sequences and 
validates the use of flexible ~-alanine residue to reset the register of adjacent 1m residues 
within the hairpin motif and provides an opportunity to target new biologically important 
DNA sequences in gene regulation studies. 
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Introduction 
Polyamides containing three aromatic amino acids, N-methylpyrrole (Py), N-
methylimidazole (1m) and 3-hydroxy-l-methylpyrrole (Hp) are synthetic ligands that 
have affinities and specificities for DNA comparable to those of naturally occurring 
DNA-binding proteins.' DNA recognition depends on side by side antiparallel pairing of 
amino acids in the minor groove. Antiparallel pairing of 1m opposite Py (ImJPy) pair 
binds G-C, while a Py/lm pair recognizes C-G. A Py/Py pair binds both A-T and T-A 
base pairs in preference to G-C and C-G. An Hp/Py pair prefers T-A over A -T, C-G or 
G-e. Eight-ring pyrrole imidazole polyamides have been shown to be cell permeable and 
to inhibit transcription of designated genes in cell culture.2 
Efforts have been made to increase the DNA-binding affinity and sequence 
specificity by covalently linking polyamide heterodimers and homodimers. Polyamide 
dimers linked by a y-aminobutyric acid unit (y) creates a hairpin structure which binds 
with IOO-fold enhanced affinity relative to the unlinked subunits. The placement of an 1m 
and Py in the first and eighth position of an eight-ring polyamide creates an ImJPy pair at 
the N- and C-terminal positions of the hairpin, which targets DNA sequences beginning 
with a G-C base pair. In the process of designing polyamides capable of targeting 
sequences beginning with C-G base pairs, we found it was necessary to incorporate a 
flexible ~-alanine monomer to reset the imidazole at the C-terminus of the four-ring 
subunit. 3 
Numerous eight-ring hairpin polyamides have been synthesized and published by 
our research group; however, notably absent in the list are compounds containing 
imidazoles immediately preceding the y turn due to the lack of specificity of the 
imidazole ring. To solve this issue it might be necessary to incorporate flexible ~-alanine 
monomer similar to the case for sequences beginning with C-G base pairs. Two head to 
tail linked hairpin polyamides ImPyPyIm-(R)H2Ny-PyPyPyPy-~-Dp (1) and ImPy-~-Im-
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P-(R)H2Ny-pyPyPyPy-P-Dp (2) were synthesized and tested towards the general DNA 
binding sites 5'-CWWC-3' and 5'-GWWG-3'. Compounds 1 and 2 differs from the two 
previously synthesized polyamides designed for sequences beginning with C-G base 
pairs PyPyPyPy-(R)H2Ny-ImPyPyIm-p-Dp (3) and pyPyPYPy-(R)H2Ny-IrnPy-p-Im-p-Dp 
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Figure 5.1. (a) Hydrogen bonding model of the polyamide:DNA complex between an seven-ring hairpin 
polyamide PyPyPyPy(R)H2Ny-ImPy-~-Im-~-Dp (4) and a 5'-TCTACA-3' site. A circle with two dots 
represents the lone pairs of N3 of purines and 02 of cytosine. Two touching circles with dots represent the 
two lone pairs of the 02 of thymine. Circles containing an H represent the exocyclic amino hydrogen of 
guanine. Putative hydrogen bonds are illustrated by dotted lines. The filled and unfilled circles represent 
imidazole and pyrrole rings, respectively, curved line represents y-aminobutyric acid, and diamond 
represent ~-alanine. (b) Hydrogen bonding model of the polyamide:DNA complex between a six-ring 
hairpin polyamide ImPy-~-Im(R)H2Ny_pypyPyPy-~-Dp (2) and a 5'-TCTACA-3' site. 
The two polyamides PyPyPyIm-(R)H2Ny-PyPyPyIm-p-Dp (5) and PyPy-p-Im-p-
(R)H2N "fPyPy-p-Im-p-Dp (6) were then designed to target a general 5'-CWWG-3' site 
(Figure 5.2). A control compound ImPyPyPy-(R)H2Ny-ImPyPyPy-P-Dp (7) was also 
synthesized to establish a baseline with previously published work.4 
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Figure 5.2. (a) Hydrogen bonding model of the polyamide:DNA complex between an eight-ring hairpin 
polyamide PyPyPylm-(R)H2Ny-pyPyPylm-p-Dp (5) and a 5'-TCTAGA-3' site. (b) Hydrogen bonding 
model of the polyamide:DNA complex between a seven-ring hairpin polyamide PyPy-p-Im-(R)H2Ny-
PyPy-p-Im-p-Dp (4) and a 5'- TCTAGA -3' site. 
The plasmid pCW20 was designed to contain the four six-base pair recognition 
sites 5'-tACTAGTg-3', 5'-tACTACTg-3', 5'-tAGTAGTg-3', and 5'-tAGTACTg-3' 
which differ by the placement of the cytosine and guanine bases. We chose different 
flanking sequences bordering the core four base pairs in order to bias the binding of the 
polyamide to only one direction. In one direction the beta-tail would be over the guanine 
base pair which has been shown to be deleterious for binding.5 
Results and Discussion 
Synthesis: Polyamides 3, 4, and 7 were prepared as previously described.34 ImPyPyIm-
(R)Fmocy_pyPyPyPy-~ -PAM-resin, 1m Py -~-Im-~-(R)Fmocy-Py Py Py Py-PAM-resin, 
PyPyPyIm-(R)Fmocy-PyPyPyIm-~-PAM-resin and PyPy-~-Im-(R)Fmocy-pyPy-~-Im-~-
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PAM-resin were synthesized in a stepwise manner from Boc-~-alanine-PAM resin (0.55 
mmol/g) using solid-phase methodologl in 14 steps. A sample of the resin was then 
cleaved by aminolysis with ((dimethyl)amino)propylamine (5SOC, 16 hours) and purified 
by reversed-phase HPLC to provide ImPyPyIm-(R)H2Ny-PyPyPyPy-~-Dp (1), ImPy-
~-Im-~-(R)H2Ny_PyPyPyPy-~-Dp (2), PyPyPyIm-(R)H2Ny-PyPyPyIm-~-Dp (5), and 
PyPy-~-Im-(R)H2Ny-PyPy-~-Im-~-Dp (6) (Figure 5.3). For the synthesis of compounds 
1-7-E, a sample of the parent polyamide was treated with an excess of EDTA-
dianhydride (DMSO/NMP, DIEA 55°C, 30 minutes), and the remaining anhydride was 
hydrolyzed (O.IM NaOH, 55°C, 10 minutes). The polyamide-EDTA conjugates 1-7-E 
were then isolated by reversed-phase HPLe. 
Identification of binding orientation by affinity cleaving: Affinity cleavage 
experiments with compounds 1-7-E, which have an EDTA-Fe(II) moiety attached to the 
y-turn, were used to confirm binding orientation. Affinity cleavage titration were 
performed on the 3'- or 5,-32P-end labeled EcoRIIPvuII restriction fragment from the 
plasmid pCW20 which contains the four binding sites 5'-tACTAGTg-3', 5'-tACTACTg-
3', 5'-tAGTAGTg-3', and 5'-tAGTACTg-3'. The affinity cleavage assays revealed 
cleavage patterns that are 3'-shifted, as is expected for hairpin formation and occupation 
in the minor groove of DNA. For the two sites 5'-tACTACTg-3' and 5'-tAGTAGTg-3' a 
single cleavage pattern was observed for compounds 1-4-E, consistent with hairpin 
polyamides binding in a forward orientation (5'-3', N-C) (Figure 5.4). We observed that 
polyamides 1- 4-E bound the two sites 5'-tAGTACTg-3' and 5'-tACTAGTg-3' in only 
one orientation. The cleavage patterns were located on the right side of the binding site 
suggesting a binding orientation which would place the Dp charge over an A-T base pair 
instead of G-e. A single cleavage pattern 3' for all four binding sites was observed for 
affinity compounds 5-E and 6-E (Figure 5.5). For compound 7-E single cleavage pattern 
was observed for the DNA sites 5'-tACTACTg-3', 5'-tAGTACTg-3' and 5'-tACTAGTg-3' 
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EcoRI pCW20 2X6 bp 
32~~~=~~==~~~ 
Pvull 
ImpypYlm-~E~~~)-PYPYPYPY~~;Dp(lE) III ,I I 
5'-TTACTAGTGGGATGGCGGCTTACTACTGGGATGGCGGCTTAGTAGTGGGATGGCGGCTTAGTACTGGG-3' 
~ ~ ~ ~ 
3' -AATGATCACCCTACCGCCGAATGATGACCCTACCGCCGAATCATCACCCTACCGCCGAATCATGACCC-5' 
'II' III 1111 I II 
Impyplm-~EDTA)-PyPyPyPy-~-Dp (2E) 
5'-TTACTAGTGGGATGGCGGCTTACTACTGGGATGGCGGCTTAGTAGTGGGATGGCGGCTTAGTACTGGG-3' 
~ ~ ~ ~ 
3 ! _AATGATCACCCTACCGCCGAATGATGACCCTACCGCCGAATCATCACCCTACCGCCGAATCATGACCC- 5 ' 
III' III 'III 'II 
PyPyPyPy-~EDTA)-ImPyPylm-B-Dp(3E) 
,II III" I III 5'_TTACTAGTGGGATGGCGGCTTACTACTGGGATGGCGGCTTAGTAGTGGGATGGCGGCTTAGTACTGGG-3' 
~~J1E} r~1D ~ ~ 
3'_AATGATCACCCTACCGCCGAATGATGACCCTACCGCCGAATCATCACCCTACCGCCGAATCATGACCC-5' 
" I ' 1111' II' I II 
PyPYPYPY-~EDTA)-ImPY~Im-p-Dp(4E) 
, I, III ill II, 
5'-TTACTAGTGGGATGGCGGCTTACTACTGGGATGGCGGCTTAGTAGTGGGATGGCGGCTTAGTACTGGG-3' 
~~ iV~ ~ ~1D 
3'_AATGATCACCCTACCGCCGAATGATGACCCTACCGCCGAATCATCACCCTACCGCCGAATCATGACCC-5' " , ' IIII IIII , I 
Figure 5.4. Affinity cleavage experiments with EDT A-polyamides IE-4E on the 5' 32P-labeled 284 base 
pair EcoRIIPvuII restriction fragment derived from plasmid pCW20, The designed 5'-ACTAGT-3', 5'-
ACTACT-3', 5'-AGTAGT-3', and 5'-AGTACT-3' are shown on the left side of the autoradiogram, Lane 1, 
intact DNA; lane 2, A reaction; lane 3, G reaction; lane 4-11, digestion products obtained in the presence of 
I-E, 2-E, 3-E, or 4-E; 500 nM or 50 nM polyamide, Results of affinity cleavage experiments with EDT A-
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EcoRI pCW20 286 hp 
32~~~=====~===~~==== 
Pvull 
PyPyPylm-Y(EDTAl -PYPYPYlm-J3-Dp (SE) 
III ,II III III 
5'-TTACTAGTGGGATGGCGGCTTACTACTGGGATGGCGGCTTAGTAGTGGGATGGCGGCT~AGTACTGGG-3' 
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Figure 5.5. Affinity cleavage experiments with EDTA-polyamides SE-7E on the 5' 32P-labeled 284 base 
pair EcoRVPvuII restriction fragment derived from plasmid pCW20. The designed 5'-ACTAGT-3', 5'-
ACTACT-3', 5'-AGTAGT-3', and 5'-AGTACT-3' are shown on the left side of the autoradiogram. Lane I, 
intact DNA; lane 2, A reaction; lane 3, G reaction; lane 4-11, digestion products obtained in the presence of 
S-E, 6-E, or 7 -E; 500 nM or 50 nM polyamide. Results of affinity cleavage experiments with EDTA-
polyamides SE-7E. Arrow height is proportional to the amount of cleavage at the indicated base. 
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and two cleavage patterns was observed for S'-tAGTAGTg-3'. For compounds S-E and 6-
E to bind to the S'-tACTAGTg-3' site while following the pairing rules would require the 
hairpin polyamides to be binding in a forward orientation (S' -3', N-C) while the two 
polyamides need to bind in a reverse orientation (3'-S', N-C) to the S'-tAGTACTg-3' 
site. For polyamide 7-E, S'-tACTAGTg-3' would instead be a reverse site and S'-
tAGTACTg-3' would be a forward site. 
Equilibrium association constants: Quantitative DNase I footprint titrations (10 mM 
Tris·HCl, 10 mM KCl, 10 mM MgCl2 and S mM CaCl2, pH 7.0, 22°C) (Figure S.6) were 
performed on the S,-12P-end-labeled 286 bp PCR fragment from plasmid pCW20 to 
determine the equilibrium association constants for polyamide 1-7 for the four target sites 
(S'-tACTAGTg-3', S'-tACTACTg-3', S'-tAGTAGTg-3', S'-tAGTACTg-3'). Polyamide 1 
and 2 bound their designed match site S'-tAGT AGTg-3' with comparable affinities Ka = 
7.9 x IOYM-l and Ka = 8.6 x 109 M-I. For the S'-tAGTACTg-3' site, polyamide 1 bound 
with an affinity of Ka = 3.8 x I09 M-I and polyamide 2 bound with an affinity of Ka =1.3 
x 109 M-l. We observed greater specificity between the S'-tAGTAGTg-3' and S'-
tAGTACTg-3' sites for compound 2, probably due to the flexible ~ alanine. Polyamide 1 
and 2 bound S'-tACTAGTg-3' with an affinity of Ka =1.6 x I09 M-I and Ka =1.7 x 109 
M-I respectively. In both cases a five-fold drop in affinity compared to the match site 
was observed due to the selectivity of the ImJPy pair when 1m is at the N-terminus of the 
ring system. The mismatch site Sf-tACT ACTg-3' was bound by both 1 and 2 with three to 
five-fold lower affinity compared to the match site due to the placement of the Dp tail 
over the G·C base pair. The same trend was observed for polyamide 3 and 4. The match 
sites are bound by 3 and 4 with comparable affinities (Ka = 1. 7 X 101o M -1 and Ka =2.0 x 
IOlo M-l). However, polyamide 4 with the flexible ~ alanine bound S'-tAGTACTg-3' with 
twelve-fold lower affinity while 3 showed no preference between the two sites. 
Polyamide 5 and 6 were designed to bind S'-tACTAGTg-3'. Polyamide 5 bound S'-
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Figure 5.6. Partial sequence of the synthesized insert from pCW20 and the illustration of the EcoRI/PvuII 
restriction fragment. The sequences in bold were the only sites analyzed by quantitative DNase I footprint 
titrations. Equilibrium association constants [MI] and schematic binding models for ImPyPylm-(R)H2Ny-
PyPyPyPy-~-Dp (1). ImPy-~-Im-~-(R)H2Ny_pypyPyPy-~-Dp (2). PyPyPyPy-(R)H2Ny-ImPyPylm-~-Dp 
(3). PyPyPyPy(R)H2Ny-ImPy-~-Im-~-Dp (4). PyPyPylm-(R)H2Ny_pyPyPylm-~-Dp (5). PyPy-~-Im­
(R)H2Ny_pyPy-~-Im-~-Dp (6). and ImPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (7) with their putative match and 
mismatch sites. Values reported are the mean values obtained from three DNase I titration experiments. 
Mismatch base pairs are marked with a shaded rectangle. 
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tACTAGTg-3', 5'-tACTACTg-3', and 5'-tAGTAGTg-3' with little specificity Ka =3.3 x 
109 M-I, Ka = 1.4 X 109 M-I, and Ka = 2.0 x 109 M-I while Polyamide 6, with two ~ 
alanine residues, restores the specificity. The two mismatch sites 5'-tACTACTg-3' and 5'-
tAGTAGTg-3' are bound with six-fold and four-fold lower affinity compared to the 
match site 5'-tACTAGTg-3'. 
Recognition of 5'-GWWG-3' sequence: Polyamide 1 bound its match site 5'-
tAGTAGTg-3' with only twofold higher affinity than its single base pair mismatch site 5'-
tAGTACTg-3' suggesting that the 1m residue located at the C-terminal end of the four-
ring polyamide subunit is not recognizing the exocyclic amine of guanine properly. 
Polyamide 2 with the flexible ~-alanine subunit shows a six-fold specificity between the 
5'-tAGTAGTg-3' and 5'-tAGTACTg-3' sites (Figure 5.7). These results suggest the need 
of the flexible ~-alanine residue to restore specificity. Similarly to the results from 
polyamides 1 and 2, we observed that polyamide 3 does not recognize 5'-tACTACTg-3' 
specifically over 5'-tAGTACTg-3'. Incorporation of the flexible ~-alanine, as in 
polyamide 4, differentiates the two sites (Figure 5.8). Comparison between polyamides 1-
4 shows that a flexible ~-alanine is necessary to reset the fourth imidazole in the four-ring 
subunit and the result is general, regardless of the placement of the tum. 
1 
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Figure 5.7. Equilibrium association constants 
[M·ll and schematic binding models for 
ImPyPylm-(R)H2Ny~pypyPyPy-~-Dp (1) and 
ImPy-~-Im-~-(R)H2Ny_pypyPyPy-~-Dp (2) 
with their putative match site 5'-AGTAGT-3' 
and mismatch site 5'-AGTACT-3'. 
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Recognition of 5'-CWWG-3' sequence: The results from polyamide 1-4 demonstrates 
the necessity of p-alanine to target guanine in the fourth position. Polyamide 5, without 
any p-alanine residues, does not differentiate between the 5'-tACT AGTg-3', 5'-
tACTACTg-3', and 5'-tAGTAGTg-3' sites. However, placement of two p-alanine 
residues enables the differentiation of the 5'-tACTAGTg-3' sites from the two mismatch 
sites (Figure 5.9). 
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Figure 5.9. Equilibrium association constants [M· l] and schematic binding models for PyPyPylm-(R)H2Ny-
PyPyPylm-I3-Dp (5) and PyPy-I3-Im-(R)H2Ny_pyPy-I3-Im-I3-Dp (6) with their putative match site 5'-
ACTAGT-3' and mismatch sites 5 '-ACTACT-3 , and 5'-AGTAGT-3'. 
Binding orientation: Quantitative DNase I footprinting experiments show that 
for the site 5'-tACT AGT -3' compounds 5 and 6 binding in the forward orientation are 
tighter binders than compound 7 which binds in the reverse orientation. Similarly for the 
site 5'-tAGTACT -3' compound 7 which binds in a forward orientation to the site binds 
78 
tighter than 5 and 6 which binds to the same site in a reverse orientation. We also observe 
p-alanine containing compounds to bind tighter than their all ring counterparts when 
binding to DNA sites in a reverse orientation (Figure 5.10). 
t ACT A G T g tAG T ACT g 
5 ~ ~.Et 
a T GAT CAe aTe A T G A c Figure 5.10. Equilibrium association constants 
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Conclusion 
The classic eight-ring hairpin ImPyPylm-(R)H2Ny-PyPyPyPy-P-Dp (1) showed low 
preference for its designed matched binding site 5'-tAGTAGt-3' over the single base pair 
mismatch 5' -tAGTACt-3' while polyamide ImPy-p-Im-(R)H2Ny-PyPyPyPy-P-Dp (2) 
instead showed a six-fold selectivity for the 5' -tAGTAGt-3 site over the mismatched site. 
The use of a flexible p-alanine instead of a Py ring resets the imidazole ring to provide 
the optimal hydrogen bond formation between the imidazole N3 and the exocyclic amine 
of guanine. These results provide a solution to design hairpin polyamides with imidazole 
rings preceding a y turn unit including hairpin polyamides capable in targeting the 
sequence 5' -CWWG-3'. PyPyPyIm-(R)H2Ny-PyPyPyIm-p-Dp (5) did not differentiate 
between the 5'-tACTAGTg-3', 5'-tACTACTg-3', and 5'-tAGTAGTg-3' sites. Polyamide 
PyPy-p-Im-(R)H2Ny-PyPy-p-Im-p-Dp (6), where two Py residues were replaced by p-
alanine, enabled differentiation of the 5'-tACT AGTg-3' sites from the two mismatch sites. 
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This study opens the opportunity to target general 5' -CWWG-3' sequences and 
validates the use of flexible p-alanine residue to reset the register of adjacent 1m residues 
within the hairpin motif and gives us an opportunity to target new biologically important 
DNA sequences in gene regulation studies. 
Experimental Section 
G e n era I : Boc-p-alanine-( -4-carboxamidomethyl)-benzyl-ester-copoly(styrene-
divinylbenzene) resin (Boc-P-PAM-Resin), N,N' -Dicyclohexylcarbodiimide (DCC), N-
Hydroxybenzotriazole (HOBt), 2-( IH-Benzotriazole-l-yl)-I, 1 ,3,3-tetramethyluronium 
hexa-fluorophosphate (HBTU) and Boc-p-alanine were purchased from Peptides 
International. N,N-diisopropylethylamine (DIEA) and N,N-dimethylformamide (DMF) 
were purchased from Applied Biosystems. DMF was distilled under reduced pressure 
prior to synthesis. (R)-2-Fmoc-4-Boc-diaminobutyric acid was from Bachem, 
dichloromethane (DCM) was reagent grade from EM, thiophenol (PhSH), 
dimethylaminopropylamine from Aldrich, and trifluoroacetic acid (TFA) from 
Halocarbon. 1 H NMR were recorded on a Varian Mercury 300 instrument. Chemical 
shifts are reported in ppm downfield from the signal for Me4Si, with reference to the 
solvent residual signal. UV spectra were measured on a Hewlett-Packard Model 8452A 
diode array spectrophotometer. Matrix-assisted, laser desorptionlionization time of flight 
mass spectrometry was carried out at the Protein and Peptide Microanalytical Facility at 
the California Institute of Technology. HPLC analysis was performed on a Beckman 
Gold system using a RAINEN CI8, Microsorb MV, 5 /lm, 300 x 4.6 mm reversed-phase 
column in 0.1 % (w/v) TFA with acetonitrile as eluent and a flow rate of 1.0 mUmin, 
gradient elution 1.25% acetonitrile/min. Preparatory HPLC was carried out on a 
Beckman HPLC using a Waters DeltaPak 25 x 100 mm, 100 /lm C 18 column, 0.1 % (w/v) 
TFA, 0.25% acetonitrile/min. 18MQ water was obtained from a Millipore MilliQ water 
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Figure 5.S1. Quantitative DNase I footprint titration experiment for ImPyPylm-(R)H2Ny_pypyPyPy-~-Dp (1) 
on the 286 bp EcoRIIPvuII restriction fragment from plasmid pCW20: lane I, intact DNA; lane 2, A specific 
reaction; lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 
5 nM, 10 nM ImPyPylm-(R)H2Ny_pypyPyPy-~-Dp (I), The four sites 5'-TTTACA-3', 5'-TATACA-3', 5'-
TGTACA-3' and 5'-TCTACA-3' sites that were analyzed are shown on the right side of the gel. (b) 
Quantitative DNase I footprint titration for ImPy-~-Im-~-(R)H2Ny_pypyPyPy-~-Dp (2) on the 286 bp 
EcoRIIPvuII restriction fragment from plasmid pCW20: lane 1, intact DNA; lane 2, A specific reaction lane 3, 
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Figure S2. (a) Quantitative DNase I footprint titration experiment for pyPyPYPY-(R)H2Ny-ImPypylm-
P-Dp (3) on the 286 bp EcoRV PvuII restriction fragment from plasmid pCW20: lane 1, intact DNA; 
lane 2, A specific reaction; lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 
pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM PyPyPyPy-(R)H2NY-ImPyPylm-p-Dp (3). (b) Quantitative 
DNase I footprint titration for PyPyPyPy(R)H2Ny-ImPy-p-Im-p-Dp (4) on the 286 bp EcoRVPvuII 
restriction fragment from plasmid pCW20: lane 1, intact DNA; lane 2, A specific reaction lane 3, 
DNase I standard; lanes 4-13,10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 
nM pyPyPyPY(R)H2Ny-ImPy-p-Im-p-Dp (4). 
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Figure S3. (a) Quantitative DNase I footprint titration experiment for PyPyPylm-(R)H2Ny-
PyPyPylm-~-Dp (5) on the 286 bp EcoRIIPvuII restriction fragment from plasmid pCW20: lane I, 
intact DNA; lane 2, A specific reaction; lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 
100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM PyPyPylm-(R)H2Ny_pyPyPylm-~-Dp (5). (b) 
Quantitative DNase I footprint titration for PyPy-~-Im-(R)H2Ny_pyPy-~-Im-~-Dp (6) on the 286 bp 
EcoRII Pvull restriction fragment from plasmid pCW20: lane I, intact DNA; lane 2, A specific 
reaction lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 
nM, 2 nM, 5 nM, 10 nM PyPy-~-Im-(R)H2Ny_pyPy-~-Im-~-Dp (6). (c) Quantitative DNase I 
footprint titration for ImPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (7) on the 286 bp EcoRIIPvuII restriction 
fragment from plasmid pCW20: lane 1, intact DNA; lane 2, A specific reaction lane 3, DNase I 
standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM 
ImPyPyPy-(R)H2Ny-ImPyPyPy-~-Dp (7). 
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used unless otherwise stated. 
Polyamide synthesis: Reagents and protocols for polyamide synthesis were as 
previously described.5 Polyamides were purified by reversed-phase HPLC on a Beckman 
HPLC with a Waters DeltaPak 25x100 mm, 100 m C18 column equipped with a guard, 
0.1 % (w/v) TFA, 0.25% acetonitrile min-I. Extinction coefficients were calculated based 
on £=8333 per ring at 304 nm. 
Procedure for cleavage from the resin: After the coupling was completed, the resin was 
filtered off the reaction mixture and washed with DMF (2 x 30 seconds). DMF (l mL) 
and piperidine (3 mL) were added and the mixture shaken for 30 minutes at 22°C. The 
resin was filtered off and washed with DMF (2 x 30 seconds), DCM (3 x 30 seconds), 
MeOH (l x 30 seconds), Et20 (l x 30 seconds) and dried in vacuo. The resin was treated 
with (dimethylamino )propylamine (1 mL) with periodic agitation at 55°C for 16 hours. 
The reaction mixture was then filtered to remove the resin, TFA (0.1 % (w/v), 7 mL) was 
added and the resulting solution purified by reversed-phase HPLC. The pure compounds 
were recovered as white powders upon lyophilization of the appropriate fractions. 
ImPyPylm-(R)H2Ny-PyPyPyPy-~-Dp (1): ImPyPylm-(R)Fmocy-PyPyPyPy-~-PAM-resin 
(l00 mg) was cleaved and purified by preparative HPLC to give 1 (5 mg, 3% isolated 
yield). UV Amax (H20) 240, 312 (69500); MALDI-TOF-MS calcd for CSSH73N 220 10 
(M+H): 1237.58; found: 1237.7. 
ImPy-~-Im-(R)H2Ny-PyPyPyPy-~-Dp (2): ImPy-~-Im-(R)Fmocy-pyPyPyPy-~-PAM-resin 
(100 mg) was cleaved and purified by preparative HPLC to give 2 (15 mg, 8% isolated 
yield). UV Amax (H20) 240, 312 (60830); MALDI-TOF-MS calcd for CssHnN 21 0 10 
(M+H): 1186.57; found: 1186.7. 
PyPyPylm-(R)H2Ny-PyPyPylm-~-Dp (5): PyPyPylm-(R)Fmocy-PyPyPylm-~-PAM-resin 
(l00 mg) was cleaved and purified by preparative HPLC to give 5 
84 
13% isolated yield). UV Amax (H 20) 240, 312 (69500); MALDI-TOF-MS calcd for 
CSSH73N22010 (M+H): 1237.58; found: 1237.5. 
PyPy-13-Im-(R)H2Ny-PyPy-13-Im-13 -Dp (6): PyPy-13-Im-(R)Fmocy-pyPy-13-Im-13-PAM-
resin (100 mg) was cleaved and purified by preparative HPLC to give 6 (14 mg, 11 % 
isolated yield). UV Amax (H20) 240, 312 (52160); MALDI-TOF-MS calcd for 
CssHnN21 010 (M+H): 1135.56; found: 1135.7. 
Synthesis of EDTA conjugates 
Excess EDT A-dianhydride (50 mg) was dissolved in DMSOINMP (1 mL) and DIEA (1 
mL) by heating at 55°C for 5 minutes. The dianhydride solution was added to the hairpin 
polyamide (10 mg, 5 ~mol) dissolved in DMSO (750 ~L). The mixture was heated 
(55°C, 25 minutes) and the remaining EDT A-anhydride hydrolyzed (O.lM NaOH, 3 mL, 
55°C, 10 minutes). Aqueous TFA (0.1 % wt/v) was added to adjust the total volume to 8 
mL and the solution purified directly by reversed phase HPLC to provide EDT A 
conjugate as white powders upon lyophilization of the appropriate fractions 
ImPyPylm-(R)EDTAy-PyPyPyPy-13-Dp (I-E): (0.1 mg, 12% isolated yield). UV Amax 
(H20 ) 240, 312 (69500); MALDI-TOF-MS calcd for CSSH73N22010 (M+H): 151l.66; 
found: 151l.7. 
ImPy-13-Im-(R)EDTAy-PyPyPyPy-13-Dp (2-E): (0.2 mg, 16% isolated yield). UV Amax 
(H20 ) 240, 312 (60830); MALDI-TOF-MS calcd for CssHnN21010 (M+H): 1460.65; 
found: 1460.7. 
PypyPylm-(R)EDTAy-PypyPylm-13-Dp (5-E): (0.1 mg, 15% isolated yield). UV Amax 
(H20 ) 240, 312 (69500); MALDI-TOF-MS calcd for CssH73NnOlO (M+H): 151l.66; 
found: 151l.7. 
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PyPy-~-Im-(R)EDTAy-PyPy-~-Im-~-Dp (6-E): (1.4 mg, 32% isolated yield). UV Amax 
(H20) 240, 312 (52160); MALDI-TOF-MS calcd for CssHnN21010 (M+H): 1409.64; 
found: 1409.7. 
Construction of Plasmid DNA: The plasmid pcw20 was constructed using previously 
described methods. 6 Fluorescent sequencing, performed at the DNA Sequencing Facility 
at the California Institute of Technology, was used to verify the presence of the desired 
insert. 
PCR Labeling to generate 5'-End-Labeled Restriction Fragments. Two 21 mer 
pnmers were synthesized for PCR amplification: pnmer Eco 5'-
AATTCGAGCTCGGTACCCGGG-3 ' and pflmer Pvu 5' -
CTGGCACGACAGGTTTCCCGA-3'. The labeled pnmer was treated with T4 
polynucleotide kinase and deoxyadenosine 5' _[y_32p] triphosphate as previously 
described6 PCR reactions containing 60 pmol each primer, 10 f.ll PCR buffer (Boehringer-
Mannheim), 3.7 f.ll template (0.003 f.lg/mL), 2 f.ll dNTP mix (each at 10 mM), 1 f.ll 100X 
BSA (New England Biolabs) and 83 f.ll water were heated at 70 C for 5 minutes. Four 
units of Taq Polymerase were added (Boehringer-Mannheim). Thirty amplification cycles 
were performed, each cycle consisting of the following segments: 94
0 
C for 1 min, 54 0 C 
for 1 minute, and 72°C for 1.5 minutes. Following the last cycle, 10 minutes of extension 
at 72°C completed the reaction. The 5' labeled fragment was loaded onto a 7% non-
denaturing polyacrylamide gel, and the desired 286 base pair band was visualized by 
autoradiography and isolated. Chemical sequencing reactions were performed according 
to published methods.7 
Quantitative DNase I Footprinting: DNase I Footprinting reactions were carried 
out as previously described.6 Photostimulable storage phosphorimaging plates (Kodak 
Storage Phosphor Screen S0230 obtained from Molecular Dynamics) were pressed flat 
against gel samples and exposed in the dark at 22°C for 12-16 hours. A Molecular 
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Dynamics Typhoon PhosphorImager was used to obtain data from the storage screens. 
The data were analyzed by performing volume integration of all bands using ImageQuant 
v. 3.2 software. All DNA manipulations were performed according to standard 
protocols. 8 
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Chapter 6 
Recognition of A -T Sequences by Hairpin Polyamides 
with Pyrrole / Hydroxypyrrole Pairs 
at the Terminal Position 
89 
Abstract 
Recently ring pairs have been developed to target T-A and C-G in addition to the original 
G-C base pairs at the terminal positions of hairpin polyamides. In order to evaluate 
hairpin polyamides capable of distinguishing A-T base pairs at the terminal position, four 
hairpin polyamides, PyPyPyPy-(R)H2Ny-ImPyPyHp-P-Dp (1), PyPyPyPy-(R)H2Ny-ImPy-
P-Py-P-Dp (2), BZPyPyPy-(R)H2Ny-ImPyPyHp-P-Dp (3), and BZPyPyPy-(R)H2Ny-ImPy-
P-Py-P-Dp (4), were synthesized. The equilibrium association constants (Ka) for these 
compounds are assessed and the all rings polyamides 1 and 3 showed no preference for 
the target site 5'-TATACA-3' over 5'-TTTACA-3' although ten-fold preference is shown 
over 5'-TGTACA-3' and 5'-TCTACA-3'. The addition of a flexible residue in polyamides 
2 and 4 did not improve the targeting of the intended match site 5'-TATACA-3'. Instead 
the p-alanine containing polyamides showed five to fifty-fold lower affinity for all four 
sites compared to the parent compounds. 
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Introduction 
The ability to distinguish T-A from A-T base pairs by synthetic ligands which 
bind in the minor groove of DNA is an essential milestone for targeting specific AfT rich 
sequences, within promoters for gene regulation studies.! We recently reported that the 2-
hydroxypyrrole/pyrrole pair (Hp/Py) for distinguishing T-A from A-T is most suitable for 
internal positions in polyamides.2 The Hp ring at the N-terminal position affords lower 
affinity and sequence specificity for A-T/T-A vs G-C/C-G than anticipated. T-A 
recognition at the terminal position of hairpin polyamides was finally achieved by 
substituted 2-hydroxy-benzamide/pyrrole pairs.3 To target C-G base pairs at the N-
terminal position, we recently paired a pyrrole ring with an imidazole ring.4 To our 
surprise the polyamide bound its target site 5'-TCTACA-3' with little specificity versus 
its single base pair mismatch 5'-TGTACA-3'. We found that a flexible ~-alanine was 
necessary to bring the key imidazole ring back to register in order to differentiate 5'-
TCTACA-3' from its mismatch 5'-TGTACA-3'. 
With the successful development of ring pairs to target T-A and C-G in addition 
to the original G-C at the terminal position, we turn our attention to designing hairpin 
polyamides capable of recognizing A -T base pairs using pyrrole/hydroxypyrrole pairs. 
We describe here a series of four hairpin polyamides with hydroxypyrrole in the C-
terminal position. The hydroxypyrrole is paired with an N-terminal pyrrole or benzoyl 
residue. Two compounds, with a flexible ~-alanine next to the hydroxypyrrole, were also 
included in this study with the expectation that the hydroxypyrrole ring might be out of 
register as in the case of compounds designed to target C-G (Figure 6.1, 6.2). 
91 
e 
I 0 ~NH3 
N N 0 OVH", 
a) 
tiN NH""" A'" "" /NM " \ " 'N o " ~' b- H --::- ----Ny -
~tNH -------- .~ 
"t{ ----A- "" -----2HN--..;: 0 
'- °3NH "'" HN ~ N" 
N,\:O - '\", "'~ 0 
5' 
" :n~o HN-(N; 
, 0 
" I ~ 






3'-T A TAT G T T-5' 
e 
I 0 ~NH3 
N N 0 
o VH'" 
tiN NH A '" "" ",N,,--
b) 
\ '-- , ,-\ 
~ -""" - __ .!~ ----N" N_ 
o C G-H" Y 
~tNH ------ .~ "t{ ------A- "" -----2HN-.;: 0 
" 0yNH _____ HN ~ N" 
o '\"_ "'~; 0 
5' 
, 0 " :n~o HN 
" I ~ 





5'-A TAT A C A A-3' 
3'-T A TAT G T T-5' 
Figure 6.1. a) Hydrogen bonding model of the polyamide:DNA complex between the eight-ring hairpin 
polyamide PyPyPyPy-(R)H2Ny-ImPyPyHp-~-Dp (1) with the 5' -TAT ACA-3'-site. b) Hydrogen bonding 
model of the polyamide:DNA complex between the eight-ring hairpin polyamide PyPyPyPy-(R)H2Ny-
ImPy-~-Hp-~-Dp (2) with the 5'-TATACA-3'-site, A circle with two dots represents the lone pairs ofN3 of 
purines and 02 of cytosine. Two touching circles with dots represent the two lone pairs of the 02 of 
thymine. Circles containing an H represent the exocyclic amino hydrogen of guanine. Putative hydrogen 
bonds are illustrated by dotted lines. 
92 
o ~ I 
HN~ ~Nil 0 I 
( 
N U ll-.,{N';) 0 
H H N U -
H N"" N7[N H H ~~ 
2 0 ~ ~N H 
N 0 '"O-nN 7i'!!. H OH 
I N 0 ~}--l H H I 
I N 0 7r5-,.N~N~N, 
I ~ 0 0 
3 
o ~ I 
HN~ ~N';) 0 I 
( 
N U Jl-.(.'N';) 0 I 
H H N U Jl-,,(N';) 
H N"" N7[N H H ~ U 
NrlfO I \ N H 
2 0 ~ II- .NO-nH 
I N ~ N OH 
10 rr/f1 H H I 
o ~,,»-yN~N~N, 
~ 0 0 
o ~ I 2 
HN~ ~N';) 0 I 
( 
N U Jl-.(.'N';) 0 
H H N U~ 
H2N"" N7[N H H ~ V 
o '~N7Ii\ H 
~ 0 ~»_-,(N H OH 
N 0 ~NlIi H H I 
I 0 ~,,~N~N~N, 
~ 0 0 
4 
Figure 6.2. Structures of polyamides. PyPyPyPy-(R)H2Ny-ImPyPyHp-~-Dp (1), PyPyPyPy-(R)H2Ny-
ImPy-~-Py-~-Dp (2), BzPyPyPy-(R)H2Ny-ImPyPyHp-~-Dp (3), BzPyPyPy-(R)H2Ny-ImPy-~-Py-~-Dp 
(4), 
The plasmid pCW15 was designed to contain four six-base pair recognition sites 
5'-TNTACA-3' (where N=T, A, G, C) which differ at a single common position allowing 
for comparison of the affinities between different terminal pairs and the four Watson 
Crick base pairs in the minor groove of DNA (Figure 6.3). 




S'-T~TGT~GGATGGCGGCT GGATGGCGGCT GGATGGCGGCT G-3' 
32p3'-A~CA~CCTACCGCCGA-===~=CCTACCGCCGA-===~= CCTACCGCCGA_~~=== C-S' 
Figure 6.3. 284 base pair EcoRIIPvuII restriction fragment derived from plasmid pCWlS. The targeted six-
base pair recognition sites are shown in boxes. 
Results and Discussions 
Polyamide synthesis. BocHN -Py Py Py -(R)Fmocy-ImPy PyOp-~-PAM -resin and 
BocHN-PyPyPy-(R)Fmocy-ImPy-~-Op-~-PAM-resin were synthesized in a stepwise 
manner from Boc-~-alanine-PAM resin (0.55 mmol/g) using solid-phase methodology4 in 
16 steps (Figure 4). Hydroxypyrrole amino acid residues were introduced as orthogonally 
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protected 3-methoxy-l-methylpyrrole (Op) derivatives.6 Terminal residues were coupled 
to a sample of the resin which was then cleaved by aminolysis with 
((dimethyl)amino)propylamine (55 DC, 16 hours) and purified by reversed-phase HPLC. 
The methyl-protected polyamides were subsequently deprotected by treatment with 
BBr3·SMe2 in 1,2-dichloroethane
7 and purified by reversed-phase HPLC to afford 
PyPyPyPy-(R)H2Ny-ImPyPyHp-~-Dp (1), PyPyPyPy-(R)H2Ny-ImPy-~-Hp-~-Dp (2), 
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Figure 6.4. Solid-phase synthetic scheme for PyPyPyPy-(R)H2Ny-ImPy-~-Py-~-Dp (2), starting from 
commercially available Boc-~-PAM-resin: (i) 80% TFNDCM, 0.4 M PhSH. (ii) Boc-Op-acid, HBTU, 
DIEA, DMF. (iii) 80% TFNDCM, 0.4 M PhSH. (iv) Boc-~-Ala, HBTU, DIEA, DMF. (v) 80% 
TFNDCM, 0.4 M PhSH. (vi) Boc-Py-OBt, DIEA, DMF. (vii) 80% TFA/DCM, 0.4 M PhSH. (viii) Boc-
1m-acid, DCC, HOBt, DIEA, DMF. (ix) 80% TFNDCM, 0.4 M PhSH. (x) Fmoc-a-Boc-y-diaminobutyric 
acid, HBTU, DIEA, DMF.(xi) 80% TFA/DCM, 0.4 M PhSH. (xii) Boc-Py-OBt, DIEA, DMF. (xiii) 80% 
TFNDCM, 0.4 M PhSH. (xiv) Boc-Py-OBt, DIEA, DMF. (xv) 80% TFNDCM, 0.4 M PhSH. (xvi) Boc-
Py-OBt, DIEA, DMF. (xvii) 80% TFNDCM, 0.4 M PhSH. (xviii) Py-acid, HBTU, DIEA, DMF. (xix) 
Piperidinc:DMF 3: I. (xx) (Dimcthylamino)propylamine, 55°C, 16 hours.(xxi) BBr3°SMe2, 1,2-
dichloroethane. 
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Quantitative DNase I footprinting titrations. Quantitative DNase I footprint 
titrations were performed on the 3'-32P-end-Iabeled 284 base pair EcoRVPvuII restriction 
fragment of the pCW15 plasmid2,J to determine the equilibrium association constant (Ka) 
of each hairpin polyamide to the four different binding sites 5'-TNTACA-3' (where N=T, 
A, G, C). Both compounds 1 and 3 did not differentiate the target match site 5'-
TATACA-3' from the single base pair mismatch site 5'-TTTACA-3' although the two 
other single base pair mismatch sites 5'-TGTACA-3' and 5'-TCTACA-3' were bound 
with ten-fold lower affinity. The positioning of the hydroxypyrrole ring at the C-
terminus of the hairpin could possibly put it out of register with the DNA. Therefore, 
compounds 2 and 4 with flexible p-alanine residue were also tested. Footprinting 
experiments showed that the p-alanine containing polyamides 2 and 4 did not target 5'-
TATACA-3' over their mismatch sites. Moreover, the overall affinities for all four sites 
are five to fifty-fold lower for the p-alanine containing polyamides compared to their 
parent compounds. 
Table 6.1. Equilibration Association Constants (M'l)" 
Polyamide 5'-TTTACA-3' 5'-TATACA-3' 
Py/Hp (1) 2,8 x lOy 1,] x lOY 
Py/Hp with beta (2) 1.0 x lOx 7,6 X 107 
Bz/Hp (3) 4.3 x lOY 2.4 x lOy 
Bz/Hp with beta (4) 8.5 x 107 4.2x107 
5'-TGTACA-3' 
1,] x lOX 
4.7x107 
4.0 X lOR 
4.2 X 107 
5'-TCTACA-3' 
1.0 x lOx 
1.0 X 107 
3.2 X lOR 
3.7x107 
"Values reported are mean values from at least three DNase I footprint titration experiments, with the 
standard deviation for each data set indicated in parentheses. The assays were perfomed at noc at pH 7.0 
in the presence of 10 mM TrisoHCl, 10 mM KCI, 10 mM MgCI2 , and 5 mM CaCI 2 • 
The lack of hairpin polyamides capable of binding 5' -TAT ACA-3' tighter than its 
three mismatches suggests the need for the design of alternative ring pairs. The attempt to 
use flexible p-alanine residue in place of a pyrrole ring resulted in a poorer binding 
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Figure 6.S. (a) Quantitative DNase I footprint titration 
experiment with BzPyPyPy-(R)H2Ny_pyPyPyHp-~-Dp (3) 
on the 284 bp EcoRIIPvuII restriction fragment from 
plasmid pCWI5: lane 1, intact DNA; lane 2, A specific 
reaction; lane 3, DNase I standard; lanes 4-13, 100pM, 200 
pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM, 20 nM, 50 nM, 100 
nM BzPyPyPy-(R)H2Ny_pyPyPyHp-~-Dp (3) (b) Binding 
isotherms for polyamide 3. The four sites 5'-TTTACA-3', 5'-
TATACA-3', 5'-TGTACA-3' and 5'-TCTACA-3' sites that 
were analyzed arc shown on the right side of the geL 
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Experimental Section 
B oc-f3-alanine-( -4-carboxamidomethy l)-benzy l-es ter -copol y( styrene-di viny lbenzene) 
resin (Boc-f3-PAM-Resin), N ,N' -DicycIohexylcarbodiimide (DCC), N-
Hydroxybenzotriazole (HOBt), 2-( 1H-Benzotriazole-1-yl)-1, 1,3,3-tetramethyluronium 
hexa-fluorophosphate (HBTU) and Boc-f3-alanine were purchased from Pep tides 
International. N,N-diisopropylethylamine (DIEA) and N,N-dimethylformamide (DMF) 
were purchased from Applied Biosystems. The DMF was distilled under reduced 
pressure prior to synthesis. (R)-2-Fmoc-4-Boc-diaminobutyric acid was from Bachem, 
dichloromethane (DCM) was reagent grade from EM, thiophenol (PhSH) and 
dimethylaminopropylamine from Aldrich, and trifluoroacetic acid (TFA) from 
Halocarbon. I H NMR were recorded on a Varian Mercury 300 instrument. Chemical 
shifts are reported in ppm downfield from the signal for Me4Si, with reference to the 
solvent residual signal. UV spectra were measured on a Hewlett-Packard Model 8452A 
diode array spectrophotometer. Matrix-assisted, laser desorption/ionization time of flight 
mass spectrometry was carried out at the Protein and Peptide Microanalytical Facility at 
the California Institute of Technology. HPLC analysis was performed on a Beckman 
Gold system using a RAIN EN CIS, Microsorb MV, 5/lm, 300 x 4.6 mm reversed-phase 
column in 0.1 % (w/v) TFA with acetonitrile as eluent and a flow rate of 1.0 mUmin, 
gradient elution 1.25% acetonitrile/min. Preparatory HPLC was carried out on a 
Beckman HPLC using a Waters DeltaPak 25 x 100 mm, 100/lm CIS column, 0.1 % (w/v) 
TFA, 0.25% acetonitrile/min. 18MQwater was obtained from a Millipore MilliQ water 
purification system, and all buffers were 0.2 /lm filtered. Reagent-grade chemicals were 
used unless otherwise stated. 
BocHN-PyPyPy-(R)Fmocy-ImpypyOp-f3-PAM-resin and BocHN-PyPyPy-
(R)Fmocy-ImPy-f3-0p-f3-PAM-resin. BocHN-PyPyPy-(R)Fmocy-ImPyPyOp-f3-PAM-resin 
(0.33 mmol/g) and BocHN-PyPyPy-(R)Fmocy-IrnPy-f3-0p-f3-PAM-resin (0.33 mmollg) were 
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synthesized in a stepwise fashion from 0.55 mmol/g Boc-~-PAM-resin by manual solid-
phase methods.4 
Procedure for cleavage from the resin. After the coupling was completed the resin 
was filtered off the reaction and washed with DMF (2 x 30 seconds). DMF (l mL) and 
piperidine (3 mL) were added and the mixture shaken for 30 minutes at 22°C. The resin was 
filtered off and washed with DMF (2 x 30 seconds), DCM (3 x 30 seconds), MeOH (l x 30 
seconds), Et20 (1 x 30 seconds) and dried in vacuo. The resin was treated with 
(dimethylamino)propylamine (l mL) with periodic agitation at 55°C for 16 hours. The 
reaction mixture was then filtered to remove the resin, TFA (0.1 % (w/v), 7 mL) added and 
the resulting solution purified by reversed-phase HPLC. The pure compounds were 
recovered as white powders upon lyophilization of the appropriate fractions. 
Deprotection of methyl-protected polyamides. The polyamide was dissolved in 
1,2-dichloromethane (1 mL) and BBr3-SMe2 (20 mg) was added and the mixture was heated 
to 80°C for 3 hours. 5 Water (3 mL) was added and all volatiles were removed (high vacuum, 
40°C). The residue was dissolved in I mL CH3CN and TFA (7 mL, 0.1 % (w/v)) and purified 
by reverse phase HPLC. 
PyPyPyPy_(R)H2Ny-ImPyPyHp-~-Dp (1). l-methylpyrrole-2-carboxylic acid (50 
mg, 0.40 mmol) was dissolved in DMF (l mL) and HBTU (75 mg, 0.20 mmol) and DIEA 
(0.5 mL) were added and the mixture stirred for 10 minutes and added to deprotected 
BocHN-PyPyPy-(R)Fmocy-ImPyPyOp-~-PAM-resin (100 mg) and the mixture shaken for 4 
hours at 22°C. The compound was then cleaved from the resin according to the general 
procedure. Preparative HPLC gave PyPyPyPy-(R)H2Ny-ImPyPyOp-~-Dp (26 mg, 62% 
isolated yield). UV Amax (H20) 240, 312 (69500); MALDI-TOF-MS calcd. for 
C60H7SN21011 (M+H): 1266.6 found: 1266.8. The methyl-protected PyPyPyPy-(R)H2Ny-
ImPyPyOp-~-Dp (3.8 mg, 3.0 Ilmol) was deprotected according to the general procedure to 
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give 1 (1.4 mg, 37% isolated yield). UV Amax (H20) 312 (69500); MALDI-TOF-MS calcd. 
for CS9H73N21 Oil (M+H): 1252.6; found: 1252.4. 
PyPyPyPy_(R)H2Ny-ImPy-p-Hp-P-Dp (2). I-methylpyrrole-2-carboxylic acid (50 
mg, 0.40 mmol) was dissolved in DMF (1 mL) and HBTU (75 mg, 0.20 mmol) and DIEA 
(0.5 mL) were added and the mixture stirred for 10 minutes and added to deprotected 
BocHN-PyPyPy-(R)Fmocy-ImPy-P-Op-p-PAM-resin (100 mg) and the mixture shaken for 
1.5 hours at 37°C. The compound was then cleaved from the resin according to the general 
procedure. Preparative HPLC gave PyPyPyPy-(R)H2Ny-ImPy-p-Op-P-Dp (14 mg, 36% 
isolated yield). UV Amax (H20) 240, 312 (60830); MALDI-TOF-MS calcd. for 
CS7H74N20011 (M+H): 1215.6 found: 1215.6. The methyl-protected PyPyPyPy-(R)H2Ny-
ImPy-p-Op-P-Dp (3.8 mg, 3.1 f.lmol) was deprotected according to the general procedure to 
give 2 (1.4 mg, 38% isolated yield). UV Amax (H20) 242, 312 (60830); MALDI-TOF-MS 
calcd. for CS6HnN20011 (M+H): 1201.6; found: 1201.54. 
BZPyPyPy-(R)H2Ny-ImPyPyHp-P-Dp (3). Benzoic acid (70 mg, 0.57 mmol) was 
dissolved in DMF (1.0 mL) and HBTU (75 mg, 0.20 mmol) and DIEA (0.5 mL) were 
added. The mixture was allowed to stir for 10 minutes and added to the BocHN-PyPyPy-
(R)Fmocy-ImPyPyOp-p-PAM-resin (l00 mg). The mixture was shaken for 5.0 hours at 
22°C, and the polyamide was cleaved from the resin according to the general procedure. 
Preparative HPLC gave BZPyPyPy-(R)H2Ny-ImPyPyOp-P-Dp (16 mg, 39% isolated yield). 
UV Amax (H20) 240, 312 (69500); MALDI-TOF-MS calcd. for C61H74N20011 (M+H): 
1263.6 found: 1263.7. The methyl-protected BzPyPyPy-(R)H2Ny-ImPyPyOp-P-Dp (6.4 mg, 
5.1 f.lmol) was deprotected according to the general procedure to give 3 (1.4 mg, 19% 
isolated yield). UV Amax (H20) 312 (69500); MALDI-TOF-MS calcd. for C6oH n N 200 11 
(M+H): 1249.57; found: 1249.7. 
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BzPyPyPy-(R)H2Ny-ImPy-~-Hp-~-Dp (4). A mixture of DMF (I mL), DIEA (0.5 
mL) and benzoyl chloride (0.05 mL, 0.4 mmol) was added to deprotected Boc-PyPyPy-
(R)Fmocy-ImPy~Im-~-PAM-resin (100 mg) and shaken for 20 minutes at 22°C and the 
polyamide was cleaved from the resin according to the general procedure. Preparative HPLC 
gave BzPyPyPy-(R)H2Ny-ImPy-~-Op-~-Dp (16 mg, 41 % isolated yield). UV Amax (H20) 
240,312 (60830); MALDI-TOF-MS calcd. for CSSH73N190ll (M+H): 1212.6 found: 
1212.7. The methyl-protected BzPyPyPy-(R)H2Ny-ImPy-~-Op-~-Dp (2.7 mg, 2.1 /lmol) was 
deprotected according to the general procedure to give 4 (1.5 mg, 59% isolated yield). UV 
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Chapter 7 
Sequence Specific Trapping of Topoisomerase I by DNA 
Binding Polyamide-Camptothecin Conjugates 
The text of this chapter was taken in part from a publication coauthored with Prof Peter 
B. DervcIn. 
(Wang, c. c. c.; Dervan, P. B. 1. Am. Chern. Soc. 2001 in press.) 
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Abstract 
Hairpin pyrrole-imidazole polyamides are synthetic ligands that bind in the minor groove 
of DNA with affinities and specificities comparable to DNA binding proteins. Three 
polyamide-camptothecin conjugates 1-3 with linkers varying in length between 7, 13 and 
18 atoms were synthesized to trap the enzyme Topoisomerase I and induce cleavage at 
predetermined DNA sites. One of these, polyamide-camptothecin conjugate 3 at 
nanomolar concentration (50 nM) in the presence of Topo I (3TC) induces DNA 




Pyrrole-imidazole polyamides that target DNA sequences in the promoter have 
been shown to inhibit transcription of specific genes. I.3 The question arises whether 
sequence specific DNA binding polyamides could be designed to recruit endogenous 
cellular enzymes to modify DNA at specific gene sites reminiscent of RNase H cleavage 
of DNA-RNA hybrids in the antisense field. 4 Topoisomerase I (Topo I), an endogenous 
eukaryotic enzyme essential in replication and transcription, cleaves and religates the 
phosphodiester backbone of DNA in an ATP independent fashion. 5-7 The catalytic 
activity of Topo I involves a three step process: (i) cleavage of one strand of DNA where 
upon the enzyme is covalently linked to the 3' phosphoryl end of the nick through a 
tyrosine residue termed the cleavable complex, (ii) passage of a segment of DNA through 
the nick, and (iii) resealing of the DNA break. This sequence is interrupted by the 
presence of the natural product camptothecin (Cpt) which stabilizes the cleavable 
complex and prevents religation of the DNA.8 Camptothecin-stabilized Topo I -DNA 
adducts have been shown to cause premature termination of transcription elongation by 
RNA polymerase II.9 A polyamide-camptothecin conjugate bound site-specifically in the 
minor groove within a "coding region" of a specific gene might trap a covalent adduct of 
the Topo I enzyme with DNA. The site specific protein-DNA adduct could be a gene 
specific road block for the elongation of the RNA polymerase. Targeting Topoisomerase 
I to DNA by triple helix forming oligonucleotide conjugates have been previously 
reported by Matteucci 10 and Helene. 11 These oligonucleotide-camptothecin (and 
rebeccamycin) conjugates bind in the major groove of DNA. It would be interesting to 
compare major vs minor grove positioning of the Topo I poison. We report here our 
efforts to characterize the properties of a minor groove binding hairpin polyamide-
camptothecin conjugate with regards to the structural requirements in the linker region 
for sequence specifically trapping the Topo I mediated cleavable complex. 12 
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Topo I 
S' -T A G TAT T IG C C A A-3' 
-B~CPt 
3'-A TeA T A A ,e G G T T-S' 
l' 
Figure 7.1. (A) Hydrogen-bonding model of a polyamide-eamptotheein conjugate with a generic linker 
bound to the minor groove of 5' -AGTATT-3' and Topo I. Circles with two dots represent the lone pairs of 
N3 purines and 02 of pyrimidines. Circles containing an H represent the N2 hydrogens of guanines. 
Putative hydrogen bonds are illustrated by dotted lines. (B) Binding model of a polyamide-camptothecin 
conjugate. Shaded and nonshaded circles denote imidazole (1m) and pyrrole (Py) rings, respectively. 
Diamonds, small rectangle and big oval represent ~-alanine (~), camptothecin (Cpt), and Topoisomerase I 
(Topo I) respectively. (R)-2,4-diaminobutyric acid (y) and dimethylaminopropylamine (Dp) are depicted as 
a curved line and a plus sign, respectively. 
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Currently there are no three-dimensional structures of camptothecin bound to the 
DNA-Topo I cleavable complex although several groups have presented models.6,13 
Since the requirements for camptothecin presentation are unclear, we designed and 
synthesized three polyamide conjugates 1-3 with linkers varying in length between 7, 13 
and 18 atoms and chemical composition (alkyl chain vs hydroxy alkyl chain). For 
synthetic ease, camptothecin was attached to the hairpin turn. The eight ring pyrrole-
imidazole polyamide, ImPyPyPy-y-PyPyPyPy-~-Dp (where 1m is N-methylimidazole, Py 
is N-methylpyrrole, y is y-aminobutyric acid, ~ is ~ -alanine, and Dp is 
dimethylaminopropylamine); binds its match site 5'-AGTATT-3' and its mismatch site 5'-
AGTACT-3' with equilibrium association constants of 3.5 x 109 M-1 and 5.0 x 108 M-1, 
respectively.14 We chose to modify camptothecin acid at ClO which has been shown by 
structure activity studies not to affect the ability of camptothecin to act as a Topo I 
poison. 15,16 
A plasmid pCW 1 was constructed for the cleavage assay with polyamide-
camptothecin conjugates 1-3 with one six-base pair match site 5' -AGT ATT -3', and two 
mismatch sites 5'-TGGAAA-3' (single) and 5'-TGGACA-3' (double) according to the 
pairing rules where ImlPy pairing binds GfC base pair and PyfPy are degenerate for AfT 
and TfA base pairs. The polyamide is oriented on the match site with the camptothecin to 
the 3' side of the top strand. The sequences flanking the polyamide binding sites are 5'-
GCCAAGTG-3'. Studies have shown that camptothecin induced Topo I cleavage occurs 
preferentially but not exclusively between T and G. 17,18 
Results and Discussion 
Synthesis of polyamide-camptothecin conjugate 1-3. The polyamide 
conjugates 1-3 were synthesized in a stepwise manner from Boc-~-alanine Pam resin 
using Boc-chemistry protocols (Figure 7.3).19 After the completion of the polyamide 
synthesis, the resin was split into three portions and three amino acid straight chain 
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Figure 7.2. Structures of the hairpin polyamide-camptothecin conjugates. PA-CA5-Cpt (1), PA-CAll-
Cpt (2), PA-EG4-Cpt (3). 
linkers were incorporated. The three polyamide conjugates were each cleaved by a single 
step aminolysis reaction with dimethylaminopropylamine and subsequently purified by 
reverse phase HPLC chromatography. A camptothecin analogue 6 with a carboxy 
functionality suitable for conjugation was synthesized from 1O-hydroxycamptothecin. 16a 
Alkylation of 1O-hydroxycamptothecin was accomplished with ethyl bromoacetate in 
refluxing acetone in the presence of anhydrous K2C03 in 60% yield and the ester 
intermediate was hydrolyzed to form carboxymethyloxycamptothecin 6 in 90% yield. 
Activation of the camptothecin acid 6 was accomplished by dicyclohexylcarbodiimide 
(DCC) and N-hydroxysuccinimide (NHS). Polyamides with a primary amine on the turn 
was allowed to react with the activated acid in the presence of diisopropylethylamine 
(DIEA) afforded the polyamide-camptothecin conjugates 1-3. The conjugates were 
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Figure 7.3. Synthetic scheme for polyamide-camptothecin conjugate 3 (i) ethylbromoacetate, K2C03 60%; 
(ii) EtOH, H20, K2C03, 90%; (iii) camptothecin acid 6, DCC, HOBt 24% recovery. 
purified by preparatory reverse phase HPLC. Characterization and identity was 
confirmed by MALDI-TOF-MS. 
Determination of binding affinities by Quantitative DNase I footprinting 
titration experiments. Quantitative DNase I footprint titrations were performed on the 
300 base pair EcoRIIPvuII restriction fragment of pCWI to determine the equilibrium 
association constants of the polyamide-camptothecin conjugates 1-3 for two sites 5'-
AGTATT-3' and S'-TGGAAA-3'(Table 1). The 300 base pair EcoRIIPvuII restriction 
fragment includes the 115 base pair EcoRIIAflII restriction fragment used for the Topo I 
cleavage experiment. For all three conjugates 1-3, the match site 5'-AGTATT-3' was 
preferred over the single and double mismatch sites although we note the specificity of 
the conjugate overall appears compromised relative to the parent. The three conjugates 
show 
108 
Figure 7.4. (A) Quantitative DNase I footprint titration experiment with PA-EG4-Cpt 3 on the 300 base 
pair EcoRIIPvuII restriction fragment from plasmid pCWI: lane I, intact DNA; lane 2, A specific reaction; 
lane 3, DNase I standard; lanes 4-13, 450 pM, 900 pM, 1.8 nM, 4.5 nM, 9 nM, 18 nM, 45 nM, 90 nM, 180 
nM, 450 nM PA-EG4-Cpt 3. The 5'-AGTATT-3' and 5'-TGGAAA-3' sites that were analyzed are shown on 
the right side of the gel. (B) Data from quantitative DNase I footprint titration experiments for PA-EG4-
Cpt 3 binding to the two sites 5'-AGTATT-3' and 5'-TGGAAA-3'. 8norm points were obtained using 
storage phosphor autoradiography and processed by standard methods. 14 The data for the binding of 
conjugate 3 to 5' - AGTATT -3' is indicated by filled circles and binding to 5' -TGGAAA-3' by open 
circles. The solid curves are best-fit Langmuir binding titration isotherms obtained from nonlinear least 
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lower affinity for DNA than parent hairpin polyamide by a factor of 10 which IS 
attributed to the attachment of the linker region at the y turn. 20 
Polyamide-camptothecin conjugate recruits Topo I to DNA and cleaves DNA 
in high yield. The ability of the polyamide-camptothecin conjugates to recruit Topo I 
and cleave DNA sequence specifically was tested by a simple in vitro system. 1O A radio-
labeled DNA restriction fragment generated from plasmid pCW1 was 3' labeled either on 
the top or bottom strand. The ligands were incubated with the DNA restriction fragment 
followed by addition of 10 units of calf thymus Topo I for 1 hour at 3TC. Following 
protein denaturation by treatment with SDS and protease workup, the DNA restriction 
fragments were analyzed by denaturing polyacrylamide gel electrophoresis. Analysis 
was first done on the bottom strand. Conjugate 3 at 50 nM concentration in the presence 
of 10 units of Topo I produces a distinct cleavage site between TAG located 3-4 base 
pairs to the 3' side of the polyamide binding site 5'-AGTATT-3' (Figure 7.5A, lane 4). 
Weaker cleavage proximal to the mismatch site 5' -TGGAAA-3' was also observed. 
Quantitation revealed a cleavage yield of 77% proximal to the match site 5'-AGTATT-3' 
and 16% proximal to the single base pair mismatch 5'-TGGAAA-3'. Remarkably only 
7% of the DNA fragment is left intact. In control experiments with 50 nM polyamide 4 
alone or 50 nM camptothecin acid 6 alone, no cleavage was observed. Indeed 
concentrations of 1 /lM were needed to observe cleavage with camptothecin acid 6 and 
three sites were observed at the bottom strand (Figure 7.5A, lane 9). Moreover, addition 
of 50 nM polyamide 4 and 50 nM camptothecin 6 with Topo I does not induce a cleavage 
band. Therefore, a covalent linkage between the polyamide and camptothecin is required 
for efficient site specific cleavage. Finally incubation of the conjugate 3 without Topo I 
revealed no cleavage indicating that Topo I is necessary for the DNA cleavage. 
III 
Figure 7.5. Topoisomerase I cleavage assay with polyamide-camptothecin conjugate 3 on the 115 base 
pair EcoRVAj7II restriction fragments from plasmid pCW I: (A) 3' J2p end-labeled on the bottom strand. 
lane I, intact DNA; lane 2, A specific reaction; lane 3, G specific reaction; lane 4, 50 nM of conjugate 3 
incubated with DNA followed by Topo I treatment; lane 5, 50 nM polyamide 4 with Topo I; lane 6, 50 nM 
camptothecin acid 6 and 50 nM polyamide 4 with Topo I; lane 7, 50 nM camptothecin acid 6 with Topo I; 
lane 8, I J.lM camptothecin acid 6 and 50 nM polyamide 4 with Topo I; lane 9, 1 J.lM camptothecin acid 6 
with Topo I; lane 10,50 nM conjugate 3 incubated with DNA. (B) 3' J2p end-labeled on the top strand. 
lanes 1-10, same as panel A except on different DNA. (C) Illustration of the 115 base pair restriction 
fragment with the position of the sequence indicated. Cleavage pattern for I J.lM camptothecin acid 6 and 
50 nM polyamide 4 with Topo I; Cleavage pattern for I J.lM camptothccin acid 6 with Topo I; Cleavage 
pattern for 50 nM conjugate 3 (PA-EG4-CPT) with Topo I. Arrow length is proportional to cleavage yield. 
Boxes represent polyamide hinding sites with grey boxes over mismatches. 
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EcoRl peWl 115 bp ;\f1II •• • 
Cpt 6 (111M) + PA 4 (50 nM ) + Topo I 
• l l l 
5'-T~GCCAAGTGCCGGTTAGTATTGCCAAGTGCCGGTTTGp~GCCAAGTG-3' 
3'-AlJAC!;;JTTTCGGTTCACGGCCAATCATAACGGTTCACGGCCAMc~'liliCGGTTCAC-5' I ' , r ' I 
Cpt 6 (I pM) + Topo I 
... .&. '" + 
5"T'I1TGqMAGCCAAGTGCCGGTTAGTATTGCCAAGTGCCGGT'l1T-~'GCCAAGTG-,\' 
3'-AAACdTTTCGGTTCACGGCCAATCATAACGGTTCACGGccAA!AcIc'ltircGGTTCAC-5' 
, T 1 t 




Identical assays were then conducted on the top strand (Figure 7.SB). No cleavage was 
observed when SO nM of conjugate 3 was incubated with 10 units of Topo I indicating 
that the cleavage occurs only in one strand (Figure 7.SB, lane 4). Camptothecin acid 6 at 
1 ).lM created four distinct cleavage sites (Figure 7.SB, lane 9). However, the cleavage 
yield was very low as demonstrated by the large amount of intact DNA. The strand 
specific result leads us to conclude that the Topo I enzyme is oriented in one direction in 
the DNAITopo I/polyamide-camptothecin complex. When SO nM of polyamide 4 and 1 
).lM of camptothecin acid 6 were incubated together, one of the four cleavage sites 
disappeared (Figure 7.SB, lane 8). Analysis shows that the cleavage site is also the 
polyamide binding site suggesting that minor groove hairpin polyamide binding interferes 
sterically with the cleavage reaction. 
Effects of the linker region on DNA cleavage yield. A series of polyamide-
camptothecin conjugates differing only in the linker region were tested using the same in 
vitro assay (Figure 7.6). DNA cleavage yield decreased as the number of atoms in the 
linker region decreased: conjugate 3 (PA-EG4-Cpt) > conjugate 2 (PA-CA1I-Cpt) > 
conjugate 1 (PA-CAS-Cpt). The trend is consistent within the ligand concentration range 
of 1 nM to 100 nM. For each conjugate, cleavage yield increased with increasing ligand 
concentration until leveling off at SO nM. The longer and flexible linker in conjugate 3 
possibly allows the camptothecin moiety to adopt a favorable orientation in the binding 
pocket and could be the reason for its higher activity. 
Mapping Topo I cleavage site. Trapping of Topo I by the camptothecin 
polyamide conjugate is mapped on the DNA restriction fragment by comparing the 
reaction product to Maxam and Gilbert sequencing reaction taking into account that the 
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Figure 7.6. (A) Topoisomerase cleavage assay on conjugates 1-3 and camptothecin acid 6 on the 
EcoRVAflII restriction fragments from plasmid pCW I laheled on the hottom strand: lane 1, intact DNA; 
lane 2, A reaction; lane 3, G reaction; lane 4-10,1 nM, 2 nM, 5 nM, 10 nM, 20 nM, 50 nM, 100 nM of 
conjugate 1; lane 11-17, I nM, 2 nM, 5 nM, 10 nM ,20 nM, 50 nM, 100 nM of conjugate 2; lane 18-24, 1 
nM, 2 nM, 5 nM, 10 nM , 20 nM, 50 nM, 100 nM of conjugate 3; lane 25-29, 1 nM, 10 nM, 100 nM, 111M, 
10 11M camptothecin acid 6, all ligands were incuhated with DNA and treated with Topo 1.(8) 8ar graph of 
cleavage efficiency by conjugates 1-3: grey box represent % cleavage 3-4 base pairs from polyamide 
binding site 5'-AGTATT- 3', hlack box represent % cleavage 3-4 base pairs from 5'-TGGAAA- 3', white 
box represent % cleavage 4 base pairs from 5'-TGGACA- 3', 
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Maxam and Gilbert reactions are gapping reactions while the Topo I reaction is an 
internucleotide cleavage reaction. Topo I cleavage creates a 5' OH group and a 3' Topo I 
linked fragment; therefore, the location of the cleavage site is accurately determined by 
labeling the DNA fragment at the 3' end using T4 polynucleotide kinase to add an extra 
phosphate to the 5' OH. The mapping of the cleavage site by the camptothecin polyamide 
conjugate shows the cleavage is at the 5'-ACTT"G-3' site which has been shown 
previously to be the consensus Topo I cleavage site (Figure 7.7). 
Sequence effect of conjugate cleavage. Is the camptothecin polyamide conjugate 
sequence preference dictated only by the camptothecin unit? What would happen to 
regions where strong camptothecin Topo I sites occur without polyamide match sites 
nearby? To test this hypothesis a fragment of pUC 19 was examined using a conjugate 
with a large 16 base pair binding site. The region of pUC 19 examined has strong 
camptothecin sites but no binding site for the conjugate nearby. Even under micromolar 
concentrations no cleavage sites were observed, demonstrating the necessity of a 
polyamide site to create cleavage (Figure 7.8). Alternatively a region of the cancer related 
gene HER2 coding region was examined to ask the necessity of the camptothecin Topo I 
site adjacent to the polyamide site. Would it be sufficient to just have a polyamide 
binding site for the conjugate to trap Topo I and create cleavage? The experiment shows 
that the sequence composition of the flanking sequences has a strong effect to the 
cleavage yields and it is possible to observe conjugate cleavage at sites that are not strong 
Topo I sites (Figure 7.9). The two experiments show that neither the polyamide alone nor 
the camptothecin alone dictates the cleavage of the conjugate. To achieve maximum 
cleavage it is ideal to have both an optimal polyamide binding site and an optimal Topo I 























'"' ,,", '" ::: 
"'" + 
3 
~} '" ::J c:.;::; .S 
3 ::; 
(J 
" + 2 
0 V 















Pm1ial mOdit.lcation of (j re~idue:, 
















Me j rclca:-.c of modified G rcsiduc!-. 
and h}Jroly~i,> of sugar phosphate 





"p 3' CAATCATAACGGTTCACGGCCAAACCTGTCGGTTCACS 
cleavage bCl\vcen thL' third and fOlll1h 




1 \\ o[kul' and rei ease of DNA fragmeul 
t'·CAATCATAACGG-OH-5 ' 
1 addition of phosphalc hy '1'4 kinase 
"p Y·CAATCATAACGG-OPO--), 
Figure 7.7. (A) Mapping of Topo I cleavage reaction. Lane 1, A + G reactions; lane 2, 10 nM or 
conjugate 3 with Topo I; lane 3, 10 nM or conjugate 3 with Topo I followed hy reaction with T4 
polynucleotide kinase; lane 4, A + G reactions. (B) Schematic of Maxam Gilhert G reaction. eC) 
Schematic or Topo I cleavage reaction. 
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Figure 7.8. (A) Topo I experiment with conjugate 7 on region of pUC 19 containing no polyamide match 
site next to strong Topo I cleavage site. Lane I, Intact; lane 2, A reaction; lane 3, G reaction; lane 4, Topo I; 
lane 5, 4 flM camptothecin 6 with Topo I; lane 6, 400 nM camptothecin 6 with Topo I; lane 7, 4 flM of 
conjugate 7 with Topo I; lane 8,400 nM of conjugate 7 with Topo 1. (B) Illustration of the restriction 












































































































































































































































































































































































































































Figure 7.9. (A) Tapa I experiment with conjugate 8 with pHERI containing conjugate match site flanked 
by different DNA sequences. The DNA restriction fragment is pieced together from different sections of 
the coding region of HER 2 containing polyamide match sites. Lane I, Intact; lane 2 A reaction; lane 3, G 
reaction; lane 4, Topo I; lane 5, I 11M camptothecin 6 with Topo I; lane 6, \00 nM of conjugate 8 with 
Topo I; lane 7, 10 nM of conjugate 8 with Topo I. (B) Illustration of conjugate 8Imlmpypy-{pl-
ImPyPyPy-P-Dp. (C) Illustration of the restriction fragment. Cleavage position is illustrated by straight line 



































































































































































































































































































































































































































































Binding site size of camptothecin conjugate with Topo I. MPE-Fe(II) 
footprinting experiment carried out with camptothecin conjugate 3 and Topo I shows that 
the entire complex covers the 14 base pair site 5'-CACTTI\GGCAATACT -3' (that is 
positions -5 to +9 with 0 being the position of the cleavage)(Figure 7.10, 7.11). X-ray 
structure of Topoisomerase I complex with DNA have been solved and the enzyme 
covers positions from -5 to +6 (Figure 7.12, 7.13). MPE shows conjugate 3 binds its six 
base pair site from +4 to +9. The footprint of the complex matches the sum of the 
footprint of the conjugate and footprint of Topo I seen in its crystal structure. 
Implication for the design of Topo I hairpin polyamide conjugates. The 
results presented here reveal that polyamide-camptothecin conjugates can recruit Topo I 
to cleave single DNA sites in high yield. The difference in cleavage yields in conjugates 
1-3 demonstrates the importance of linker length for conjugate activity. This sets the 
stage for the next step which is to test whether conjugates targeted to the coding region of 
specific genes can regulate transcription elongation which will be reported in due course. 
Experimental Section 
Materials. Fmoc-6-aminocaproic acid was purchased from Bachem, Fmoc-12-
aminododecanoic acid was purchased from Aldrich and Boc 17 -amino-4, 7,10,13-
tetraoxa-heptadecanoic acid was a generous gift of Dr. Anna Mapp.2 I 10-
Hydroxycamptothecin was purchased from JS International. DNA restriction fragment 
labeling protocols, DNase I footprinting, determination of equilibrium association 
constants, plasmid construction and quantitation by storage phosphor autoradiography 
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Figure 7.10. MPEoFe(II) footprinting of conjugate 3 with Topo I, conjugate 3 alone, and polyamide 4 
alone. 
1/4 
conjugate 3 + Topoisomerase I 
. ..1111111 II II 
PS'-AACTGCCGGTTAGTATTGCCAAGTGCCGGTTTGGA-3' 
3'-TTCACGGCCAATCATAACGGTTCACGGCCAAACCT-S' 








Figure 7.11. Results of MPEoFe(II) footprinting experiments. Bar heights are proportional to the extent of 
cleavage protection at the indicated base. 
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Figure 7.12. The structure of human Topo I in complex with DNA. The protein completely wraps around 
the DNA oligonucleotide contacting 4 base pair upstream and 6 base pair downstream of the cleavage site. 
Figure obtained from reference 6. 
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Figure 7.13. Schematic representation of the protein DNA interaction in the covalent complex of Topo I 
with DNA. Interactions between protein side chain and main chain atoms with DNA phosphate groups and 
minor groove atoms closer than 3.5 A are indicated. Figure obtained from reference 6. 
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Preparation of Conjugates 1-3. ImPyPyPy-(RtH2y-PyPyPyPy-p-Pam-Resin 
was synthesized in a stepwise fashion by solid phase methods according to established 
protocols. 19 Fmoc-6-aminocaproic acid (25.5 mg, 75 ,umol) and HBTU (28 mg, 75,,umol) 
were added in 2 ml of DMF and 1 ml DIEA and shaken for 1 hour. The Fmoc group was 
deprotected with piperidine and the polyamide was cleaved off the resin with neat 
dimethylaminopropylamine in 16 hours. A solution of camptothecin acid 6 (3.1 mg, 7.5 
flmol), N-hydroxysuccinimide (0.85 mg, 7.5 flmol), dicyclohexylcarbodiimide (16.7 mg, 
81 flmol) in DMF (600 fll) was allowed to stir at room temperature for 2 hours. 
ImPyPyPy_fA5NH2_PyPyPyPy_P_Dp (3.3 mg, 2.5 flmol) and diisopropylethylamine (50 
fll) in DMF (650 fll) was added and allowed to stir at room temperature for 9 hours. The 
reaction was diluted with 0.1 % trifluoroacetic acid in H20 (6 ml) and purified by 
preparatory reverse phase HPLC. Lyophilization of the pure fractions afforded conjugate 
1. For the synthesis of conjugate 2, Fmoc-6-aminocaproic acid was replaced with Fmoc-
12-aminododecanoic acid. For the synthesis of conjugate 3, Fmoc-6-aminocaproic acid 
was replaced with Boc 17-amino-4,7, 10, 13-tetraoxa-heptadecanoic acid. Yields and 
characterization: conjugate 1: 0.4 mg, 10% recovery, MALDI-TOF [M+H] 
(monoisotopic), calcd 1753.90, obsd 1753; conjugate 2: 0.5 mg, 13% recovery, MALDI-
TOF [M+H] (monoisotopic), calcd 1838.06, obsd 1838.09; conjugate 3: 1.6 mg, 24% 
recovery, MALDI-TOF [M+H] (monoisotopic), calcd 1916.08, obsd 1915.94. 
ImPy-p-ImPy-p-ImPy-p-PyPy-P-C7-TA-Cpt (7). ImPy-p-ImPy-p-ImPy-p-pyPy-
p-C7-Pam resin was synthesized in a stepwise fashion by Boc-chemistry manual solid 
phase protocols starting with a Boc-aminocaprylic acid monomer. A sample of resin was 
treated with neat 3,3'-diamino-N-methyldipropylamine (triamine-TA) (2 ml), heated 
(55°C, 24 hours) and purified by reversed phase HPLC. ImPy-p-ImPy-p-ImPy-p-pyPy-p-
C7 -TAwas recovered as a white powder upon lyophilization of the appropriate fraction. 
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A solution of camptothecin acid 6 (3.1 mg, 7.5 !lmol), N-hydroxysuccinimide (0.85 mg, 
7.5 !lmol), dicyclohexylcarbodiimide (16.7 mg, 81 !lmol) in DMF (600 Ill) was allowed 
to stir at room temperature for 2 hours. ImPy-p-ImPy-p-ImPy-p-PyPy-P-C7-TA (4.6 mg, 
3.0 !lmol) and diisopropylethylamine (50 !l1) in DMF (650 Ill) was added and allowed to 
stir at room temperature for 9 hours. The reaction was diluted with 0.1 % trifluoroacetic 
acid in H20 (6 ml) and purified by preparatory reverse phase HPLC. Lyophilization of 
the pure fractions afforded conjugate 7. 2.5 mg, 43% recovery, MALDI-TOF-MS [M+H] 
(monoisotopic), calcd 1939.88 obsd 1940.0. 
Preparation of Conjugates 8. ImlmPyPy-(R)NH2y-ImPyPyPy-p-Pam-Resin was 
synthesized in a stepwise fashion by solid phase methods according to established 
protocols. J9 Disuccinimidyl glutarate (100 mg, 306 ,umoles) in 2 ml of DMF and 1 ml 
DIEA was added to the polyamide still on the resin and shaken for 1 hour followed by the 
addition of 4,9-dioxa-l,12-dodecanediamine (81 mg, 400 ,umoles) and stirring for 5 
hours. The polyamide was cleaved off the resin with neat dimethylaminopropylamine in 
16 hours. A solution of camptothecin acid 6 (3.4 mg, 8.2 !lmo1), N-hydroxysuccinimide 
(0.95 mg, 8.2 !lmol), dicyclohexylcarbodiimide (18.7 mg, 91 !lmol) in DMF (400 Ill) was 
allowed to stir at room temperature for 2 hours. ImlmPyPy-'fH2-ImPyPyPy-P-Dp (4.7 
mg, 2.7 !lmol) and diisopropylethylamine (130 Ill) in DMF (200 Ill) was added and 
allowed to stir at room temperature for 17 hours. The reaction was diluted with 0.1 % 
trifluoroacetic acid in H20 (6 ml) and purified by preparatory reverse phase HPLC. 
Lyophilization of the pure fractions afforded conjugate 8. Yields and characterization: 
conjugate 8: 0.5 mg, 9% recovery, MALDI-TOF [M+H] (monoisotopic), calcd 1942.88, 
obsd 1942.91. 
Topoisomerase I cleavage experiment. Reaction mixtures (10 !ll each) 
containing 50 mM Tris-HCl (pH 7.2),50 mM KC1, 10 mM MgC1 2 , 0.5 mM DTT, 0.1 
mM EDTA, 15 !lg/ml BSA, 10 kcpm 3,- 32P-labeled 115 base pair pCWI EcoRII Afill 
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restriction fragment, were incubated with each polyamide-camptothecin conjugate 1-3 for 
12 hours at 22°C. The Topoisomerase I reaction was initiated by the addition of 10 U of 
calf thymus Topo I followed by incubation at 3TC for 1 hour. The reaction was 
quenched by adding 10% SDS (1 f.11) and proteinase K (1.5 mg/mL, 1.2 f.11), followed by 
incubation at 50°C for 30 min. The reaction mixtures were ethanol precipitated and 
resuspended in 100 mM Tris-borate-EDTA/80% foramide loading buffer, denatured at 
8YC for 10 min, placed on ice, and immediately loaded onto an 8YC denaturing 
polyacrylamide gel (5% cross-link, 7 M urea) at 2000 V for 1.5 hours. The gels were 
dried under vacuum at 80°C and then quantitated using storage phosphor technology. 
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Chapter 8 
Application of Camptothecin Polyamide Conjugates to Study 
DNA Repair and Recombination 
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Abstract 
Pyrrole-Imidazole (Py-Im) polyamides are cell permeable ligands that can be 
targeted to any predetermined DNA sequence. Polyamide camptothecin conjugates are 
capable of cleaving DNA in high yields at TAG sites proximal to the polyamide binding 
site by trapping the endogenous enzyme Topo I. Because of the generality of the pairing 
rules, and polyamides demonstrated utility in in vivo systems, these conjugates may be 
useful for studying the effects of this class of DNA binding ligands on homologous 
recombination and DNA repair. Described are the design and synthesis of camptothecin 
polyamide conjugates that cleave DNA at a determined site on a specific gene. 
Currently, these compounds are being studied in vivo in hopes that DNA cleavage will 
stimulate a DNA repair event and homologous recombination. If successful, these 
studies could have future applications in the areas of gene therapy. 
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Introduction 
Pyrrole imidazole polyamides that can target specific sequences of DNA and bind 
with high affinity have been shown in vitro and in vivo to inhibit or activate transcription 
by competing with the binding of required transcription factors.' By attaching activator 
peptides, ImlPy polyamides are capable of recruiting the transcription machinery in 
vitro. 2 The question arises whether polyarnides could be used to study gene repair. 
To study DNA repair and recombination, we proposed using Py-Im polyamides to 
create sequence specific damages to the DNA. The use of polyamide conjugates allows 
us to control the location of the damage inflicted in order to stimulate repair and 
recombination to the particular gene in study. In collaboration with Dr. Matt Porteus of 
the Baltimore group at Caltech, experiments were designed to use camptothecin 
polyamide conjugates to trap Topoisomerase I and create sequence specific damages to 
the DNA.3 In addition to using camptothecin, seco-CBI (Dr. Aileen Chang of the Dervan 
group) and nitrogen mustards (Mr. Nicholas Wurtz of the Dervan group) are also 
currently being studied. Described here are the efforts in using camptothecin polyamide 
conjugates for these experiments. 
Experimental Design 
The experimental design was based on observations in the Baltimore group using 
Green Fluorescent Protein (GFP). When a mutant GFP gene with an internal stop codon 
is expressed, functional GFP is not detected (Figure 8.1 a). When substrate DNA is added 
containing the wild type gene, homologous recombination occurs such that functional 
GFP can be detected for 1 in every 106 cells (Figure 8.1 b). If instead of the internal stop 
codon, a site for a rare-cutting restriction enzyme is inserted4, a double strand break can 
be generated. For the case of homologous recombination with the substrate for the 
double strand break, functional GFP can be detected for 1 in every 500 cells (Figure 
8.1 c). Thus these experiments were designed to address the question of 
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whether or not polyamides could be used to incorporate a DNA strand break, and if so 
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Figure 8.1. Experimental design for proposed polyamide conjugates. See text for further details. 
High affinity, high specificity, and large binding site Size are criteria for the 
selection of the polyamide portion of the conjugate. A large binding site would decrease 
the number of match site for the conjugate in the genome. The eight ring polyamide 
ImPy-~-ImPy-~-ImPy-~-PyPy-~-Dp capable of binding 16 contiguous base pairs 5'-
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ATAAGCAGCTGCTTTT-3' as a homodimer was chosen for the polyamide portion of 
conjugate 1.5 ImPy-p-ImPy-P-ImPy-P-PyPy-P-Dp binds its match site with an affinity of 
3.5 X 1010 M- I and a ten-fold specificity toward mismatches. A tandem hairpin conjugate 
ImPyPy-(R)[ImPyPy-(R)H2Ny-PyPyPy8]HNy-PyPyPy-P-Dp binding the 11 base paIr 
sequence 5 '-TGTTATTGTTA-3 , with an affinity of greater than 1.0 x 1012 M- I was 
chosen for the polyamide portion of conjugate 2.6 ImPyPy-(R)[ImPyPy-(R)H2Ny-
PyPyPy8tNy-PyPyPy-P-Dp binds its match site with greater than 4500-fold specificity 
over double mismatches. Both parent compounds were chosen because they match the 
criteria chosen for this study. Tandem conjugate 2 by itself will cause a single strand 
break but it is known that the single strand break will be transformed into a double strand 
break by both the replication and transcription machinery. The insert containing the 
binding site of the polyamide for each construct (homodimer and tandem) was inserted in 
the middle of the GFP gene (Figure 8.3). The sequence of the binding sites in the insert is 
identical to published result with the exception that known camptothecin polyamide sites 
are inserted next to the polyamide site. The insert includes a stop codon so that cells that 
do not undergo recombination will not express functional GFP. In the event of a double 
strand break, repair processes could correct the mutation, which would then be detectable 
by fluorescence. 
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Figure 8.2. Structures of the polyamide conjugates used for this study. 
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Figure 8.3. DNA constructs of homodimer and tandem inserts for GFP experiments. 
Results 
Synthesis of camptothecin polyamide conjugate 
The parent unmodified polyamides 1 and 2 were synthesized on solid support as 
previously reported. Polyamide 1 was cleaved from the resin with 3,3' -diamino-N-
methyldipropylamine (triamine, TA) and the conjugates were then synthesized by 
addition of the camptothecin acid activated with HOBt and Dec. Polyamide 2 was 
synthesized with (R)-2,4-diaminobutyric acid (DABA) in the turn position using Boc 
chemistry machines assisted protocol. A polyethylene linker was added to the amine of 
the turn and subsequent addition of activation of camptothecin acid yielded the desired 
camptothecin polyamide conjugate. Synthesis of conjugate 1 is shown in Figure 8.4. 
IAn 
Figure 8.4. Synthesis of polyamide camptothccin conjugate 1. 
Topoisomerase I cleavage assay 
Polyamide 1 was analyzed on a 221 base pair fragment of GFP containing the 
designed insert (Figure 8.Sa). The DNA fragments are S' 32p labeled by PCR for 
technical reasons. PCR labeling allows any section of the DNA fragment to be amplified 
and labeled without the need for restriction enzyme sites unlike labeling with 3' fill in. 
However, Topo I cleavage causes the Topo I enzyme to be physically associated with the 
S' labeled fragment. To degrade the Topo I enzyme, the fragments are treated with 
Proteinase K. Even with the protease treatment the exact location of the cleavage could 
only be estimated by comparison to the sequencing reaction. For both conjugates, the 
cleavage site is the same as the camptothecin control. Since the camptothecin cleavage 
site was artificially placed next to the polyamide binding site, the cleavage site should be 
the TAG site 3 to 4 base pairs removed from the designed binding site. At 10 nM 
concentrations, 1 cleaves this match site with a yield of 30% on the top strand (Figure 
8.6). On the bottom strand cleavage was seen at 60%. Polyamide 2 was assayed on a 21S 
base pair fragment containing the tandem polyamide match site (Figure 8.Sb). The 
tandem conjugate cleaves this match site with a yield of SO% (Figure 8.7). 
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Figure 8.S. GFP fragments used in this study. Insert with polyamide binding sites arc between the dashes, 
polyamide binding sites are in bold. (a) dimer construct, (b) tandem construct. 
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Figure 8.7. Topo I cleavage experiment with tandem conjugate 2. 
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Gene Correction Experiments 
Currently, Dr. Matt Porteus of the Baltimore group is working to set up these 
experiments to study the effects of Py-Im polyamides on homologous recombination. It 
is hoped that upon treatment with polyamide-camptothecin conjugates, cells that had 
undergone recombination or repair would be detected by expression of GFP. Preliminary 
results have shown that the polyamide-camptothecin conjugates are toxic to cells at 1 /-LM 
but not 100 nM while the camptothecin control is toxic to cells at 100 nM but not 10 nM. 
The difference in the toxicity of conjugate versus camptothecin could be due to decrease 
in cell permeability of the conjugate. Cell permeation of polyamides is currently not very 
well understood and studies are underway in the Dervan group including using nuclear 
localization sequences to traffic polyamides into the nucleus. Alternatively the difference 
in toxicity could be due to the sequence specificity of the conjugate. Maybe by being 
more selective in cleaving the DNA the conjugate is less toxic. Besides looking at 
toxicity difference, gene specific reduction in RNA synthesis was also tested. Preliminary 
experiments showed reduction in global levels RNA production but no gene specific 
reduction in RNA synthesis was observed. 
Conclusions 
The design of Py-Im polyamide conjugates with camptothecin incorporates the 
ability to target specific DNA sequences and traps Topo I onto the DNA in a sequence 
specific fashion. We believe that this class of molecules will provide powerful tools for 
studying and manipulating transcription in the cell. The results of the forthcoming in 
vivo experiments will shape the design of additional motifs for these classes of 




UV spectra were measured in water on a Hewlett-Packard Model 8452A diode array 
spectrophotometer. Matrix-assisted, laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF) was performed at the Protein and Peptide Microanalytical 
Facility at the California Institute of Technology. Preparatory reversed phase HPLC was 
performed on a Beckman HPLC with a Waters DeltaPak 25 x 100 mm, 300 A C 18 
column equipped with a guard, 0.1 % (wt/v) TFA, 0.25% acetonitrile/minutes. 
Synthesis camptothecin polyamide conjugates 
ImPy-~-ImPy-~-ImPy-~-PyPy-~-C7 -T A -Cpt (1). ImPy-~-ImPy-~-ImPy-~-PyPy-~-C7-
Pam resin was synthesized in a stepwise fashion by Boc-chemistry manual solid phase 
protocols starting with a Boc-aminocaprylic acid monomer. A sample of resin was 
treated with neat 3,3'-diamino-N-methyldipropylamine (triamine-TA) (2 ml), heated 
(55°C, 24 hours) and purified by reversed phase HPLC. ImPy-~-ImPy-~-ImPy-~-PyPy-~­
C7 -TAwas recovered as a white powder upon lyophilization of the appropriate fraction. 
A solution of camptothecin acid 4 (3.1 mg, 7.5 /lmol), N-hydroxysuccinimide (0.85 mg, 
7.5 /lmol), dicyclohexylcarbodiimide (16.7 mg, 81 /lmol) in DMF (600 /ll) was allowed 
to stir at room temperature for 2 hours. ImPy-~-ImPy-~-ImPy-~-PyPy-~-C7-TA (4.6 mg, 
3.0 /lmol) and diisopropylethylamine (50 /ll) in DMF (650 /ll) was added and allowed to 
stir at room temperature for 9 hours. The reaction was diluted with 0.1 % trifluoroacetic 
acid in H20 (6 ml) and purified by preparatory reverse phase HPLC. Lyophilization of 
the pure fractions afforded conjugate 1. 2.5 mg, 43% recovery, MALDI-TOF-MS [M+H] 
(monoisotopic), calcd 1939.88 obsd 1940.0. 
ImPyPy-(R)[ImPyPy-(R)Cpty-PyPyPyo]HNy-PyPyPy-~ -Dp ( 2 ) . ImP y P y-
(R)[ImPyPy(R)H2Ny-PyPyPyO]HNy-PyPyPy-~-Pam resin was synthesized in a stepwise 
fashion by Boc-chemistry machine assisted solid phase. A sample of resin was treated 
with neat (dimethylamino)-propylamine (2 ml), heated (55°C, 24 hours) and purified by 
reversed phase HPLC. ImPyPy-(R)[ImPyPy-(R)Cpty-PyPyPy8]HNy-PyPyPy-~-Dp was 
recovered as a white powder upon lyophilization of the appropriate fraction. A solution 
of camptothecin acid 4 (3.1 mg, 7.5 ~mol), N-hydroxysuccinimide (0.85 mg, 7.5 ~mol), 
dicyclohexylcarbodiimide (16.7 mg, 81 ~mol) in DMF (600 ~l) was allowed to stir at 
room temperature for 2 hours. ImPy-~-ImPy-~-ImPy-~-PyPy-~-C7-TA (3.3 mg, 2.5 
~mol) and diisopropylethylamine (50 ~l) in DMF (650 ~l) was added and allowed to stir 
at room temperature for 9 hours. The reaction was diluted with 0.1 % trifluoroacetic acid 
in H20 (6 ml) and purified by preparatory reverse phase HPLC. Lyophilization of the 
pure fractions afforded conjugate 2. (14.4 mg, 10.4 Ilmoles, 6.8% recovery). UV (H20) 
Amax (E), 312 nm, (104,250); MALDI-TOF-MS (monoisotopic) [M+H] 138l.70 
(calculated 1380.64 for C62HsoN26012)' 
DNA Reagents and Materials. Enzymes were purchased from Boehringer-Mannheim 
and used with their supplied buffers. Deoxyadenosine 5'_[y_32p] triphosphates were 
purchased from I.C.N. Sonicated, deproteinized calf thymus DNA was acquired from 
Pharmacia. RNase free water was obtained from USB and used for all reactions. All 
other reagents and materials were used as received. All DNA manipulations were 
performed according to standard protocols. 
Construction of Plasmid DNA. The plasmids GFP 1 and GFP2 were constructed by Dr. 
Matt Porteus. Concentration of the prepared plasmid was determined at 260 nm from the 
relationship of 1 OD unit=50 ~g mLl duplex DNA. 
PCR Labeling to generate 5'-End-Labeled Restriction Fragments. Two 21 mer 
primers were synthesized for PCR amplification: primer A (top)5'-AAG-CAG-CAC-
GAC-TTC-TTC-AAG-3' and primer B (bottom) 5'-CAG-GAT-GTT-GCC-GTC-CTC-
CTT-3'. To label the top strand, primer A was treated with T4 polynucleotide kinase and 
deoxyadenosine 5' _[y_32p] triphosphate as previously described. PCR reactions 
containing 60 pmol each primer, 10 ~l PCR buffer (Boehringer-Mannheim), 3.7 ~l 
1.17 
template (0.003 Ilg/mL), 2111 dNTP mix (each at 10 mM), 1 III 100X BSA (New England 
Biolabs) and 83 III water were heated at 70°C for 5 minutes. Four units of Taq 
Polymerase were added (Boehringer-Mannheim). Thirty amplification cycles were 
performed, each cycle consisting of the following segments: 94°C for 1 minute, 54°C for 
1 minute, and 72°C for 1.5 minutes. Following the last cycle, 10 minutes of extension at 
72°C completed the reaction. The PCR products were gel purified as previously reported 
for 3' -end labeling protocols. To label the bottom strand, primer B was labeled. 
Topoisomerase I cleavage experiment. Reaction mixtures (10 III each) containing 50 
mM Tris-HCl (pH 7.2),50 mM KC1, 10 mM MgC12 , 0.5 mM DTT, 0.1 mM EDTA, 15 
Ilg/ml BSA, 10 kcpm 5,-32P-labeled 115 bp pCWI EcoRU Afill restriction fragment, were 
incubated with each polyamide-camptothecin conjugate 1 and 2 for 4 hours. The 
Topoisomerase I reaction was initiated by the addition of 10 U of calf thymus Topo I 
followed by incubation at 3TC for 1 hour. The reaction was quenched by adding 10% 
SDS (1111) and proteinase K (1.5 mg/mL, 1.2 Ill), followed by incubation at 50°C for 30 
minutes. The reaction mixtures were ethanol precipitated and resuspended in 100 mM 
Tris-borate-EDTA/80% foramide loading buffer, denatured at 8YC for 10 minutes, 
placed on ice, and immediately loaded onto an 85°C denaturing polyacrylamide gel (5% 
cross-link, 7 M urea) at 2000 V for 1.5 hours. The gels were dried under vacuum at 80°C 
and then quantitated using storage phosphor technology. 
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